MALABAR CANCER CENTRE, THALASSERYmcc.kerala.gov.in/dept_CanReg/HBCR_AnnualReport2010.pdf · Malabar...

MALABAR CANCER CENTRE, THALASSERY

(an autonomous centre under Government of Kerala) [Partially supported by the National Cancer Registry Programme,

Indian Council of Medical Research]

ANNUAL REPORT FOR THE YEAR 2010

Published by Malabar Cancer Centre, Thalassery

Kerala, India– 670 103 January 2012

FOREWORD

Malabar Cancer Centre is the only comprehensive cancer centre under public sector in the

northern part of Kerala which caters to cancer patients from four states –Kerala, Tamil Nadu,

Karnataka, and Pondicherry. Though it was established in November 2001, we could set up

Hospital Based Cancer Registry only recently, thanks to enormous support from Ministry and

Department of Health and Family welfare, Government of Kerala, Indian Council of Medical

Research, Regional Cancer Centre and staff of tumor registry of MCC, especially Dr. Saina Sunil

Kumar and team. This is our first step towards establishing a population based cancer registry

which is essential to study the pattern of cancer incidence and prevalence in this part of the State.

Though the population based registry was set up in Regional Cancer Centre long back, it may not

represent the entire state for variation in dietary habits and other life style modifications.

We really feel proud to announce the arrival of Hospital Based Cancer Registry (HBCR) as it was a

dream to come true among the adverse factor of limited staff to support the programme. But the

team entrusted the task stood upto the challenge to bring out their opus. Hope the shortcomings

we had in establishing HBCR would be rectified by we progress to PBCR.

The data of HBCR is an eye opener for oncologists and epidemiologists of MCC to invest in the

epidemiological research to probe the cause behind high incidence of lung cancers. Similarly there

is apparent increase of young breast cancer patients that too warrants a detailed search for genetic

and environmental factors. We expect the data from HBCR will help our oncologists to evaluate the

treatment strategy and organize result oriented research to help the policy makers of the state to

develop an intervention strategy. We expect this report to be a good educational tool for those

keen on cancer epidemiological studies and data.

Once again I express my sincere gratitude both on my personal account and for the cancer

patients of the region to all those participated both directly and indirectly in establishing HBCR and

bringing out the annual report.

Director

MESSAGE

Malabar Cancer Centre expressed their interest to participate in the project on

Hospital Based Cancer Registry under National Cancer Registry Programme

(ICMR) during October 2010 and registered under the project during November

2010. After procuring the hardware required for the HBCR Data Management

Software, the registry has been supplied with the software during February 2011

along with specific login ID and password for the centre. With the dedicated staff

working under the able guidance of Dr. Satheesan Balasubramanium, the registry

has submitted the final data after corrections for the year 2010 of about 2254 cases

during November 2011.

The data submitted by the centre will be of importance as it will reveal the type and

quantum of cancer in the patients attending the centre and over the years it will

become an important input in formulating the cancer preventive programmes under

National Cancer Control Programmes. It will also give an idea of the picture of

cancer in the region and later on also in developing an Atlas of Cancer in Kerala.

Dr. A. Nandakumar MD, MPH (USA) Director-in-charge

National Centre For Disease Informatics And Research National Cancer Registry Programme

Indian Council of Medical Research, Bangalore - 562 110 Tel: 91 80 28467643; Fax: 91 80 28467644 E-mail: [email protected], [email protected]

PREFACE

Hospital based cancer registries (HBCR) provides an idea of the magnitude and

patterns of patient care in a given hospital.They help in planning the facilities

required in the respective hospital and help in evaluation of outcome of

treatment.

Malabar Cancer Centre – Cancer Registry was established in 2011 and the

present report provides a descriptive analysis of the cancer cases seen in MCC

for the year 2010. The reporting has followed the internationally systemized

methodologies and standards for cancer registries. The current reporting has

been consistent with National Cancer Registry Programme of Indian Council of

Medical Research. The report provides an insight into the complex issues

involved in cancer patient care in the Indian context. In bringing about an

assessment of the magnitude and care of cancer patients, the need for

systematic recording of clinical information is essential. This report will hopefully

serve as a guide to the treating oncologist to look into various aspects in cancer

patient management in our institution and country. Reports are planned for the

continuous reporting of not only the cancer cases seen but also of more

analytical work with regard to treatment methods, survival estimation and

prognostic factor studies. These are planned as supplements to periodically

prepared descriptive summary experience as in the present report.

Dr Saina Sunil Kumar Head of the Department – In- charge Dept. of Cancer Registry

ACKNOWLEDGEMENT

The Hospital Based Cancer Registry of Malabar Cancer Centre, Thalassery expresses

its sincere thanks and gratitude to the following Institutions/ Departments/ individuals

for supporting and promoting the activities of the Registry.

1. Dr. Satheesan B, Director, MCC

2. National Cancer Registry Programme, Indian Council of Medical Research, Bangalore

3. HOD and staff of Cancer Registry, Regional Cancer Centre, Thiruvananthapuram

4. Department of Pathology, MCC, Thalassery

5. Shri. Padmakumar C.S., Administrative Officer (Clinical Services), MCC, Thalassery

6. Medical Records Division, MCC, Thalassery

7. Mrs. Bhavina C, Junior System Analyst, MCC, Thalassery

8. Mrs. Seena K, PA to the Director, MCC, Thalassery

9. Mrs. Jisha, Counsellor, Kerala Social Security Mission

CONTENTS

Sl No Title Page No.

I 1. INTRODUCTION .............................................................................. 1-14 Malabar Cancer Centre .................................................................... 1-3 Academic Departments and Faculty ................................................ 4-5 Clinical and Ancillary Departments ................................................... 6-11 National Cancer Registry Programme ............................................. 12 Hospital Based Cancer Registry ...................................................... 13 2 Summary of Results ......................................................................... 14 3 Functioning of HBCR ........................................................................ 15 4 Magnitude of Total Cancers ............................................................. 16 5 Tobacco Related Cancers ............................................................... 16-20 6 Leading Sites of Cancer ................................................................... 21-22 II STATISTICS .............................................................................................. 23-108 1 Five year age groups distribution -Male .......................................... 24-25 2 Five year age groups distribution –Female ...................................... 26-27 3 Broad treatment groups distribution –Male ....................................... 28-29 4 Broad treatment groups distribution -Female ................................... 30-31 5 Distribution of clinical extent of disease -Male/Female ..................... 32-51 6 Distribution of detailed microscopic diagnosis – Male ...................... 52-53 7 Distribution of detailed microscopic diagnosis – Female .................. 54-55 8 Educational status of patients – Male ............................................... 56-57 9 Educational status of patients – Female ........................................... 58-59 10 Intention to treat at reporting institution -Male ................................ 60-61 11 Intention to treat at reporting institution – Female ........................... 62-63 12 Marital status of patients – Male ....................................................... 64-65 13 Marital status of patients – Female ................................................... 66-67 14 Method of diagnosis – Male .............................................................. 68-69 15 Method of diagnosis – Female ......................................................... 70-71 16 Mother tongue of patients – Male .................................................... 72-73 17 Mother tongue of patients – Female ................................................. 74-75 18 Religion of patients – Male ............................................................... 76-77 19 Religion of patients – Female ........................................................... 78-79 20 Treatment status at RI – Male .......................................................... 80-81 21 Treatment status at RI – Female ...................................................... 82-83 22 Type of treatment - Male/Female ..................................................... 84-99

23 Any specific treatment -Male/Female ............................................... 100-107 24 Distribution of all cases by language spoken – Male/Female ........... 108 III SUMMARY OF STATISTICS .................................................................... 109-119 1 Any specific treatment ...................................................................... 110 2 Broad age groups ............................................................................. 111 3 Broad group of treatment at RI ......................................................... 112 4 Clinical extent of diseases at RI ....................................................... 113 5 Education status ............................................................................... 114 6 Marital status .................................................................................... 114 7 Different types of microscopic diagnosis ......................................... 115 8 Different methods of diagnosis ......................................................... 116 9 Religion ............................................................................................. 117 10 Any specific treatment according to clinical extent ........................... 118 11 Type of treatment only at RI ............................................................. 119 IV SUMMARY OF ALL CANCERS DEMOGRAPHIC DIAGNOSTIC

& CLINICAL DETAILS .............................................................................. 120-132 V LEADING CANCERS- DETAILED INFORMATION ................................. 133-202 1 Breast Cancer ................................................................................... 134-140 2 Lung Cancer ..................................................................................... 141-147 3 Oral Cancer ...................................................................................... 148-154 4 Cervical Cancer ................................................................................ 155-160 5 Stomach Cancer ............................................................................... 161-167 6 Oesophageal Cancer ........................................................................ 168-174 7 Rectal Cancer ................................................................................... 175-181 8 Tongue Cancer ................................................................................. 182-188 9 Ovarian Cancer ................................................................................ 189-195 10 Laryngeal Cancer ............................................................................. 196-202 VI MULTIPLE CANCERS .............................................................................. 203-204 VII NON MALIGNANT TUMORS .................................................................... 205-207 VIII ABBREVIATIONS .................................................................................. 208 IX REFERENCES .......................................................................................... 209

Malabar Cancer Centre HBCR 2010

1

INTRODUCTION

MCC- A Comprehensive Cancer Centre in Northern Kerala

Malabar Cancer Centre is an autonomous institution under Health and Family Welfare Department; Government of Kerala, registered under Societies Registration Act XXI of 1860, and was started its clinical activities from March 2001 onwards with an aim to establish a hospital, providing the much-required oncology care to the population of North Kerala. The main objective being establishing a modern Cancer Hospital and Research and Training Centre of international standard in treatment and prevention of cancer. It is also the only comprehensive centre for cancer prevention, control, treatment and research in the northern region of Kerala. The control and management of the Society are vested in the Governing Body consisting of 23 members with the Hon’ble Chief Minister of Kerala as the Chairman, Hon’ble Minister for Health as Vice Chairman and Hon’ble Minister for Power as Alternate Vice-Chairman. The routine activities and functions of the Centre are supervised by the Executive Committee, consisting of 8 members, with the Secretary, Department of Health and Family Welfare, Government of Kerala, being the Chairman of the Committee. The members in the Governing Body and Executive Committee are functioning by virtue of their official positions.


2

ORGANISATION GOVERNING BODY

The Governing Body of the Society consists of 23 members.

1. Chief Minister of Kerala Chairman

2. Minister for Health & Family Welfare, Kerala Vice-Chairman

3. Minister for Electricity, Kerala Alternate Vice Chairman

4. Secretary, Department of Finance, Kerala Member

5. Secretary, Department of Power, Kerala Member

6. District Medical Officer, Kannur Member

7. Secretary ,Department of Health and Family Welfare Member & convener

8. An eminent Medical Scientist Member

9. Secretary, Department of Science, Technology & Environment Member

10. One nominee of the Ministry of Health, Government of India Member

11. Principal, Medical College, Kozhikode Member

12. Secretary- Planning & Economic Affairs Department, Kerala Member

13. Director- Rajiv Gandhi Centre for Bio technology, Trivandrum Member

14. Director of Medical Education, Trivandrum Member

15. Director, Malabar Cancer Centre, Thalassery Member & Secretary to Governing Body

16. M.L.A. of the Thalassery constituency Member

17. President, District Panchayat, Kannur District Member

18. Chairman, Thalassery Municipality, Thalassery Member

19. A public man from North Malabar region(to be nominated by Government of Kerala)

Member

20. One Head of the department nominated from Malabar Cancer centre, Thalassery by the Government

Member

21. One nominee of the Charitable Society established for rehabilitation and financial assistance for poor cancer patients

Member

22. Principal/Chief Executive Officer of Medical College, Pariyaram Member

23. Director, Regional Cancer Centre, Trivandrum Member


3

EXECUTIVE COMMITTEE

The Executive Committee shall be composed of:

1

Secretary, Department of Health & FW, Government of Kerala

Chairman

2 Secretary, Department of Power, Government of Kerala Member

3 Secretary, Department of Finance, Government of Kerala Member

4 Chairman- Thalassery Municipality Member

5 A public man from North Malabar to be nominated by Government of Kerala

Member

6 Secretary, Department of Planning, Government of Kerala Member

7 Director, Regional Cancer Centre, Trivandrum Member

8 Director, Malabar Cancer Centre, Thalassery Member/Convener


4

ACADEMIC DEPARTMENTS AND FACULTY

Surgical Oncology:

Dr. Satheesan Balasubramanian, MS, DNB, M.Ch Professor & Head (Oncosurgery).

Dr.Surij Salih, MS, M.Ch (Head & Neck Onco-Surgery)

Associate Professor

Dr.Sajith Babu,MS Fellow in Head & Neck surgery(RCC)

Associate Professor

Dr.Shyam Vikram, DNB Assistant Professor

Dr.Santhosh Kuriakose, MS, Fellow in Gynaecologic oncology(AIMS)

Assistant Professor

Dr. Nizamudheen MS Lecturer

Fellows In Head And Neck Oncology 2011-2012 Dr. Anju Elizebath Mathai ,MS ENT Dr. Dinesh Kumar K.B. MDS

Fellows In Gynec Oncology 2011-2012 Dr. Nizamudheen M.P. MS

Radiation Oncology

Dr.Milind Kumar M.B.B.S, M.D Associate Professor & Head Radiotherapy

Dr. Geetha M M.B.B.S, D.M.R.T,M.D Assistant Professor (Radiotherapy)

Dr Sameer E.P M.B.B.S, D.M. R. T, Lecturer

Dr Greeshma M.B.B.S, D.M. R. T, Lecturer

Department of Hematology/Medical Oncology

Dr. Chandran K Nair MBBS, MD, DNB, DM (Fellowship in Bone Marrow/Stem Cell Transplantation)

Haematologist


5

Cancer Palliative Medicine

Dr. M.S Biji, MBBS, PGDPPM Assistant Professor

Department of Transfusion Medicine

Dr. Neethu A.P MBBS Lecturer

Department of Dental Rehabilitation

Dr. Phinse Philip BDS Lecturer

Department of Community Oncology

Dr. Neethu A.P, MBBS Lecturer

Dr. Phinse, BDS Lecturer

Department of Cancer Registry

Dr. Saina Sunilkumar, MBBS Dr. B Binukumar, PhD

Lecturer Lecturer

Department of Onco-Pathology and Medical Laboratory Services

Dr. Sangeetha, MBBS, MD Dr. Sithara,MBBS, MD Dr. Aswathi Krishnan, MD Dr. Sreejesh MD

Professor and HOD Assistant professor Assistant professor Assistant professor

Department of Molecular oncology :

Dr. Geo Francis, PhD Lecturer


6

CLINICAL AND ANCILLARY DEPARTMENTS

DEPARTMENT OF RADIATION ONCOLOGY AND MEDICAL PHYSICS

Malabar Cancer Centre (MCC) started radiation treatment of cancer patients with the commissioning of a Telecobalt therapy machine and CMS XiO Treatment Planning System in 2005. This was followed by commissioning of a HDR Brachytherapy system with all accessories, a digital radiotherapy simulator and helical CT unit with Radiotherapy Simulation facility in the year 2007. The Centre recently has installed the High end Linear Accelerator (Rapid arc ix) and this unit has started functioning. It can offer all modern modalities of radiation treatment like intensity modulated radiotherapy, image guided radiotherapy, stereotactic radiotherapy and volumetric modulated arc therapy (Rapid Arc) etc. As the statistics indicate need for second Linear Accelerator is imminent and same is likely to be installed sooner. Head and Neck, Breast and Cervical Cancers form the major group of patients receiving radio therapy. DEPARTMENT OF SURGICAL ONCOLOGY MCC have two major operation theatres fully equipped for performing all types of cancer surgeries. The Surgical Oncology Division in MCC is equipped with state of art equipments. Limb salvage surgeries with custom made megaprosthesis, orthotopic neobladders after radical cystectomy with extended lymphadenectomy, exenterative surgeries, radical gastrectomy with extended lymphadenectomy and radical esophagectomy with lymphadenectomy are some of the major procedures performed in the division. Laparoscopic oncology has also put its foothold in the form of laparoscopic anterior resections and abdomino-perineal resections. Oncoplastic surgeries for breast cancer and vascular resections for soft tissue sarcomas are also being performed. Microvascular free flap reconstructive surgeries are routinely performed for head and neck resections. Extensive resections for ovarian cancers attract gynaecologists of nearby centres for training in the Centre. The endoscopy division has the facilities to perform both diagnostic and therapeutic procedures. A well equipped high dependency post-operative care unit supports the surgical division. DEPARTMENT OF ONCO-ANESTHESIOLOGY This Department is in charge of postoperative intensive care unit and central line insertions for chemotherapy patients. Apart from patient care, regular training programs for nurses are conducted in intensive care, basic life support and central line management. This Department has two states of art anesthesia workstations and two ventilators. Five bedded postoperative intensive care unit is equipped with state of art equipments to deliver drugs and monitor the patients.


7

DEPARTMENT OF MEDICAL ONCOLOGY & CLINICAL HAEMETOLOGY This department is supported partly by department of Radiation oncology for solid tumors. Haemato-oncology OP clinic is conducted on all week days. Benign hematological disorders are also treated at MCC. The department has a dedicated intensive care unit. It is in the process of establishing a state of art Stem cell transplantation and Cord blood bank unit shortly. Chemotherapy for all solid tumors is administered in this Division. Pediatric Oncology as a subdivision is in its infancy and a separate Pediatric Oncology Block is being planned. In near future, Medical Oncology Division is expected to grow to the fullest potential. DEPARTMENT OF IMAGEOLOGY: This department is equipped with the following equipments for imaging and diagnosis.

X-ray, Mammography & Ultrasound

GE DX 525 X-Ray Unit was commissioned in 2005 along with Automatic Film Processing Unit. A GE Genius Portable X-Ray machine is also available in the Department.

Equipped with one GE Sonograph Mammography Unit.

Three Ultrasound Scanners available in the Department (One GE LOGIQ 200 Ultrasound Machine and One Portable Ultrasound Scanner MUS 602) A new Color Doppler Ultrasound Scanner (Hitachi EUB) installed on 30/09/2010.

CT Scanner The GE Light speed Multi slice CT scanner with GE Advantage Sim Virtual simulation workstations was commissioned in 2007. DEPARTMENT OF CLINICAL LABORATORY SERVICES The Department of Clinical Laboratory services is committed to provide the best possible support in the diagnosis and management of cancer patients being treated in Malabar Cancer Centre. The laboratory has Biochemistry, Haematology and Cytopathology and histopathology facilities. The department is equipped with a fully automated Biochemistry analyser, Arterial blood gas analyser and automated Haematology analyser (Beckmann Coulter) which provide quick and accurate results. The quality control of the tests is done regularly. Internal quality control is checked daily with the automated biochemistry analyser and hematology machine. External quality is done from Department of Clinical Biochemistry, Christian Medical College under the ACBI/CMC External Quality Assurance Scheme (EQAS).


8

DEPARTMENT OF ONCO-PATHOLOGY This department is recently established and this is the pivot of the clinical services of MCC. All biopsies, cytology specimens and minor and major surgical specimen are examined and reported. It will soon start immune-histochemistry studies. The department will be upgraded with state of art equipments. DEPARTMENT OF TRANSFUSION MEDICINE Blood Bank of Malabar Cancer Centre has been functioning since 2002 and at present is a full-fledged one with state of art equipments. Component separation was started in 2006. In addition to routine activities of blood bank we have also been conducting regular blood donation and blood grouping camps. We are also supplying blood components to all hospitals around Thalassery. Activities in blood bank and the details of voluntary blood donation and grouping camps conducted. DEPARTMENT OF CANCER PALLIATIVE MEDICINE Cancer Palliative Medicine has been functioning here since November 2002.The Centre is a recognized medical institution for possession and supply of Oral Morphine. The Palliative Care Services also provide counseling to patients and their family members. Cancer palliative medicine aims at improving the quality of life of cancer patients especially those for whom curative options have been exhausted. Cancer palliative medicine has an inpatient, outpatient and home care facility. Homecare facility for the needy patients was started on June 20, 2009. It caters the need of patients staying around 35 kms from MCC. There are so far 78 patients registered in homecare facility. Patients are given medication free of cost. Department also conducts regular training programmes and courses for doctors, nurses and volunteers. DEPARTMENT OF COMMUNITY ONCOLOGY Community Oncology department has been regularly organizing early cancer detection camps, awareness classes, exhibition for cancer awareness among public. In addition the department also conducts tobacco awareness campaign among school students and general public. It has a few epidemiological research projects and they have started a comprehensive cancer detection and life style disease prevention programme with Kannur District Panchayath. Regular cancer detection camps and awareness classes are conducted in Kannur, Kasargod, Wayanad, Calicut and Malapuram Districts in Kerala. DEPARTMENT OF DENTAL REHABILIATION AND CARE The dental division of MCC started functioning on 1-6-2009 onwards with the objective of providing necessary Dental treatment for our patients in the centre itself at an affordable cost. This division provides a variety of treatment modalities for the oral health and radiation protection of teeth of cancer patients. These included procedures like oral biopsies, oral prophylaxis, conservative therapy, dental extractions, occlusal adjustments, therapeutic management of pre-cancerous oral lesions, pre and post-radiation care of management of ulcers, spontaneous bleeding, toothache, trismus etc.


9

DEPARTMENT OF CANCER REGISTRY Cancer Registry was established in the year 2011 partially supported by National Cancer Registry Programme (ICMR), Bangalore. This is the first annual report of Hospital Based Cancer Registry of 2010 that is published. DEPARTMENT OF ONCO-NURSING Along with the development in the Hospital the Nursing Division also achieved several mile stones during the last 11 years. Major activities during this period are follows: The Radiotherapy unit was expanded with Brachy therapy, ICR / 1CA – CT scan with contrast with the personnel support of trained Nursing Staff. Training was provided to staff in day care and in patient Chemotherapy, for assisting all oncological surgical procedures. Staff nurses actively participate in the academic activities, Early Cancer Detection Camps, Blood Donation Camps and all outreach programmes of the Centre. They conduct regular Health Education Programs for patient and their bystanders. Continuing Nursing Education Programs (CNE) are also conducting every 6 months for updating the recent trends in the field of nursing care. In order to update and upgrade the knowledge nursing staff, they are regularly sent for Training Programmes conducted by various hospitals. They also co-ordinate Oncology Nursing course for Nurses, Nursing Assistant course etc. CLINICAL ADMINISTRATION & PUBLIC RELATIONS Public Relations and Clinical Services Management includes, front office management, Public Relations Activities, Medical Records Management and Patients Accounting and Billing. This Department deals with all social activities and public relations including receiving and guiding patients and other visitors, new Patients Registration according to their Socio Economic Background, case file arrangement and issue of Identity cards, issue of all investigatory reports, all cash transactions of patients, patients and relatives guidance and counseling, issue of various certificates to patients, guidance and issue of certificates for financial aid from both government and private agencies, death register maintenance and periodical reporting to concerned authority, all types of correspondence related to patients, treatment expenditure reimbursement procedures for various agencies, guidance and assistance to various trainees coming here for training, press releases of activities in the Centre, and management of patients and their relatives complaints and suggestions. During this period many students have successfully completed their concurrent and Block fieldwork in Medical setting in this centre as part of their Master of Social Work course. Patient Welfare Activities The Patient Welfare Committee was constituted for the smooth functioning of our Patient Welfare Activities has attributed a boost to our patient services and management. The Committee consists of Doctors of different specialties, representatives from Administrative section, Social Scientist and Nursing personnel. The Committee co-ordinates all the welfare activities of the patients who are undergoing treatment at this Centre. It promotes to raise the money for the patient welfare fund from the general public as well as staff members of Malabar Cancer Centre.


10

Drug Bank Apart from the above a Drug Bank is also formulated for collection of drugs from Doctors in and around Thalassery and also sample medicines issued from various pharmaceutical companies. Such medicines are issued free of cost to the needy poor patients, who are undergoing treatment from this Centre. Patient Free Food Scheme As most of our patients belong to lower socio-economic strata struggling to earn for their meal, with the financial assistance from philanthropists and like-minded organizations, all in-patients are given mid-day meal at free of cost. Authorities intend to extend this program to a full day total free meal program for all in-patients in future, if adequate financial assistance could be obtained. Tele Medicine Unit Telemedicine facility has been started in MCC during the period with the financial assistance from NRHM and technical assistance from CDAC and Kerala IT mission Cancer Support Groups

1. THEJUS - Breast Support Group started on 30.09.2009 2. SPANDANAM - Ostomy Association started on 21.11.2011

Academic Courses With the increased incidence of cancer, more institutions are getting equipped for treatment of cancer. We realize the need for focused training in oncology, especially for medical and paramedical courses. This is a step towards better care for patients in the present milieu. It is already proposed to develop MCC as a Post-Graduate Institute of Oncology.

Teaching Courses at MCC

Palliative Care

1. Basic Certificate Course in Palliative Nursing(BCCPN)

2. Certificate Course in Community Palliative Auxillary Nursing Course(CCPAN)

6 weeks 3 months

10

10

Institute of Palliative Medicine, Kozhikode Institute of Palliative Medicine, Kozhikode

Existing Existing

Radiation Physics

B. Sc MRT, (Medical Radiology Technology),

4 yrs 25 Kannur University Existing

Nursing 1. Certificate course in Oncology Nursing

2. Nursing Assistant Course

2 yrs 2 yrs

10 20

Kannur University Kannur University

Existing Existing

Medical 1. Fellowship in Head and neck oncology

2. Fellowship in Gynaecologic oncology

I yr

1 yr

2

2

Institutional fellowship Existing


11

Regular Academic Programs: All new cases are presented in the Daily Multi Specialty Board which are reviewed and decisions on treatment taken accordingly. Interactive discussions on a specific topic are carried out on all Wednesdays afternoon in the Radiation Oncology Cub. All Thursday morning, lectures on the recent trends in oncological care by one faculty are carried out in the Centre. On Saturdays morning, Journal club/ lecture/ morbidity meet are carried out in the centre. Apart from the regular academic programs, Continuing Medical Education Program for Doctors and Post-Graduate Students of nearby Medical Colleges are organized by MCC. During the calendar year 2010 MCC has organized the following CME/Training Programme:

1. Two weeks training programme on Cancer Palliative Medicine for Doctors in the month of January, 2010 at MCC.

2. CME on “Gastric Cancer” on March 7, 2010 at Hotel Sree Gokulam Fort, Thalassery Research Activities: Institutional Review Board (Scientific Committee) and Ethics committee have been constituted recently in the centre. There are few clinical studies going on in the centre. Medical Library A medical library is being set up at this hospital. Presently 43 foreign Journals and 1500 medical books are available with this library. Apart from this online facility to access 13000 Journals are provided. 21 more Journals and 1000 medical books worth Rupees one crore are planned for purchase during this financial year. Construction of a separate building for library cum auditorium has already proposed and procedures initiated. Hospital Library for Patients and Relatives A unique Hospital library for patients, their relatives and staff is functioning in the centre since December 27, 2005. The library is funded by Kerala State Library Council.


12

National Cancer Registry Programme

(Indian Council of Medical Research)

The National Cancer Registry Programme (NCRP) was commenced by the Indian Council of Medical Research (ICMR) with a network of cancer registries across the country in December 1981. The main objectives of this programme were: 1. To generate reliable data on the magnitude and patterns of cancer

2. Undertake epidemiological studies based on results of registry data

3. Help in designing, planning, monitoring and evaluation of cancer control activities under the National Cancer Control Programme (NCCP)

4. Develop training programs in cancer registration and epidemiology.

With these objectives three Population Based Cancer Registries (PBCRs) at Bangalore, Chennai and Mumbai and three Hospital Based Cancer Registries (HBCRs) at Chandigarh, Dibrugarh and Thiruvananthapuram were commenced from 1 January 1982. The PBCRs have gradually expanded over the years and as of now there are 23 PBCRs under the NCRP network.

Fig.1: NCRP Network


13

HOSPITAL BASED CANCER REGISTRY Staff:

Dr Saina Sunil Kumar Head of the Department- in charge

Dr. Binukumar B Lecturer in Biostatistics

Mrs Bhavina C Junior System Analyst

The primary purpose of Hospital Based Cancer Registries is to contribute to patient care by providing readily accessible information on the patients with cancer, the treatment received and its results. The data is also used for clinical research and for epidemiological purposes. Hospital based cancer registries are concerned with recording of information on the cancer patients seen in a particular hospital (Isabel dos Santos Silva et al, 1999). Within the hospital, a registry is often considered to be an integral part of the hospital’s cancer programme or health care delivery system.

The stated Objectives of Hospital Based Cancer Registries (HBCRs) (Maclennan et al, 1978; Young, J.L. 1991) are outlined below:

1. GENERAL: 1.1 Assess Patient Care

1.2 Participate in Clinical Research to Evaluate Therapy

1.3 Provide an idea of the patterns of cancer in the area

1.4 Help plan hospital facilities.

2. SPECIFIC:

a. Contribute to active follow-up of the cancer patient

b. Describe length and quality of survival in relation to anatomical site, clinical stage and aspects of types of treatment.

c. Contribute to the Population Based Cancer Registries (PBCRs) in the given area

d. Undertake epidemiological research through short-term case control studies

e. Show time trends in proportion of early to late stages at the time of diagnosis

f. Help assess quality of hospital care and cancer services in covered area.

Data collection is done by the individual registries using a standardized common core form. The information in this form mainly consists of patient identifying and demographic information, details of diagnosis the clinical stage of the disease and the broad type of treatment instituted.

The Hospital Based Cancer Registry (HBCR) of the Malabar Cancer Centre, Thalassery, Kannur was started in 2010 under the network of Indian Council of Medical Research (ICMR) with code MCC 524. Malabar Cancer Centre is an exclusive Cancer Speciality Hospital established in 2000. MCC caters patients from Kannur, Kozhikode, Kasaragod, Wayanad, Malappuram, Palakkad, Kottayam, Alappuzha, Kollam and Thrissur districts in Kerala and the neighbouring states Pondicherry(Mahe), Tamil Nadu, Karnataka. MCC registers all patients attending to the centre and the HBCR abstracts information of only cancer patients.


14

The registry is restricted to patients from MCC only. A total of 2273 patients were registered in the MCC in 2010. The total HBCR cases recorded were 2253 (males -1199 -53.2% and females -1054-46.8%).

Pattern of patient registration (Malabar Cancer Centre, Kannur, 2010) Type Total Malignant Tumours (With one Primary -2nd in situ) 2221

Non-Neoplastic 29

Diagnosis not Confirmed 9

Diagnosis uncertain 8

In-situ 6

Total 2273

SUMMARY OF RESULTS During the year 2010 , 2253 HBCR cases where recorded (males 1199 and females 1054) at Malabar Cancer Centre ,Thalassery,Kannur .The 10 leading cancers found in males were Lung,Mouth,Stomach,Larynx,Tongue,Esophagus,Rectum,Prostate,Hypo pharynx and Colon. Where as in females-Breast, Cervix Uteri, Mouth, Ovary, Corpus Uteri, Lung, Rectum, Esophagus, Colon and NHL.

Total proportion of Tobacco Related Cancers (TRC) relative to all sites is 53.1% in Males and 19.4% in Females. TRC with respect to all sites in Male is more in Lung 20.1% where as female more in mouth 7.7%.TRC with respect to specific site in males is Lung 37.8% and in females is mouth 39.7%.

As per educational status both in males and in females, primary education was 49.5% in males and 39% in females. According to the marital status, 89.5% were married males and 54.1% were married females .Microscopic mode of method of diagnosis was 82.7% in males and 87.8% in females. Majority of patients belong to Malayalam speaking group .The relative percentages in Hindu males and females were 62.3% and 68.6% respectively. Male: Female ratio is 53.8:46.2.

Among children, for age group 0-14 years, the males constituted 0.6% and females 0.4%; between 15-34 years, It was 3.2% in males and 4.6% in females ;between 35-64 years 53.1% in males and 64.5% in females and in 65+ 43.1% in males and 30.5% in females were the relative percentage of these broad age group.

Both in males and females, the mode was Microscopic with 82.7% in Males and 87.8% in females. Similarly, based on different types of Microscopic Diagnosis Primary Histology was 64.1% in males and 74.8% in females.

According to the broad group of treatment at RI and /or elsewhere, prior treatment taken only was 21.5% in males and 22.7% in females. Prior treatment elsewhere and treatment at RI among males and females were 15.7% and 21.3 % respectively. Treatment only at RI was 33.7% among males and 36.1% among females. No treatment was received by 29.1% males and 19.9% females.

For the group of “Treatment only at RI”, the disease was localized with extension to regional lymph nodes 56.7% of males and 66.3% of females. Among patients who took to treatment


15

any RT was 44.3% in males and 34.1% in females .So also those who took treatment only at RI in localized disease category- Surgery was done in 41.7% of Males and 48.1% of females. Among regional lymph node involvement group -Radiation was given in 43.6% of males and 34.3% of females. In distant metastasis group, Radiation was given to 41.6% of males and Chemotherapy (CT) was given to 46.5% of females. Palliative Radiation was given to 57.1% of males and 48.1% of females. According to type of treatment given at RI only (Males 404 and females 380), specific treatment was Chemotherapy and radiation (RT+CT) -27.5% in males and 20.3% in females.

Single modality treatment was given to 57.7% of males and 41.1% of females .Combined treatment was given to 42.1% of males and 58.9% of females.

FUNCTIONING OF HBCR

1. DATA ABSTRACTION, CODING AND DATA ENTRY The data abstraction and entry are done using the hospital files. The demographic data are

collected and entered into the computer at the time of new patient registration at MCC and

transfer to the core- pro forma of the National Cancer Registry Progamme (NCRP) of Indian

Council of Medical Research (ICMR). The data transfer of the ICMR Core pro forma- first

part (demographic details) and second part (diagnostic treatment and follow up details) is

entered using the ICMR software after retrieving case sheets from the MCC Medical Records

division. All variables in the core pro forma except age and various dates are directly

selected. The selection box contains all the codes along with their descriptions for each

variable. Hence, this helps to avoid mistakes beyond the range of values for each variable.

The selection box corresponding to the variable topography and morphology contains the

third edition of international classification of diseases for oncology (ICD-O-3) and the

international classification of diseases (ICD-10).

2. DATA PROCESSING ANALYSIS After abstraction, coding and data entry the data were sent to the coordinating unit of the

NCRP of ICMR, Bangalore in an electronic format and the data was subjected to various

range, consistency, unlikely combinations, and duplicate checks. Necessary corrections are

done based on the error list of the cases sent by the coordinating unit and this report is

generated.


16

RESULTS MAGNITUDE OF TOTAL CANCERS According to cancer registration in the Hospital Based Cancer Registry of MCC, Thalassery, and Kannur during the year 2010, the number of cancer patients and their relative proportion according to sex and sex ratio percentage have been represented in Table 1. The number of cancer patients recorded in the HBCR was 2253 [males 1199 (53.2%) and females 1054 (46.8%)]

Table 1: Number (#) and Proportion (%) according to Sex

Males

Females

Male to female

Ratio

Total Cases

#

% # %

1199 53.2 1054 46.8 1.14 : 1 2253

TOBACCO RELATED CANCERS (TRC)

Total proportion of tobacco related cancers (TRC) relative to all sites is 53.1% and 19.4% among males and females respectively. TRC with respect to all sites, lung cancer predominates (20.1%) among male, where as in females, it is mouth (7.7%). TRC with respect to specific site, among males it is Lung (37.8%) and among females, it is mouth (39.7%).

Table 2:

Fig.2

Per

cent

age


17

Table 3:

Fig. 3

Per

cent

age


18

Fig. 4

Per

cent

age


19

Table 4 :

Fig.5

Perc

ent

age


20

Fig.6

Per

cent

age


21

LEADING SITES OF CANCER AND MAGNITUDE

The number, relative proportion and ranking of 10 leading sites of cancer for males and females are presented in table 6.

Table 6: Rank, Number (#) and Relative Proportion (%)

of Leading Sites of Cancer -Male

Rank Sites (ICD-10) # %

1 Lung etc. (C33-34) 241 20.12 Mouth (C03-06) 106 8.83 Stomach (C16) 97 8.14 Larynx (C32) 63 5.35 Tongue (C01-02) 61 5.16 Oesophagus (C15) 58 4.87 Rectum (C19-20) 52 4.38 Prostate (C61) 52 4.39 Hypopharynx (C12-13) 48 4.0

10 Colon (C18) 38 3.2 Total 816 68.1

All Sites 1199

100.0

Fig.7: Proportion (%) of Leading Sites of Cancer - Male

Percentage

C33-34

C03-06

C16

C32

C01-02

C15

C19-20

C61

C12-13

C18

0 4 8 12 16 20 24

20.1

8.8

8.1

5.3

5.1

4.8

20.1

4.3

4.0

3.2

Percentage

C33-34

C03-06

C16

C32

C01-02

C15

C19-20

C61

C12-13

C18

0 4 8 12 16 20 24

20.1

8.8

8.1

5.3

5.1

4.8

20.1

4.3

4.0

3.2


22

Table 7: Rank, Number(#) and Relative Proportion(%)

of Leading Sites of Cancer-Female

Rank

Sites (ICD-10) # %

1 Breast (C50) 301 28.6

2 Cervix Uteri (C53) 124 11.8

3 Mouth (C03-06) 81 7.7

4 Ovary etc. (C56) 75 7.1

5 Corpus Uteri (C54) 46 4.4

6 Lung etc. (C33-34) 40 3.8

7 Rectum (C19-20) 35 3.3

8 Oesophagus (C15) 32 3.0

9 Colon (C18) 27 2.6

100 NHL (C82-85,C96) 27 2.6 Total 788 74.8

All Sites 1054 100.0

Fig.8: Proportion (%) of Leading Sites of Cancer-Female

Percentage

C50

C53

C03-06

C56

C54

C33-34

C19-20

C15

C18

C82-85,C96

28.6

11.8

7.7

4.4

7.1

3.8

3.3

3.0

2.6

2.6


23

STATISTICS

Malabar Cancer Centre HBCR - 2010

24

Table 8: Five year age groups distribution – Male

ICD10 Site 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 ≥ Un

Total % 4 9 14 19 24 29 34 39 44 49 54 59 64 69 74 75 Kn C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 3 0.3C01-02 Tongue 0 0 0 0 1 00 1 2 1 7 10 3 10 7 3 16 0 61 5.1C03-06 Mouth 0 0 0 0 0 0 0 0 3 4 7 15 17 17 12 31 0 106 8.8C07-08 Salivary Gland 0 0 0 0 0 0 0 1 1 0 1 0 1 0 1 0 0 5 0.4C09 Tonsil 0 0 0 0 0 0 0 0 1 1 0 3 3 2 1 1 0 12 1C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 1 0 5 5 7 3 3 3 0 27 2.3C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 0.2C12-13 Hypopharynx 0 0 0 0 0 0 1 0 1 4 5 6 10 5 12 4 0 48 4

C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0.1

C15 Oesophagus 0 0 0 0 0 0 0 1 1 6 4 13 10 7 7 9 0 58 4.8C16 Stomach 0 0 0 0 0 0 0 3 3 5 13 13 13 13 13 21 0 97 8.1C17 Small Intestine 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 3 0.3C18 Colon 0 0 0 0 0 0 2 2 2 9 5 3 1 6 4 4 0 38 3.2C19-20 Rectum 0 0 0 0 0 0 2 3 2 5 2 8 3 11 4 12 0 52 4.3

C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.1

C22 Liver 0 0 0 0 0 0 0 0 2 0 5 2 2 5 2 2 0 20 1.7C23-24 Gallbladder 0 0 0 0 0 0 0 2 0 0 0 1 0 0 2 2 0 7 0.6C25 Pancreas 0 0 0 0 0 0 0 0 0 0 3 3 3 0 5 4 0 18 1.5C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 4 0.3C32 Larynx 0 0 0 0 0 0 0 0 1 1 3 13 10 11 10 14 0 63 5.3C33-34 Lung 0 0 0 0 0 0 0 1 3 14 29 47 51 41 34 21 0 241 20.1

C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0.1

C40-41 Bone 0 0 2 6 1 0 0 3 0 1 1 1 1 1 0 0 0 17 1.4C43 Melanoma of Skin 0 0 0 0 0 0 0 0 1 1 1 1 2 0 2 1 0 9 0.8C44 Other Skin 0 0 0 0 0 0 1 1 2 3 3 1 0 4 1 3 0 19 1.6C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C47+C49 Conn. & Soft Tissue 0 0 0 0 0 2 3 0 2 3 0 3 3 1 1 2 0 20 1.7

C50 Breast 0 0 0 0 0 1 0 0 1 0 1 1 2 0 1 0 0 7 0.6


25

C60 Penis 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 2 0 5 0.4C61 Prostate 0 0 0 0 0 0 0 0 0 0 0 5 8 13 12 14 0 52 4.3C62 Testis 0 0 0 0 2 0 1 1 0 1 0 0 0 0 0 1 0 6 0.5

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C64 Kidney 0 0 0 0 0 0 0 0 0 1 6 3 1 1 0 2 0 14 1.2C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 0 0 0 0 0 1 1 1 4 4 3 6 1 8 0 29 2.4

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 1 0 1 1 1 2 1 1 3 4 1 1 1 0 1 0 19 1.6C73 Thyroid 0 0 0 0 0 0 1 2 0 1 2 2 2 0 3 0 0 13 1.1C74 Adrenal Gland 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0.2C81 Hodgkins Disease 0 0 1 0 1 0 0 0 1 1 0 1 0 0 0 0 0 5 0.4C82-85,C96 NHL 0 0 0 3 1 0 1 0 2 4 1 9 4 7 3 2 0 37 3.1C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 0 0 0 0 1 2 6 0 2 3 3 3 0 20 1.7C91 Lymphoid Leuk. 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0.3

C92-94 Myeloid Leukaemia 0 0 1 0 0 0 1 0 0 2 0 1 0 1 1 0 0 7 0.6

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 0 0 0 1 2 4 5 8 8 5 5 9 0 47 3.9

All Sites 0 2 5 11 7 4 16 26 37 88 127 179 180 175 148 194 0 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


26

Table 9: Five year age groups distribution -Female

ICD10 Site 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 ≥ Un

Total % 4 9 14 19 24 29 34 39 44 49 54 59 64 69 74 75 Kn C00 Lip 0 0 0 0 0 0 0 0 0 0 0 1 1 1 2 5 0 10 0.9C01-02 Tongue 0 0 0 0 0 0 1 1 1 2 2 2 5 1 2 5 0 22 2.1C03-06 Mouth 0 0 0 0 0 0 0 0 0 3 2 9 19 22 7 19 0 81 7.7C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 3 0.3C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2 0.2C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0.1C11 Nasopharynx 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 2 0.2C12-13 Hypopharynx 0 0 0 0 0 0 1 0 0 1 0 3 3 1 0 2 0 11 1C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 0 0 0 0 0 0 0 1 1 4 8 5 4 9 0 32 3C16 Stomach 0 0 0 0 0 0 0 1 0 2 1 3 3 3 2 8 0 23 2.2C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.1C18 Colon 0 0 0 0 0 0 0 0 1 1 2 5 7 1 4 6 0 27 2.6C19-20 Rectum 0 0 0 0 0 1 1 0 1 2 1 5 2 11 5 6 0 35 3.3C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 1 0 4 0.4C22 Liver 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 3 0.3C23-24 Gallbladder 0 0 0 0 0 0 0 1 0 1 0 1 1 0 1 1 0 6 0.6C25 Pancreas 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 1 0 5 0.5C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 0 3 0.3C32 Larynx 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 1 0 4 0.4C33-34 Lung 0 0 0 0 0 0 0 0 4 1 3 9 7 8 4 4 0 40 3.8

C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C40-41 Bone 0 1 2 4 2 1 0 2 0 0 1 3 1 0 1 0 0 18 1.7C43 Melanoma of Skin 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 4 0.4C44 Other Skin 0 0 0 0 0 0 0 1 0 1 1 2 3 3 2 3 0 16 1.5C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 0 0 0 0 2 1 1 1 1 2 1 4 1 0 1 0 0 15 1.4C50 Breast 0 0 0 0 0 2 11 25 48 60 51 40 33 9 9 13 0 301 28.6C51 Vulva 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 4 0.4


27

C52 Vagina 0 0 0 0 0 0 0 0 0 0 1 1 2 0 1 2 0 7 0.7C53 Cervix Uteri 0 0 0 0 0 0 0 3 4 27 18 16 17 13 9 17 0 124 11.8C54 Corpus Uteri 0 0 0 0 0 0 0 0 4 9 7 8 9 5 3 1 0 46 4.4C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 0 0 0 0 1 1 4 3 6 10 7 13 5 12 3 10 0 75 7.1C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.1C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 0 0 0 0 0 1 0 3 0 2 0 0 0 6 0.6C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0.1C67 Bladder 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 3 0.3C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0.1C70-72 Brain, NS 0 0 0 0 0 0 2 0 1 2 1 0 1 1 0 1 0 9 0.9C73 Thyroid 0 0 0 0 1 0 3 2 1 3 2 4 3 2 2 2 0 25 2.4C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 2 1 0 0 0 0 1 0 0 0 0 2 0 6 0.6C82-85,C96 NHL 0 0 1 0 0 1 0 0 1 2 4 3 4 1 3 7 0 27 2.6C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 0 0 0 0 1 1 2 4 5 2 1 5 0 21 2C91 Lymphoid Leuk. 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.1C92-94 Myeloid Leukaemia 0 0 0 0 0 0 1 1 0 1 0 0 1 0 0 0 0 4 0.4C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 0 1 1 2 3 5 3 1 3 1 2 2 0 24 2.3

All Sites 0 1 3 5 8 10 26 44 77 140 117 153 149 108 72 141 0 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


28

Table 10: Broad treatment groups distribution - Male

ICD10 Site

Treatment Groups Prior Tmt. Only Prior & Tmt. at RI Tmt. Only at RI No Treatment Total

# % # % # % # % # % C00 Lip 2 66.7 0 0 0 0 1 33.3 3 100C01-02 Tongue 11 18 8 13.1 35 57.4 7 11.5 61 100C03-06 Mouth 18 17 8 7.5 57 53.8 23 21.7 106 100C07-08 Salivary Gland 0 0 4 80 1 20 0 0 5 100C09 Tonsil 1 8.3 1 8.3 8 66.7 2 16.7 12 100C10 Oth. Oropharynx 5 18.5 3 11.1 16 59.3 3 11.1 27 100C11 Nasopharynx 1 50 0 0 1 50 0 0 2 100C12-13 Hypopharynx 9 18.8 6 12.5 24 50 9 18.8 48 100

C14 Pharynx Unspecified 0 0 0 0 0 0 1 100 1 100

C15 Oesophagus 11 19 2 3.4 17 29.3 28 48.3 58 100C16 Stomach 24 24.7 18 18.6 19 19.6 36 37.1 97 100C17 Small Intestine 1 33.3 0 0 1 33.3 1 33.3 3 100C18 Colon 13 34.2 11 28.9 11 28.9 3 7.9 38 100C19-20 Rectum 10 19.2 12 23.1 14 26.9 16 30.8 52 100

C21 Anus & Anal Canal 0 0 0 0 0 0 1 100 1 100

C22 Liver 2 10 2 10 1 5 15 75 20 100C23-24 Gallbladder 3 42.9 0 0 1 14.3 3 42.9 7 100C25 Pancreas 0 0 1 5.6 3 16.7 14 77.8 18 100C30-31 Nose,Sinuses 1 25 2 50 1 25 0 0 4 100C32 Larynx 13 20.6 8 12.7 30 47.6 12 19 63 100C33-34 Lung 30 12.4 25 10.4 98 40.7 88 36.5 241 100

C37-38 Other Thoracic Organs 1 100 0 0 0 0 0 0 1 100

C40-41 Bone 5 29.4 8 47.1 2 11.8 2 11.8 17 100C43 Melanoma of Skin 3 33.3 1 11.1 4 44.4 1 11.1 9 100C44 Other Skin 4 21.1 1 5.3 8 42.1 6 31.6 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0


29

C47+C49 Conn. & Soft Tissue 6 30 5 25 5 25 4 20 20 100

C50 Breast 2 28.6 1 14.3 4 57.1 0 0 7 100C60 Penis 2 40 0 0 3 60 0 0 5 100C61 Prostate 12 23.1 23 44.2 10 19.2 7 13.5 52 100C62 Testis 3 50 3 50 0 0 0 0 6 100

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0

C64 Kidney 5 35.7 4 28.6 1 7.1 4 28.6 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0C67 Bladder 12 41.4 8 27.6 4 13.8 5 17.2 29 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 12 63.2 7 36.8 0 0 0 0 19 100C73 Thyroid 5 38.5 2 15.4 4 30.8 2 15.4 13 100C74 Adrenal Gland 1 50 0 0 0 0 1 50 2 100C81 Hodgkins Disease 1 20 0 0 2 40 2 40 5 100C82-85,C96 NHL 14 37.8 3 8.1 3 8.1 17 45.9 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 9 45 4 20 1 5 6 30 20 100C91 Lymphoid Leuk. 1 33.3 2 66.7 0 0 0 0 3 100

C92-94 Myeloid Leukaemia 2 28.6 2 28.6 0 0 3 42.9 7 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 3 6.4 3 6.4 15 31.9 26 55.3 47 100 All Sites 258 21.5 188 15.7 404 33.7 349 29.1 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


30

Table 11: Broad treatment groups distribution - Female

ICD10 Site

Treatment Groups Prior Tmt. Only Prior & Tmt. at RI Tmt. Only at RI No Treatment Total

# % # % # % # % # % C00 Lip 3 30 0 0 5 50 2 20 10 100C01-02 Tongue 3 13.6 3 13.6 13 59.1 3 13.6 22 100C03-06 Mouth 15 18.5 14 17.3 42 51.9 10 12.3 81 100C07-08 Salivary Gland 0 0 1 33.3 2 66.7 0 0 3 100C09 Tonsil 0 0 0 0 2 100 0 0 2 100C10 Oth. Oropharynx 0 0 1 100 0 0 0 0 1 100C11 Nasopharynx 0 0 0 0 0 0 2 100 2 100C12-13 Hypopharynx 1 9.1 1 9.1 4 36.4 5 45.5 11 100

C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0

C15 Oesophagus 6 18.8 3 9.4 8 25 15 46.9 32 100C16 Stomach 4 17.4 3 13 5 21.7 11 47.8 23 100C17 Small Intestine 0 0 0 0 0 0 1 100 1 100C18 Colon 9 33.3 4 14.8 5 18.5 9 33.3 27 100C19-20 Rectum 3 8.6 10 28.6 11 31.4 11 31.4 35 100

C21 Anus & Anal Canal 0 0 1 25 1 25 2 50 4 100

C22 Liver 0 0 1 33.3 0 0 2 66.7 3 100C23-24 Gallbladder 1 16.7 1 16.7 3 50 1 16.7 6 100C25 Pancreas 0 0 1 20 1 20 3 60 5 100C30-31 Nose,Sinuses 2 66.7 0 0 1 33.3 0 0 3 100C32 Larynx 0 0 0 0 4 100 0 0 4 100C33-34 Lung 3 7.5 6 15 19 47.5 12 30 40 100

C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0

C40-41 Bone 4 22.2 8 44.4 3 16.7 3 16.7 18 100C43 Melanoma of Skin 0 0 4 100 0 0 0 0 4 100C44 Other Skin 6 37.5 4 25 4 25 2 12.5 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0


31

C47+C49 Conn. & Soft Tissue 4 26.7 2 13.3 4 26.7 5 33.3 15 100

C50 Breast 69 22.9 81 26.9 121 40.2 30 10 301 100C51 Vulva 1 25 0 0 1 25 2 50 4 100C52 Vagina 1 14.3 3 42.9 3 42.9 0 0 7 100C53 Cervix Uteri 29 23.4 19 15.3 49 39.5 27 21.8 124 100C54 Corpus Uteri 11 23.9 16 34.8 16 34.8 3 6.5 46 100

C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0

C56 Ovary 19 25.3 19 25.3 18 24 19 25.3 75 100

C57 Other Female Genital 0 0 0 0 1 100 0 0 1 100

C58 Placenta 0 0 0 0 0 0 0 0 0 0C64 Kidney 4 66.7 1 16.7 0 0 1 16.7 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 1 100 0 0 0 0 1 100C67 Bladder 2 66.7 0 0 1 33.3 0 0 3 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0

C69 Eye 1 100 0 0 0 0 0 0 1 100C70-72 Brain, NS 4 44.4 3 33.3 0 0 2 22.2 9 100C73 Thyroid 10 40 4 16 7 28 4 16 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 1 16.7 1 16.7 2 33.3 2 33.3 6 100C82-85,C96 NHL 7 25.9 1 3.7 11 40.7 8 29.6 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 8 38.1 6 28.6 4 19 3 14.3 21 100C91 Lymphoid Leuk. 1 100 0 0 0 0 0 0 1 100

C92-94 Myeloid Leukaemia 3 75 0 0 0 0 1 25 4 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 4 16.7 2 8.3 9 37.5 9 37.5 24 100 All Sites 239 22.7 225 21.3 380 36.1 210 19.9 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


32

Table 12: Distribution of Clinical Extent of Disease (Prior Treatment Only) – Male

ICD10 Site

Clinical Extent of Disease Localised Regional Distant Others Unknown Total

# % # % # % # % # % # % C00 Lip 1 50 0 0 0 0 1 50 0 0 2 100 C01-02 Tongue 0 0 3 27.3 0 0 8 72.7 0 0 11 100 C03-06 Mouth 1 5.6 4 22.2 4 22.2 9 50 0 0 18 100 C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0 C09 Tonsil 0 0 0 0 0 0 1 100 0 0 1 100 C10 Oth. Oropharynx 0 0 3 60 1 20 1 20 0 0 5 100 C11 Nasopharynx 0 0 1 100 0 0 0 0 0 0 1 100 C12-13 Hypopharynx 1 11.1 5 55.6 0 0 3 33.3 0 0 9 100 C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 C15 Oesophagus 0 0 5 45.5 3 27.3 3 27.3 0 0 11 100 C16 Stomach 1 4.2 10 41.7 8 33.3 5 20.8 0 0 24 100 C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 1 100 C18 Colon 1 7.7 4 30.8 3 23.1 5 38.5 0 0 13 100 C19-20 Rectum 0 0 3 30 5 50 2 20 0 0 10 100 C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 C22 Liver 0 0 2 100 0 0 0 0 0 0 2 100 C23-24 Gallbladder 0 0 2 66.7 1 33.3 0 0 0 0 3 100 C25 Pancreas 0 0 0 0 0 0 0 0 0 0 0 0 C30-31 Nose,Sinuses 0 0 0 0 0 0 1 100 0 0 1 100 C32 Larynx 4 30.8 4 30.8 2 15.4 3 23.1 0 0 13 100 C33-34 Lung 0 0 14 46.7 14 46.7 2 6.7 0 0 30 100

C37-38 Other Thoracic Organs 0 0 0 0 1 100 0 0 0 0 1 100

C40-41 Bone 0 0 0 0 1 20 4 80 0 0 5 100 C43 Melanoma of Skin 0 0 0 0 1 33.3 2 66.7 0 0 3 100 C44 Other Skin 2 50 0 0 0 0 2 50 0 0 4 100 C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0


33

C47+C49 Conn. & Soft Tissue 0 0 1 16.7 1 16.7 4 66.7 0 0 6 100 C50 Breast 1 50 1 50 0 0 0 0 0 0 2 100 C60 Penis 1 50 0 0 0 0 1 50 0 0 2 100 C61 Prostate 0 0 5 41.7 7 58.3 0 0 0 0 12 100 C62 Testis 1 33.3 2 66.7 0 0 0 0 0 0 3 100 C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 C64 Kidney 0 0 0 0 5 100 0 0 0 0 5 100 C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 C67 Bladder 0 0 3 25 3 25 6 50 0 0 12 100 C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 C70-72 Brain, NS 0 0 4 33.3 2 16.7 6 50 0 0 12 100 C73 Thyroid 0 0 2 40 0 0 3 60 0 0 5 100 C74 Adrenal Gland 0 0 0 0 0 0 1 100 0 0 1 100 C81 Hodgkins Disease 0 0 0 0 1 100 0 0 0 0 1 100 C82-85,C96 NHL 0 0 3 21.4 3 21.4 8 57.1 0 0 14 100 C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 C90 Multiple Myeloma 0 0 0 0 2 22.2 7 77.8 0 0 9 100 C91 Lymphoid Leuk. 0 0 0 0 0 0 1 100 0 0 1 100 C92-94 Myeloid Leukaemia 0 0 0 0 0 0 2 100 0 0 2 100 C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 O&U Other and Uns 0 0 0 0 1 33.3 2 66.7 0 0 3 100 All Sites 14 5.4 81 31.4 70 27.1 93 36 0 0 258 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


34

Table 13: Distribution of Clinical Extent of Disease (Prior Treatment Only) – Female

ICD10 Site

Clinical Extent of Disease Localised Regional Distant Others Unknown Total # % # % # % # % # % # %

C00 Lip 0 0 0 0 0 0 3 100 0 0 3 100C01-02 Tongue 0 0 0 0 0 0 3 100 0 0 3 100C03-06 Mouth 1 6.7 3 20 1 6.7 10 66.7 0 0 15 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 1 100 0 0 0 0 0 0 1 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 2 33.3 2 33.3 2 33.3 0 0 6 100C16 Stomach 1 25 1 25 2 50 0 0 0 0 4 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 1 11.1 4 44.4 2 22.2 2 22.2 0 0 9 100C19-20 Rectum 0 0 3 100 0 0 0 0 0 0 3 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 0 0 0 0 0 0 0 0 0 0 0 0C23-24 Gallbladder 0 0 0 0 0 0 1 100 0 0 1 100C25 Pancreas 0 0 0 0 0 0 0 0 0 0 0 0C30-31 Nose,Sinuses 0 0 0 0 0 0 2 100 0 0 2 100C32 Larynx 0 0 0 0 0 0 0 0 0 0 0 0C33-34 Lung 0 0 0 0 3 100 0 0 0 0 3 100C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0C40-41 Bone 0 0 1 25 1 25 1 25 1 25 4 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 3 50 1 16.7 0 0 2 33.3 0 0 6 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 0 0 1 25 0 0 3 75 0 0 4 100C50 Breast 15 21.7 25 36.2 19 27.5 10 14.5 0 0 69 100C51 Vulva 0 0 1 100 0 0 0 0 0 0 1 100


35

C52 Vagina 0 0 1 100 0 0 0 0 0 0 1 100C53 Cervix Uteri 1 3.4 12 41.4 3 10.3 13 44.8 0 0 29 100C54 Corpus Uteri 1 9.1 5 45.5 1 9.1 4 36.4 0 0 11 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 0 0 9 47.4 7 36.8 3 15.8 0 0 19 100C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 0 0C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 1 25 2 50 1 25 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 0 0 0 0 2 100 0 0 2 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 1 100 0 0 0 0 0 0 1 100C70-72 Brain, NS 0 0 1 25 0 0 3 75 0 0 4 100C73 Thyroid 0 0 7 70 1 10 2 20 0 0 10 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 1 100 0 0 0 0 0 0 1 100C82-85,C96 NHL 0 0 4 57.1 0 0 3 42.9 0 0 7 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 4 50 4 50 0 0 8 100C91 Lymphoid Leuk. 0 0 0 0 0 0 1 100 0 0 1 100C92-94 Myeloid Leukaemia 0 0 0 0 0 0 3 100 0 0 3 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 0 0 4 100 0 0 4 100 All Sites 23 9.6 85 35.6 48 20.1 82 34.3 1 0.4 239 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


36

Table 14: Distribution of Clinical Extent of Disease (Treatment Only At RI) – Male

ICD10 Site


# % # % # % # % # % # % C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 4 11.4 31 88.6 0 0 0 0 0 0 35 100C03-06 Mouth 2 3.5 48 84.2 7 12.3 0 0 0 0 57 100C07-08 Salivary Gland 0 0 1 100 0 0 0 0 0 0 1 100C09 Tonsil 0 0 8 100 0 0 0 0 0 0 8 100C10 Oth. Oropharynx 1 6.2 12 75 3 18.8 0 0 0 0 16 100C11 Nasopharynx 0 0 1 100 0 0 0 0 0 0 1 100C12-13 Hypopharynx 0 0 21 87.5 3 12.5 0 0 0 0 24 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 8 47.1 9 52.9 0 0 0 0 17 100C16 Stomach 3 15.8 5 26.3 11 57.9 0 0 0 0 19 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 1 100C18 Colon 0 0 5 45.5 6 54.5 0 0 0 0 11 100C19-20 Rectum 2 14.3 8 57.1 4 28.6 0 0 0 0 14 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 0 0 0 0 1 100 0 0 0 0 1 100C23-24 Gallbladder 0 0 1 100 0 0 0 0 0 0 1 100C25 Pancreas 0 0 2 66.7 1 33.3 0 0 0 0 3 100C30-31 Nose,Sinuses 0 0 0 0 1 100 0 0 0 0 1 100C32 Larynx 3 10 25 83.3 2 6.7 0 0 0 0 30 100C33-34 Lung 0 0 27 27.6 71 72.4 0 0 0 0 98 100


C40-41 Bone 0 0 1 50 1 50 0 0 0 0 2 100C43 Melanoma of Skin 0 0 3 75 1 25 0 0 0 0 4 100C44 Other Skin 3 37.5 4 50 0 0 1 12.5 0 0 8 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 1 20 3 60 1 20 0 0 0 0 5 100C50 Breast 0 0 4 100 0 0 0 0 0 0 4 100


37

C60 Penis 0 0 3 100 0 0 0 0 0 0 3 100C61 Prostate 0 0 7 70 3 30 0 0 0 0 10 100C62 Testis 0 0 0 0 0 0 0 0 0 0 0 0C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 1 100 0 0 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 4 100 0 0 0 0 0 0 4 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 0 0 4 100 0 0 0 0 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 2 100 0 0 0 0 0 0 2 100C82-85,C96 NHL 0 0 2 66.7 0 0 1 33.3 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 1 100 0 0 0 0 1 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 1 6.7 14 93.3 0 0 15 100 All Sites 19 4.7 241 59.7 128 31.7 16 4 0 0 404 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


38

Table 15: Distribution of Clinical Extent of Disease (Treatment Only At RI) –Female

ICD10 Site


# % # % # % # % # % # % C00 Lip 2 40 3 60 0 0 0 0 0 0 5 100C01-02 Tongue 1 7.7 11 84.6 1 7.7 0 0 0 0 13 100C03-06 Mouth 2 4.8 36 85.7 2 4.8 2 4.8 0 0 42 100C07-08 Salivary Gland 0 0 2 100 0 0 0 0 0 0 2 100C09 Tonsil 0 0 2 100 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 4 100 0 0 0 0 0 0 4 100

C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0

C15 Oesophagus 2 25 4 50 2 25 0 0 0 0 8 100C16 Stomach 0 0 3 60 2 40 0 0 0 0 5 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 0 0 4 80 1 20 0 0 0 0 5 100C19-20 Rectum 0 0 6 54.5 5 45.5 0 0 0 0 11 100

C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100

C22 Liver 0 0 0 0 0 0 0 0 0 0 0 0C23-24 Gallbladder 0 0 2 66.7 1 33.3 0 0 0 0 3 100C25 Pancreas 0 0 0 0 1 100 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 1 100 0 0 0 0 0 0 1 100C32 Larynx 1 25 3 75 0 0 0 0 0 0 4 100C33-34 Lung 0 0 6 31.6 13 68.4 0 0 0 0 19 100


C40-41 Bone 0 0 2 66.7 1 33.3 0 0 0 0 3 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 1 25 3 75 0 0 0 0 0 0 4 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0


39

C47+C49 Conn. & Soft Tissue 0 0 4 100 0 0 0 0 0 0 4 100C50 Breast 4 3.3 87 71.9 28 23.1 2 1.7 0 0 121 100C51 Vulva 0 0 1 100 0 0 0 0 0 0 1 100C52 Vagina 0 0 2 66.7 0 0 1 33.3 0 0 3 100C53 Cervix Uteri 3 6.1 39 79.6 7 14.3 0 0 0 0 49 100C54 Corpus Uteri 0 0 15 93.8 1 6.2 0 0 0 0 16 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 1 5.6 3 16.7 14 77.8 0 0 0 0 18 100C57 Other Female Genital 0 0 1 100 0 0 0 0 0 0 1 100C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 0 0 0 0 0 0 0 0C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 0 0 0 0 1 100 0 0 1 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 0 0 5 71.4 2 28.6 0 0 0 0 7 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 1 50 0 0 1 50 0 0 2 100C82-85,C96 NHL 0 0 5 45.5 3 27.3 2 18.2 1 9.1 11 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 1 25 3 75 0 0 4 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 1 11.1 1 11.1 7 77.8 0 0 9 100 All Sites 17 4.5 257 67.6 86 22.6 19 5 1 0.3 380 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


40

Table 16: Distribution of Clinical Extent of Disease (Prior+ Treatment At RI) – Male

ICD10 Site


# % # % # % # % # % # % C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 0 0 4 50 0 0 4 50 0 0 8 100C03-06 Mouth 0 0 4 50 2 25 2 25 0 0 8 100C07-08 Salivary Gland 0 0 2 50 1 25 1 25 0 0 4 100C09 Tonsil 0 0 0 0 0 0 1 100 0 0 1 100C10 Oth. Oropharynx 0 0 2 66.7 0 0 1 33.3 0 0 3 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 1 16.7 1 16.7 4 66.7 0 0 6 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 0 0 1 50 1 50 0 0 2 100C16 Stomach 2 11.1 8 44.4 5 27.8 3 16.7 0 0 18 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 0 0 5 45.5 3 27.3 3 27.3 0 0 11 100C19-20 Rectum 0 0 7 58.3 3 25 2 16.7 0 0 12 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 0 0 1 50 1 50 0 0 0 0 2 100C23-24 Gallbladder 0 0 0 0 0 0 0 0 0 0 0 0C25 Pancreas 0 0 0 0 1 100 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 2 100 0 0 0 0 0 0 2 100C32 Larynx 0 0 3 37.5 2 25 3 37.5 0 0 8 100C33-34 Lung 0 0 5 20 20 80 0 0 0 0 25 100


C40-41 Bone 0 0 4 50 3 37.5 1 12.5 0 0 8 100C43 Melanoma of Skin 0 0 0 0 1 100 0 0 0 0 1 100C44 Other Skin 0 0 0 0 1 100 0 0 0 0 1 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 0 0 3 60 0 0 2 40 0 0 5 100C50 Breast 0 0 0 0 1 100 0 0 0 0 1 100


41

C60 Penis 0 0 0 0 0 0 0 0 0 0 0 0C61 Prostate 0 0 6 26.1 17 73.9 0 0 0 0 23 100C62 Testis 0 0 2 66.7 0 0 1 33.3 0 0 3 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 3 75 1 25 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 2 25 0 0 6 75 0 0 8 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 3 42.9 0 0 4 57.1 0 0 7 100C73 Thyroid 0 0 1 50 1 50 0 0 0 0 2 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 0 0 0 0 0 0 0 0C82-85,C96 NHL 0 0 2 66.7 1 33.3 0 0 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 2 50 2 50 0 0 4 100C91 Lymphoid Leuk. 0 0 0 0 0 0 2 100 0 0 2 100C92-94 Myeloid Leukaemia 0 0 0 0 0 0 2 100 0 0 2 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 0 0 3 100 0 0 3 100 All Sites 2 1.1 67 35.6 70 37.2 49 26.1 0 0 188 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


42

Table 17: Distribution of Clinical Extent of Disease (Prior+ Treatment At RI) – Female

ICD10 Site


C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 0 0 0 0 1 33.3 2 66.7 0 0 3 100C03-06 Mouth 0 0 4 28.6 3 21.4 7 50 0 0 14 100C07-08 Salivary Gland 0 0 0 0 1 100 0 0 0 0 1 100C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0C10 Oth. Oropharynx 0 0 1 100 0 0 0 0 0 0 1 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 1 100 0 0 0 0 0 0 1 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 1 33.3 1 33.3 1 33.3 0 0 3 100C16 Stomach 0 0 1 33.3 2 66.7 0 0 0 0 3 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 0 0 2 50 2 50 0 0 0 0 4 100C19-20 Rectum 0 0 9 90 1 10 0 0 0 0 10 100C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 1 100C22 Liver 0 0 0 0 1 100 0 0 0 0 1 100C23-24 Gallbladder 0 0 0 0 0 0 1 100 0 0 1 100C25 Pancreas 0 0 0 0 1 100 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 0 0 0C32 Larynx 0 0 0 0 0 0 0 0 0 0 0 0C33-34 Lung 0 0 1 16.7 4 66.7 1 16.7 0 0 6 100C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0C40-41 Bone 0 0 6 75 2 25 0 0 0 0 8 100C43 Melanoma of Skin 0 0 0 0 1 25 3 75 0 0 4 100C44 Other Skin 0 0 2 50 0 0 2 50 0 0 4 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 0 0 0 0 0 0 2 100 0 0 2 100C50 Breast 7 8.6 50 61.7 16 19.8 8 9.9 0 0 81 100C51 Vulva 0 0 0 0 0 0 0 0 0 0 0 0


43

C52 Vagina 1 33.3 1 33.3 0 0 1 33.3 0 0 3 100C53 Cervix Uteri 1 5.3 12 63.2 5 26.3 1 5.3 0 0 19 100C54 Corpus Uteri 0 0 14 87.5 1 6.2 1 6.2 0 0 16 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 1 5.3 5 26.3 8 42.1 5 26.3 0 0 19 100C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 0 0C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 0 0 1 100 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 1 100 0 0 0 0 0 0 1 100C67 Bladder 0 0 0 0 0 0 0 0 0 0 0 0C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 2 66.7 1 33.3 0 0 0 0 3 100C73 Thyroid 0 0 2 50 1 25 1 25 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 0 0 1 100 0 0 1 100C82-85,C96 NHL 0 0 0 0 1 100 0 0 0 0 1 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 5 83.3 1 16.7 0 0 6 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 1 50 1 50 0 0 0 0 2 100 All Sites 11 4.9 116 51.6 59 26.2 39 17.3 0 0 225 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


44

Table 18: Distribution of Clinical Extent of Disease (No Treatment) – Male

ICD10 Site


C00 Lip 0 0 1 100 0 0 0 0 0 0 1 100C01-02 Tongue 0 0 5 71.4 2 28.6 0 0 0 0 7 100C03-06 Mouth 3 13 19 82.6 0 0 1 4.3 0 0 23 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0C09 Tonsil 0 0 2 100 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 3 100 0 0 0 0 0 0 3 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 8 88.9 1 11.1 0 0 0 0 9 100C14 Pharynx Unspecified 0 0 1 100 0 0 0 0 0 0 1 100C15 Oesophagus 1 3.6 11 39.3 10 35.7 4 14.3 2 7.1 28 100C16 Stomach 1 2.8 11 30.6 19 52.8 5 13.9 0 0 36 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 1 100C18 Colon 0 0 1 33.3 1 33.3 1 33.3 0 0 3 100C19-20 Rectum 0 0 8 50 6 37.5 2 12.5 0 0 16 100C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100C22 Liver 1 6.7 4 26.7 10 66.7 0 0 0 0 15 100C23-24 Gallbladder 0 0 2 66.7 1 33.3 0 0 0 0 3 100C25 Pancreas 0 0 2 14.3 12 85.7 0 0 0 0 14 100C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 0 0 0C32 Larynx 1 8.3 9 75 1 8.3 0 0 1 8.3 12 100C33-34 Lung 2 2.3 40 45.5 43 48.9 3 3.4 0 0 88 100C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0C40-41 Bone 0 0 1 50 1 50 0 0 0 0 2 100C43 Melanoma of Skin 0 0 0 0 0 0 1 100 0 0 1 100C44 Other Skin 2 33.3 4 66.7 0 0 0 0 0 0 6 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 0 0 4 100 0 0 0 0 0 0 4 100C50 Breast 0 0 0 0 0 0 0 0 0 0 0 0C60 Penis 0 0 0 0 0 0 0 0 0 0 0 0


45

C61 Prostate 0 0 4 57.1 3 42.9 0 0 0 0 7 100C62 Testis 0 0 0 0 0 0 0 0 0 0 0 0C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 1 25 2 50 1 25 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 3 60 0 0 2 40 0 0 5 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 0 0 1 50 1 50 0 0 0 0 2 100C74 Adrenal Gland 0 0 0 0 1 100 0 0 0 0 1 100C81 Hodgkins Disease 0 0 0 0 0 0 2 100 0 0 2 100C82-85,C96 NHL 0 0 10 58.8 2 11.8 5 29.4 0 0 17 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 3 50 3 50 0 0 6 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 3 100 0 0 3 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 3 11.5 23 88.5 0 0 26 100 All Sites 11 3.2 156 44.7 123 35.2 56 16 3 0.9 349 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


46

Table 19: Distribution of Clinical Extent of Disease (No Treatment) – Female

ICD10 Site


# % # % # % # % # % # % C00 Lip 0 0 2 100 0 0 0 0 0 0 2 100C01-02 Tongue 0 0 3 100 0 0 0 0 0 0 3 100C03-06 Mouth 0 0 9 90 1 10 0 0 0 0 10 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 2 100 0 0 0 0 0 0 2 100C12-13 Hypopharynx 0 0 3 60 1 20 1 20 0 0 5 100


C15 Oesophagus 0 0 10 66.7 4 26.7 1 6.7 0 0 15 100C16 Stomach 0 0 0 0 10 90.9 1 9.1 0 0 11 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 1 100C18 Colon 0 0 2 22.2 5 55.6 1 11.1 1 11.1 9 100C19-20 Rectum 1 9.1 6 54.5 3 27.3 1 9.1 0 0 11 100

C21 Anus & Anal Canal 0 0 2 100 0 0 0 0 0 0 2 100

C22 Liver 0 0 1 50 1 50 0 0 0 0 2 100C23-24 Gallbladder 0 0 1 100 0 0 0 0 0 0 1 100C25 Pancreas 0 0 0 0 2 66.7 1 33.3 0 0 3 100C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 0 0 0C32 Larynx 0 0 0 0 0 0 0 0 0 0 0 0C33-34 Lung 0 0 6 50 6 50 0 0 0 0 12 100


C40-41 Bone 0 0 2 66.7 1 33.3 0 0 0 0 3 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 0 0 1 50 0 0 1 50 0 0 2 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0


47

C47+C49 Conn. & Soft Tissue 0 0 4 80 1 20 0 0 0 0 5 100

C50 Breast 3 10 19 63.3 8 26.7 0 0 0 0 30 100C51 Vulva 1 50 1 50 0 0 0 0 0 0 2 100C52 Vagina 0 0 0 0 0 0 0 0 0 0 0 0C53 Cervix Uteri 3 11.1 17 63 7 25.9 0 0 0 0 27 100C54 Corpus Uteri 0 0 1 33.3 2 66.7 0 0 0 0 3 100

C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0

C56 Ovary 0 0 5 26.3 13 68.4 1 5.3 0 0 19 100

C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 0 0

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 1 100 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 0 0 0 0 0 0 0 0 0 0

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 2 100 0 0 2 100C73 Thyroid 0 0 4 100 0 0 0 0 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 1 50 0 0 1 50 0 0 2 100C82-85,C96 NHL 1 12.5 6 75 0 0 1 12.5 0 0 8 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 1 33.3 2 66.7 0 0 3 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0

C92-94 Myeloid Leukaemia 0 0 0 0 0 0 1 100 0 0 1 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 2 22.2 7 77.8 0 0 9 100 All Sites 9 4.3 108 51.4 70 33.3 22 10.5 1 0.5 210 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


48

Table 20: Distribution of Clinical Extent of Disease

(Prior Treatment Only, Prior + Treatment at RI, Treatment Only at RI, No Treatment) – Male

ICD10 Site


C00 Lip 1 33.3 1 33.3 0 0 1 33.3 0 0 3 100C01-02 Tongue 4 6.6 43 70.5 2 3.3 12 19.7 0 0 61 100C03-06 Mouth 6 5.7 75 70.8 13 12.3 12 11.3 0 0 106 100C07-08 Salivary Gland 0 0 3 60 1 20 1 20 0 0 5 100C09 Tonsil 0 0 10 83.3 0 0 2 16.7 0 0 12 100C10 Oth. Oropharynx 1 3.7 20 74.1 4 14.8 2 7.4 0 0 27 100C11 Nasopharynx 0 0 2 100 0 0 0 0 0 0 2 100C12-13 Hypopharynx 1 2.1 35 72.9 5 10.4 7 14.6 0 0 48 100


C15 Oesophagus 1 1.7 24 41.4 23 39.7 8 13.8 2 3.4 58 100C16 Stomach 7 7.2 34 35.1 43 44.3 13 13.4 0 0 97 100C17 Small Intestine 0 0 0 0 3 100 0 0 0 0 3 100C18 Colon 1 2.6 15 39.5 13 34.2 9 23.7 0 0 38 100C19-20 Rectum 2 3.8 26 50 18 34.6 6 11.5 0 0 52 100

C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100

C22 Liver 1 5 7 35 12 60 0 0 0 0 20 100C23-24 Gallbladder 0 0 5 71.4 2 28.6 0 0 0 0 7 100C25 Pancreas 0 0 4 22.2 14 77.8 0 0 0 0 18 100C30-31 Nose,Sinuses 0 0 2 50 1 25 1 25 0 0 4 100C32 Larynx 8 12.7 41 65.1 7 11.1 6 9.5 1 1.6 63 100C33-34 Lung 2 0.8 86 35.7 148 61.4 5 2.1 0 0 241 100


C40-41 Bone 0 0 6 35.3 6 35.3 5 29.4 0 0 17 100C43 Melanoma of Skin 0 0 3 33.3 3 33.3 3 33.3 0 0 9 100C44 Other Skin 7 36.8 8 42.1 1 5.3 3 15.8 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0


49

C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0

C47+C49 Conn. & Soft Tissue 1 5 11 55 2 10 6 30 0 0 20 100

C50 Breast 1 14.3 5 71.4 1 14.3 0 0 0 0 7 100C60 Penis 1 20 3 60 0 0 1 20 0 0 5 100C61 Prostate 0 0 22 42.3 30 57.7 0 0 0 0 52 100C62 Testis 1 16.7 4 66.7 0 0 1 16.7 0 0 6 100

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0

C64 Kidney 0 0 2 14.3 10 71.4 2 14.3 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 12 41.4 3 10.3 14 48.3 0 0 29 100


C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 7 36.8 2 10.5 10 52.6 0 0 19 100C73 Thyroid 0 0 8 61.5 2 15.4 3 23.1 0 0 13 100C74 Adrenal Gland 0 0 0 0 1 50 1 50 0 0 2 100C81 Hodgkins Disease 0 0 2 40 1 20 2 40 0 0 5 100C82-85,C96 NHL 0 0 17 45.9 6 16.2 14 37.8 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 8 40 12 60 0 0 20 100C91 Lymphoid Leuk. 0 0 0 0 0 0 3 100 0 0 3 100


C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 5 10.6 42 89.4 0 0 47 100 All Sites 46 3.8 545 45.5 391 32.6 214 17.8 3 0.3 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


50

Table 21: Distribution of Clinical Extent of Disease (Prior Treatment Only, Prior + Treatment at RI, Treatment Only at RI, No Treatment) – Female

ICD10 Site


# % # % # % # % # % # %C00 Lip 2 20 5 50 0 0 3 30 0 0 10 100C01-02 Tongue 1 4.5 14 63.6 2 9.1 5 22.7 0 0 22 100C03-06 Mouth 3 3.7 52 64.2 7 8.6 19 23.5 0 0 81 100C07-08 Salivary Gland 0 0 2 66.7 1 33.3 0 0 0 0 3 100C09 Tonsil 0 0 2 100 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 1 100 0 0 0 0 0 0 1 100C11 Nasopharynx 0 0 2 100 0 0 0 0 0 0 2 100C12-13 Hypopharynx 0 0 9 81.8 1 9.1 1 9.1 0 0 11 100


C15 Oesophagus 2 6.2 17 53.1 9 28.1 4 12.5 0 0 32 100C16 Stomach 1 4.3 5 21.7 16 69.6 1 4.3 0 0 23 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 1 100C18 Colon 1 3.7 12 44.4 10 37 3 11.1 1 3.7 27 100C19-20 Rectum 1 2.8 24 66.7 9 25 2 5.6 0 0 36 100

C21 Anus & Anal Canal 1 25 3 75 0 0 0 0 0 0 4 100

C22 Liver 0 0 1 33.3 2 66.7 0 0 0 0 3 100C23-24 Gallbladder 0 0 3 50 1 16.7 2 33.3 0 0 6 100C25 Pancreas 0 0 0 0 4 80 1 20 0 0 5 100C30-31 Nose,Sinuses 0 0 1 33.3 0 0 2 66.7 0 0 3 100C32 Larynx 1 25 3 75 0 0 0 0 0 0 4 100C33-34 Lung 0 0 13 32.5 26 65 1 2.5 0 0 40 100


C40-41 Bone 0 0 11 61.1 5 27.8 1 5.6 1 5.6 18 100C43 Melanoma of Skin 0 0 0 0 1 25 3 75 0 0 4 100C44 Other Skin 4 25 7 43.8 0 0 5 31.2 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0


51

C47+C49 Conn. & Soft Tissue 0 0 9 60 1 6.7 5 33.3 0 0 15 100

C50 Breast 29 9.6 181 60.1 71 23.6 20 6.6 0 0 301 100C51 Vulva 1 25 3 75 0 0 0 0 0 0 4 100C52 Vagina 1 14.3 4 57.1 0 0 2 28.6 0 0 7 100C53 Cervix Uteri 8 6.5 80 64.5 22 17.7 14 11.3 0 0 124 100C54 Corpus Uteri 1 2.2 35 76.1 5 10.9 5 10.9 0 0 46 100

C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0

C56 Ovary 2 2.7 22 29.3 42 56 9 12 0 0 75 100


C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 1 16.7 3 50 2 33.3 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 1 100 0 0 0 0 0 0 1 100C67 Bladder 0 0 0 0 0 0 3 100 0 0 3 100


C69 Eye 0 0 1 100 0 0 0 0 0 0 1 100C70-72 Brain, NS 0 0 3 33.3 1 11.1 5 55.6 0 0 9 100C73 Thyroid 0 0 18 72 4 16 3 12 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 3 50 0 0 3 50 0 0 6 100C82-85,C96 NHL 1 3.7 15 55.6 4 14.8 6 22.2 1 3.7 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 11 52.4 10 47.6 0 0 21 100C91 Lymphoid Leuk. 0 0 0 0 0 0 1 100 0 0 1 100


C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 2 8.3 4 16.7 18 75 0 0 24 100 All Sites 60 5.7 566 53.6 263 24.9 163 15.5 3 0.3 1055 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


52

Table 22: Distribution of detailed microscopic diagnosis – Male

ICD10 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total

# % # % # % # % # % # % # %C00 Lip 3 100 0 0 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 53 86.9 1 1.6 0 0 0 0 0 0 7 11.5 61 100C03-06 Mouth 80 75.5 1 0.9 1 0.9 0 0 0 0 24 22.6 106 100C07-08 Salivary Gland 4 80 0 0 1 20 0 0 0 0 0 0 5 100C09 Tonsil 11 91.7 1 8.3 0 0 0 0 0 0 0 0 12 100C10 Oth. Oropharynx 23 85.2 2 7.4 0 0 0 0 0 0 2 7.4 27 100C11 Nasopharynx 0 0 0 0 1 50 0 0 0 0 1 50 2 100C12-13 Hypopharynx 35 72.9 2 4.2 5 10.4 0 0 0 0 6 12.5 48 100

C14 Pharynx Unspecified 1 100 0 0 0 0 0 0 0 0 0 0 1 100

C15 Oesophagus 44 75.9 1 1.7 0 0 0 0 0 0 13 22.4 58 100C16 Stomach 82 84.5 2 2.1 1 1 0 0 0 0 12 12.4 97 100C17 Small Intestine 2 66.7 1 33.3 0 0 0 0 0 0 0 0 3 100C18 Colon 34 89.5 0 0 0 0 0 0 0 0 4 10.5 38 100C19-20 Rectum 46 88.5 1 1.9 0 0 0 0 0 0 5 9.6 52 100C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 0 0 1 100C22 Liver 4 20 0 0 4 20 0 0 0 0 12 60 20 100C23-24 Gallbladder 4 57.1 1 14.3 0 0 0 0 0 0 2 28.6 7 100C25 Pancreas 3 16.7 2 11.1 2 11.1 0 0 0 0 11 61.1 18 100C30-31 Nose,Sinuses 4 100 0 0 0 0 0 0 0 0 0 0 4 100C32 Larynx 50 79.4 0 0 1 1.6 0 0 0 0 12 19 63 100C33-34 Lung 61 25.3 35 14.5 90 37.3 0 0 0 0 55 22.8 241 100

C37-38 Other Thoracic Organs 1 100 0 0 0 0 0 0 0 0 0 0 1 100

C40-41 Bone 13 76.5 0 0 2 11.8 0 0 1 5.9 1 5.9 17 100C43 Melanoma of Skin 9 100 0 0 0 0 0 0 0 0 0 0 9 100C44 Other Skin 18 94.7 0 0 0 0 0 0 0 0 1 5.3 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0


53

C47+C49 Conn. & Soft Tissue 18 90 0 0 0 0 0 0 0 0 2 10 20 100

C50 Breast 5 71.4 0 0 1 14.3 0 0 0 0 1 14.3 7 100C60 Penis 5 100 0 0 0 0 0 0 0 0 0 0 5 100C61 Prostate 39 75 5 9.6 0 0 0 0 0 0 8 15.4 52 100C62 Testis 6 100 0 0 0 0 0 0 0 0 0 0 6 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 12 85.7 0 0 0 0 0 0 0 0 2 14.3 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 25 86.2 0 0 0 0 0 0 0 0 4 13.8 29 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 19 100 0 0 0 0 0 0 0 0 0 0 19 100C73 Thyroid 9 69.2 1 7.7 2 15.4 0 0 0 0 1 7.7 13 100C74 Adrenal Gland 2 100 0 0 0 0 0 0 0 0 0 0 2 100C81 Hodgkins Disease 3 60 0 0 2 40 0 0 0 0 0 0 5 100C82-85,C96 NHL 30 81.1 1 2.7 6 16.2 0 0 0 0 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 2 10 0 0 11 55 7 35 20 100C91 Lymphoid Leuk. 1 33.3 0 0 0 0 0 0 2 66.7 0 0 3 100

C92-94 Myeloid Leukaemia 3 42.9 0 0 0 0 3 42.9 1 14.3 0 0 7 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 6 12.8 13 27.7 14 29.8 0 0 0 0 14 29.8 47 100

All Sites 769 64.1 70 5.8 135 11.3 3 0.3 15 1.3 207 17.3 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


54

Table 23: Distribution of detailed microscopic diagnosis - Female

ICD10 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total

# % # % # % # % # % # % # % C00 Lip 9 90 0 0 0 0 0 0 0 0 1 10 10 100C01-02 Tongue 20 90.9 0 0 0 0 0 0 0 0 2 9.1 22 100C03-06 Mouth 71 87.7 0 0 1 1.2 0 0 0 0 9 11.1 81 100C07-08 Salivary Gland 2 66.7 0 0 1 33.3 0 0 0 0 0 0 3 100C09 Tonsil 1 50 0 0 0 0 0 0 0 0 1 50 2 100C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 1 100 1 100C11 Nasopharynx 1 50 0 0 1 50 0 0 0 0 0 0 2 100C12-13 Hypopharynx 9 81.8 0 0 0 0 0 0 0 0 2 18.2 11 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 27 84.4 0 0 0 0 0 0 0 0 5 15.6 32 100C16 Stomach 20 87 0 0 0 0 0 0 0 0 3 13 23 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 1 100 1 100C18 Colon 20 74.1 1 3.7 0 0 0 0 0 0 6 22.2 27 100C19-20 Rectum 33 94.3 0 0 1 2.9 0 0 0 0 1 2.9 35 100C21 Anus & Anal Canal 3 75 0 0 0 0 0 0 0 0 1 25 4 100C22 Liver 2 66.7 0 0 1 33.3 0 0 0 0 0 0 3 100C23-24 Gallbladder 4 66.7 1 16.7 0 0 0 0 0 0 1 16.7 6 100C25 Pancreas 1 20 0 0 0 0 0 0 0 0 4 80 5 100C30-31 Nose,Sinuses 3 100 0 0 0 0 0 0 0 0 0 0 3 100C32 Larynx 4 100 0 0 0 0 0 0 0 0 0 0 4 100C33-34 Lung 10 25 8 20 12 30 0 0 0 0 10 25 40 100

C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C40-41 Bone 15 83.3 0 0 1 5.6 0 0 0 0 2 11.1 18 100C43 Melanoma of Skin 3 75 1 25 0 0 0 0 0 0 0 0 4 100C44 Other Skin 16 100 0 0 0 0 0 0 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0


55

C47+C49 Conn. & Soft Tissue 15 100 0 0 0 0 0 0 0 0 0 0 15 100C50 Breast 233 77.4 4 1.3 45 15 0 0 0 0 19 6.3 301 100C51 Vulva 4 100 0 0 0 0 0 0 0 0 0 0 4 100C52 Vagina 7 100 0 0 0 0 0 0 0 0 0 0 7 100C53 Cervix Uteri 101 81.5 1 0.8 4 3.2 0 0 0 0 18 14.5 124 100C54 Corpus Uteri 42 91.3 0 0 1 2.2 0 0 0 0 3 6.5 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 33 44 7 9.3 14 18.7 0 0 0 0 21 28 75 100

C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 1 100 1 100

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 6 100 0 0 0 0 0 0 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 1 100 0 0 0 0 0 0 0 0 0 0 1 100C67 Bladder 3 100 0 0 0 0 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 1 100 0 0 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 7 77.8 0 0 0 0 0 0 0 0 2 22.2 9 100C73 Thyroid 18 72 1 4 6 24 0 0 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 6 100 0 0 0 0 0 0 0 0 0 0 6 100C82-85, C96 NHL 22 81.5 0 0 4 14.8 0 0 1 3.7 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 9 42.9 0 0 0 0 1 4.8 5 23.8 6 28.6 21 100C91 Lymphoid Leuk. 0 0 0 0 0 0 1 100 0 0 0 0 1 100C92-94 Myeloid Leukaemia 3 75 0 0 0 0 1 25 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 3 12.5 6 25 6 25 0 0 0 0 9 37.5 24 100

All Sites 788 74.8 30 2.8 98 9.3 3 0.3 6 0.6 129 12.2 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


56

Table 24: Educational status of patients - Male

ICD10 Site Primary Secondary Illiterate Literate College Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 0 0 1 33.3 1 33.3 1 33.3 0 0 0 0 0 0 3 100C01-02 Tongue 29 47.5 15 24.6 6 9.8 5 8.2 4 6.6 1 1.6 1 1.6 61 100C03-06 Mouth 58 54.7 20 18.9 14 13.2 11 10.4 3 2.8 0 0 0 0 106 100C07-08 Salivary Gland 1 20 2 40 0 0 1 20 1 20 0 0 0 0 5 100C09 Tonsil 7 58.3 1 8.3 3 25 1 8.3 0 0 0 0 0 0 12 100C10 Oth. Oropharynx 14 51.9 7 25.9 1 3.7 5 18.5 0 0 0 0 0 0 27 100C11 Nasopharynx 1 50 0 0 0 0 0 0 1 50 0 0 0 0 2 100C12-13 Hypopharynx 24 50 11 22.9 7 14.6 5 10.4 1 2.1 0 0 0 0 48 100C14 Pharynx Unspecified 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C15 Oesophagus 33 56.9 13 22.4 6 10.3 2 3.4 1 1.7 2 3.4 1 1.7 58 100C16 Stomach 59 60.8 24 24.7 4 4.1 4 4.1 2 2.1 2 2.1 2 2.1 97 100C17 Small Intestine 1 33.3 2 66.7 0 0 0 0 0 0 0 0 0 0 3 100C18 Colon 15 39.5 16 42.1 1 2.6 0 0 6 15.8 0 0 0 0 38 100C19-20 Rectum 25 48.1 22 42.3 3 5.8 1 1.9 1 1.9 0 0 0 0 52 100C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C22 Liver 14 70 4 20 0 0 0 0 1 5 0 0 1 5 20 100C23-24 Gallbladder 1 14.3 5 71.4 1 14.3 0 0 0 0 0 0 0 0 7 100C25 Pancreas 9 50 3 16.7 4 22.2 0 0 0 0 1 5.6 1 5.6 18 100C30-31 Nose,Sinuses 2 50 1 25 0 0 0 0 0 0 0 0 1 25 4 100C32 Larynx 30 47.6 15 23.8 8 12.7 5 7.9 3 4.8 0 0 2 3.2 63 100C33-34 Lung 134 55.6 47 19.5 22 9.1 22 9.1 8 3.3 3 1.2 5 2.1 241 100C37-38 Other Thoracic Organs 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C40-41 Bone 2 11.8 8 47.1 1 5.9 0 0 1 5.9 2 11.8 3 17.6 17 100C43 Melanoma of Skin 5 55.6 3 33.3 1 11.1 0 0 0 0 0 0 0 0 9 100C44 Other Skin 5 26.3 10 52.6 3 15.8 0 0 1 5.3 0 0 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 5 25 12 60 1 5 0 0 2 10 0 0 0 0 20 100C50 Breast 2 28.6 2 28.6 1 14.3 0 0 1 14.3 0 0 1 14.3 7 100C60 Penis 2 40 1 20 2 40 0 0 0 0 0 0 0 0 5 100


57

C61 Prostate 24 46.2 15 28.8 4 7.7 5 9.6 2 3.8 1 1.9 1 1.9 52 100C62 Testis 1 16.7 1 16.7 0 0 1 16.7 1 16.7 2 33.3 0 0 6 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 10 71.4 3 21.4 1 7.1 0 0 0 0 0 0 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 11 37.9 7 24.1 2 6.9 4 13.8 2 6.9 2 6.9 1 3.4 29 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 6 31.6 12 63.2 0 0 0 0 0 0 1 5.3 0 0 19 100C73 Thyroid 9 69.2 3 23.1 0 0 0 0 1 7.7 0 0 0 0 13 100C74 Adrenal Gland 1 50 1 50 0 0 0 0 0 0 0 0 0 0 2 100C81 Hodgkins Disease 3 60 1 20 0 0 0 0 1 20 0 0 0 0 5 100C82-85, C96 NHL 15 40.5 13 35.1 2 5.4 3 8.1 2 5.4 2 5.4 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 8 40 6 30 0 0 1 5 3 15 1 5 1 5 20 100C91 Lymphoid Leuk. 1 33.3 0 0 1 33.3 0 0 1 33.3 0 0 0 0 3 100C92-94 Myeloid Leukaemia 2 28.6 4 57.1 0 0 1 14.3 0 0 0 0 0 0 7 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 24 51.1 15 31.9 4 8.5 3 6.4 1 2.1 0 0 0 0 47 100

All Sites 594 49.5 327 27.3 104 8.7 82 6.8 51 4.3 20 1.7 21 1.8 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


58

Table 25: Educational status of patients - Female

ICD10 Site Primary Secondary Illiterate Literate College Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 1 10 1 10 5 50 1 10 0 0 1 10 1 10 10 100C01-02 Tongue 9 40.9 3 13.6 5 22.7 3 13.6 0 0 1 4.5 1 4.5 22 100C03-06 Mouth 17 21 7 8.6 41 50.6 10 12.3 1 1.2 1 1.2 4 4.9 81 100C07-08 Salivary Gland 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C09 Tonsil 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C11 Nasopharynx 1 50 1 50 0 0 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 4 36.4 2 18.2 4 36.4 1 9.1 0 0 0 0 0 0 11 100

C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C15 Oesophagus 11 34.4 2 6.2 9 28.1 5 15.6 1 3.1 2 6.2 2 6.2 32 100C16 Stomach 12 52.2 1 4.3 4 17.4 3 13 1 4.3 0 0 2 8.7 23 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C18 Colon 11 40.7 11 40.7 4 14.8 1 3.7 0 0 0 0 0 0 27 100C19-20 Rectum 11 31.4 8 22.9 5 14.3 6 17.1 3 8.6 2 5.7 0 0 35 100

C21 Anus & Anal Canal 0 0 3 75 1 25 0 0 0 0 0 0 0 0 4 100

C22 Liver 1 33.3 0 0 1 33.3 0 0 1 33.3 0 0 0 0 3 100C23-24 Gallbladder 4 66.7 1 16.7 1 16.7 0 0 0 0 0 0 0 0 6 100C25 Pancreas 3 60 1 20 1 20 0 0 0 0 0 0 0 0 5 100C30-31 Nose,Sinuses 2 66.7 1 33.3 0 0 0 0 0 0 0 0 0 0 3 100C32 Larynx 3 75 1 25 0 0 0 0 0 0 0 0 0 0 4 100C33-34 Lung 11 27.5 8 20 8 20 6 15 2 5 2 5 3 7.5 40 100

C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C40-41 Bone 6 33.3 8 44.4 1 5.6 0 0 3 16.7 0 0 0 0 18 100C43 Melanoma of Skin 1 25 2 50 1 25 0 0 0 0 0 0 0 0 4 100C44 Other Skin 7 43.8 2 12.5 4 25 2 12.5 1 6.2 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


59

C47+C49 Conn. & Soft Tissue 4 26.7 6 40 2 13.3 0 0 3 20 0 0 0 0 15 100

C50 Breast 109 36.2 111 36.9 29 9.6 13 4.3 26 8.6 10 3.3 3 1 301 100C51 Vulva 3 75 0 0 1 25 0 0 0 0 0 0 0 0 4 100C52 Vagina 3 42.9 2 28.6 2 28.6 0 0 0 0 0 0 0 0 7 100C53 Cervix Uteri 58 46.8 29 23.4 24 19.4 6 4.8 3 2.4 0 0 4 3.2 124 100C54 Corpus Uteri 23 50 15 32.6 4 8.7 1 2.2 2 4.3 0 0 1 2.2 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 34 45.3 17 22.7 13 17.3 6 8 4 5.3 1 1.3 0 0 75 100

C57 Other Female Genital 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 5 83.3 1 16.7 0 0 0 0 0 0 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C67 Bladder 2 66.7 0 0 0 0 1 33.3 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 5 55.6 2 22.2 1 11.1 1 11.1 0 0 0 0 0 0 9 100C73 Thyroid 10 40 7 28 4 16 0 0 4 16 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 1 16.7 2 33.3 0 0 2 33.3 1 16.7 0 0 0 0 6 100C82-85, C96 NHL 9 33.3 5 18.5 8 29.6 3 11.1 1 3.7 1 3.7 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 10 47.6 2 9.5 6 28.6 0 0 1 4.8 1 4.8 1 4.8 21 100C91 Lymphoid Leuk. 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 1 25 2 50 1 25 0 0 0 0 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 11 45.8 8 33.3 2 8.3 2 8.3 1 4.2 0 0 0 0 24 100

All Sites 411 39 274 26 193 18.3 73 6.9 59 5.6 22 2.1 22 2.1 1054 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


60

Table 26: Intention to Treat at Reporting Institution (Excluding the Cancers Previously Treated) - Male

ICD10 Site Radical Palliative Pain Relief Only Symptomatic Unknown Total

# % # % # % # % # % # % C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 26 74.3 9 25.7 0 0 0 0 0 0 35 100C03-06 Mouth 34 59.6 23 40.4 0 0 0 0 0 0 57 100C07-08 Salivary Gland 1 100 0 0 0 0 0 0 0 0 1 100C09 Tonsil 5 62.5 3 37.5 0 0 0 0 0 0 8 100C10 Oth. Oropharynx 10 62.5 6 37.5 0 0 0 0 0 0 16 100C11 Nasopharynx 1 100 0 0 0 0 0 0 0 0 1 100C12-13 Hypopharynx 17 70.8 7 29.2 0 0 0 0 0 0 24 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 2 11.8 15 88.2 0 0 0 0 0 0 17 100C16 Stomach 8 42.1 11 57.9 0 0 0 0 0 0 19 100C17 Small Intestine 0 0 1 100 0 0 0 0 0 0 1 100C18 Colon 8 72.7 3 27.3 0 0 0 0 0 0 11 100C19-20 Rectum 10 71.4 4 28.6 0 0 0 0 0 0 14 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 0 0 1 100 0 0 0 0 0 0 1 100C23-24 Gallbladder 1 100 0 0 0 0 0 0 0 0 1 100C25 Pancreas 0 0 3 100 0 0 0 0 0 0 3 100C30-31 Nose,Sinuses 0 0 1 100 0 0 0 0 0 0 1 100C32 Larynx 23 76.7 6 20 0 0 0 0 1 3.3 30 100C33-34 Lung 20 20.4 77 78.6 0 0 0 0 1 1 98 100


C40-41 Bone 2 100 0 0 0 0 0 0 0 0 2 100C43 Melanoma of Skin 4 100 0 0 0 0 0 0 0 0 4 100C44 Other Skin 6 75 2 25 0 0 0 0 0 0 8 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 4 80 1 20 0 0 0 0 0 0 5 100C50 Breast 3 75 1 25 0 0 0 0 0 0 4 100C60 Penis 3 100 0 0 0 0 0 0 0 0 3 100


61

C61 Prostate 8 80 2 20 0 0 0 0 0 0 10 100C62 Testis 0 0 0 0 0 0 0 0 0 0 0 0C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 1 100 0 0 0 0 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 3 75 1 25 0 0 0 0 0 0 4 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 4 100 0 0 0 0 0 0 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 2 100 0 0 0 0 0 0 0 0 2 100C82-85, C96 NHL 2 66.7 1 33.3 0 0 0 0 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 1 100 0 0 0 0 0 0 1 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 5 33.3 10 66.7 0 0 0 0 0 0 15 100 All Sites 213 52.7 189 46.8 0 0 0 0 2 0.5 404 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


62

Table 27: Intention to Treat at Reporting Institution (Excluding the Cancers Previously Treated) - Female

ICD10 Site Radical Palliative Pain Relief Only Symptomatic Unknown Total

# % # % # % # % # % # % C00 Lip 2 40 3 60 0 0 0 0 0 0 5 100C01-02 Tongue 8 61.5 4 30.8 0 0 1 7.7 0 0 13 100C03-06 Mouth 29 69 12 28.6 0 0 0 0 1 2.4 42 100C07-08 Salivary Gland 1 50 1 50 0 0 0 0 0 0 2 100C09 Tonsil 1 50 1 50 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 4 100 0 0 0 0 0 0 0 0 4 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 2 25 5 62.5 0 0 0 0 1 12.5 8 100C16 Stomach 0 0 5 100 0 0 0 0 0 0 5 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 4 80 1 20 0 0 0 0 0 0 5 100C19-20 Rectum 9 81.8 2 18.2 0 0 0 0 0 0 11 100C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100C22 Liver 0 0 0 0 0 0 0 0 0 0 0 0C23-24 Gallbladder 2 66.7 1 33.3 0 0 0 0 0 0 3 100C25 Pancreas 0 0 1 100 0 0 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 1 100 0 0 0 0 0 0 1 100C32 Larynx 2 50 2 50 0 0 0 0 0 0 4 100C33-34 Lung 0 0 19 100 0 0 0 0 0 0 19 100


C40-41 Bone 2 66.7 1 33.3 0 0 0 0 0 0 3 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 3 75 1 25 0 0 0 0 0 0 4 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 4 100 0 0 0 0 0 0 0 0 4 100C50 Breast 99 81.8 22 18.2 0 0 0 0 0 0 121 100C51 Vulva 0 0 1 100 0 0 0 0 0 0 1 100


63

C52 Vagina 1 33.3 1 33.3 0 0 0 0 1 33.3 3 100C53 Cervix Uteri 43 87.8 6 12.2 0 0 0 0 0 0 49 100C54 Corpus Uteri 15 93.8 1 6.2 0 0 0 0 0 0 16 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 7 38.9 10 55.6 0 0 1 5.6 0 0 18 100C57 Other Female Genital 1 100 0 0 0 0 0 0 0 0 1 100C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 0 0 0 0 0 0 0 0C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 1 100 0 0 0 0 0 0 0 0 1 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 5 71.4 2 28.6 0 0 0 0 0 0 7 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 2 100 0 0 0 0 0 0 0 0 2 100C82-85, C96 NHL 6 54.5 5 45.5 0 0 0 0 0 0 11 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 4 100 0 0 0 0 0 0 4 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 1 11.1 7 77.8 0 0 1 11.1 0 0 9 100 All Sites 254 66.8 120 31.6 0 0 3 0.8 3 0.8 380 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


64

Table 28: Marital status of patients - Male

ICD10 Site Unmarried Married Widowed Divorced Seperated Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 0 0 3 100 0 0 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 3 4.9 55 90.2 2 3.3 0 0 0 0 1 1.6 0 0 61 100C03-06 Mouth 2 1.9 95 89.6 9 8.5 0 0 0 0 0 0 0 0 106 100C07-08 Salivary Gland 0 0 5 100 0 0 0 0 0 0 0 0 0 0 5 100C09 Tonsil 1 8.3 11 91.7 0 0 0 0 0 0 0 0 0 0 12 100C10 Oth. Oropharynx 1 3.7 26 96.3 0 0 0 0 0 0 0 0 0 0 27 100C11 Nasopharynx 0 0 2 100 0 0 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 3 6.2 43 89.6 1 2.1 0 0 0 0 0 0 1 2.1 48 100


C15 Oesophagus 1 1.7 55 94.8 2 3.4 0 0 0 0 0 0 0 0 58 100C16 Stomach 0 0 91 93.8 6 6.2 0 0 0 0 0 0 0 0 97 100C17 Small Intestine 0 0 3 100 0 0 0 0 0 0 0 0 0 0 3 100C18 Colon 1 2.6 35 92.1 2 5.3 0 0 0 0 0 0 0 0 38 100C19-20 Rectum 1 1.9 47 90.4 4 7.7 0 0 0 0 0 0 0 0 52 100C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C22 Liver 1 5 16 80 3 15 0 0 0 0 0 0 0 0 20 100C23-24 Gallbladder 0 0 5 71.4 2 28.6 0 0 0 0 0 0 0 0 7 100C25 Pancreas 1 5.6 16 88.9 1 5.6 0 0 0 0 0 0 0 0 18 100C30-31 Nose,Sinuses 1 25 3 75 0 0 0 0 0 0 0 0 0 0 4 100C32 Larynx 4 6.3 55 87.3 3 4.8 0 0 0 0 0 0 1 1.6 63 100C33-34 Lung 1 0.4 227 94.2 11 4.6 0 0 0 0 1 0.4 1 0.4 241 100


C40-41 Bone 10 58.8 7 41.2 0 0 0 0 0 0 0 0 0 0 17 100C43 Melanoma of Skin 0 0 9 100 0 0 0 0 0 0 0 0 0 0 9 100C44 Other Skin 0 0 16 84.2 3 15.8 0 0 0 0 0 0 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C47+C49 Conn. & Soft Tissue 4 20 16 80 0 0 0 0 0 0 0 0 0 0 20 100

C50 Breast 0 0 4 57.1 2 28.6 0 0 0 0 0 0 1 14.3 7 100


65

C60 Penis 0 0 5 100 0 0 0 0 0 0 0 0 0 0 5 100C61 Prostate 1 1.9 46 88.5 4 7.7 0 0 0 0 0 0 1 1.9 52 100C62 Testis 3 50 3 50 0 0 0 0 0 0 0 0 0 0 6 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 14 100 0 0 0 0 0 0 0 0 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 0 0 27 93.1 2 6.9 0 0 0 0 0 0 0 0 29 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 4 21.1 14 73.7 1 5.3 0 0 0 0 0 0 0 0 19 100C73 Thyroid 0 0 13 100 0 0 0 0 0 0 0 0 0 0 13 100C74 Adrenal Gland 0 0 2 100 0 0 0 0 0 0 0 0 0 0 2 100C81 Hodgkins Disease 2 40 3 60 0 0 0 0 0 0 0 0 0 0 5 100C82-85, C96 NHL 5 13.5 31 83.8 1 2.7 0 0 0 0 0 0 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 1 5 17 85 2 10 0 0 0 0 0 0 0 0 20 100C91 Lymphoid Leuk. 2 66.7 0 0 0 0 0 0 0 0 1 33.3 0 0 3 100C92-94 Myeloid Leukaemia 2 28.6 5 71.4 0 0 0 0 0 0 0 0 0 0 7 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 46 97.9 1 2.1 0 0 0 0 0 0 0 0 47 100

All Sites 56 4.7 1073 89.5 62 5.2 0 0 0 0 3 0.3 5 0.4 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


66

Table 29: Marital status of patients - Female

ICD10 Site Unmarried Married Widowed Divorced Seperated Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 0 0 2 20 8 80 0 0 0 0 0 0 0 0 10 100C01-02 Tongue 0 0 10 45.5 11 50 0 0 0 0 0 0 1 4.5 22 100C03-06 Mouth 4 4.9 33 40.7 43 53.1 0 0 1 1.2 0 0 0 0 81 100C07-08 Salivary Gland 1 33.3 1 33.3 1 33.3 0 0 0 0 0 0 0 0 3 100C09 Tonsil 0 0 0 0 2 100 0 0 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C11 Nasopharynx 0 0 1 50 1 50 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 2 18.2 4 36.4 5 45.5 0 0 0 0 0 0 0 0 11 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 1 3.1 15 46.9 16 50 0 0 0 0 0 0 0 0 32 100C16 Stomach 4 17.4 8 34.8 11 47.8 0 0 0 0 0 0 0 0 23 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C18 Colon 1 3.7 14 51.9 12 44.4 0 0 0 0 0 0 0 0 27 100C19-20 Rectum 3 8.6 12 34.3 20 57.1 0 0 0 0 0 0 0 0 35 100C21 Anus & Anal Canal 0 0 3 75 1 25 0 0 0 0 0 0 0 0 4 100C22 Liver 1 33.3 1 33.3 1 33.3 0 0 0 0 0 0 0 0 3 100C23-24 Gallbladder 0 0 4 66.7 2 33.3 0 0 0 0 0 0 0 0 6 100C25 Pancreas 0 0 3 60 2 40 0 0 0 0 0 0 0 0 5 100C30-31 Nose,Sinuses 1 33.3 2 66.7 0 0 0 0 0 0 0 0 0 0 3 100C32 Larynx 0 0 3 75 1 25 0 0 0 0 0 0 0 0 4 100C33-34 Lung 3 7.5 17 42.5 19 47.5 0 0 0 0 0 0 1 2.5 40 100


C40-41 Bone 7 38.9 8 44.4 2 11.1 0 0 0 0 1 5.6 0 0 18 100C43 Melanoma of Skin 0 0 2 50 2 50 0 0 0 0 0 0 0 0 4 100C44 Other Skin 2 12.5 6 37.5 8 50 0 0 0 0 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 1 6.7 13 86.7 1 6.7 0 0 0 0 0 0 0 0 15 100C50 Breast 17 5.6 202 67.1 76 25.2 1 0.3 0 0 3 1 2 0.7 301 100


67

C51 Vulva 0 0 0 0 4 100 0 0 0 0 0 0 0 0 4 100C52 Vagina 0 0 3 42.9 4 57.1 0 0 0 0 0 0 0 0 7 100C53 Cervix Uteri 6 4.8 68 54.8 50 40.3 0 0 0 0 0 0 0 0 124 100C54 Corpus Uteri 2 4.3 32 69.6 12 26.1 0 0 0 0 0 0 0 0 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 13 17.3 33 44 28 37.3 0 0 0 0 0 0 1 1.3 75 100C57 Other Female Genital 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 4 66.7 2 33.3 0 0 0 0 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C67 Bladder 0 0 2 66.7 1 33.3 0 0 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 2 22.2 4 44.4 3 33.3 0 0 0 0 0 0 0 0 9 100C73 Thyroid 2 8 14 56 9 36 0 0 0 0 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 4 66.7 2 33.3 0 0 0 0 0 0 0 0 6 100C82-85, C96 NHL 5 18.5 10 37 12 44.4 0 0 0 0 0 0 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 11 52.4 9 42.9 0 0 0 0 0 0 1 4.8 21 100C91 Lymphoid Leuk. 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 1 25 3 75 0 0 0 0 0 0 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 2 8.3 16 66.7 6 25 0 0 0 0 0 0 0 0 24 100

All Sites 82 7.8 570 54.1 390 37 1 0.1 1 0.1 4 0.4 6 0.6 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


68

Table 30: Method of Diagnosis - Male

ICD10 Site Microscopic X-Ray / Imaging Clinical Others Unknown Total # % # % # % # % # % # %

C00 Lip 3 100 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 54 88.5 0 0 5 8.2 2 3.3 0 0 61 100C03-06 Mouth 82 77.4 1 0.9 17 16 5 4.7 1 0.9 106 100C07-08 Salivary Gland 5 100 0 0 0 0 0 0 0 0 5 100C09 Tonsil 12 100 0 0 0 0 0 0 0 0 12 100C10 Oth. Oropharynx 25 92.6 0 0 0 0 2 7.4 0 0 27 100C11 Nasopharynx 1 50 0 0 1 50 0 0 0 0 2 100C12-13 Hypopharynx 42 87.5 0 0 1 2.1 5 10.4 0 0 48 100C14 Pharynx Unspecified 1 100 0 0 0 0 0 0 0 0 1 100C15 Oesophagus 45 77.6 1 1.7 1 1.7 11 19 0 0 58 100C16 Stomach 85 87.6 1 1 0 0 11 11.3 0 0 97 100C17 Small Intestine 3 100 0 0 0 0 0 0 0 0 3 100C18 Colon 34 89.5 0 0 0 0 4 10.5 0 0 38 100C19-20 Rectum 47 90.4 1 1.9 1 1.9 2 3.8 1 1.9 52 100C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 1 100C22 Liver 8 40 10 50 1 5 1 5 0 0 20 100C23-24 Gallbladder 5 71.4 2 28.6 0 0 0 0 0 0 7 100C25 Pancreas 7 38.9 11 61.1 0 0 0 0 0 0 18 100C30-31 Nose,Sinuses 4 100 0 0 0 0 0 0 0 0 4 100C32 Larynx 51 81 0 0 2 3.2 10 15.9 0 0 63 100C33-34 Lung 186 77.2 49 20.3 1 0.4 5 2.1 0 0 241 100


C40-41 Bone 16 94.1 0 0 1 5.9 0 0 0 0 17 100C43 Melanoma of Skin 9 100 0 0 0 0 0 0 0 0 9 100C44 Other Skin 18 94.7 0 0 0 0 1 5.3 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 18 90 2 10 0 0 0 0 0 0 20 100C50 Breast 6 85.7 0 0 0 0 1 14.3 0 0 7 100


69

C60 Penis 5 100 0 0 0 0 0 0 0 0 5 100C61 Prostate 44 84.6 0 0 0 0 8 15.4 0 0 52 100C62 Testis 6 100 0 0 0 0 0 0 0 0 6 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 12 85.7 2 14.3 0 0 0 0 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 25 86.2 1 3.4 0 0 3 10.3 0 0 29 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 19 100 0 0 0 0 0 0 0 0 19 100C73 Thyroid 12 92.3 0 0 0 0 1 7.7 0 0 13 100C74 Adrenal Gland 2 100 0 0 0 0 0 0 0 0 2 100C81 Hodgkins Disease 5 100 0 0 0 0 0 0 0 0 5 100C82-85, C96 NHL 37 100 0 0 0 0 0 0 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 13 65 2 10 0 0 5 25 0 0 20 100C91 Lymphoid Leuk. 3 100 0 0 0 0 0 0 0 0 3 100C92-94 Myeloid Leukaemia 7 100 0 0 0 0 0 0 0 0 7 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 33 70.2 11 23.4 2 4.3 1 2.1 0 0 47 100

All Sites 992 82.7 94 7.8 33 2.8 78 6.5 2 0.2 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


70

Table 31: Method of Diagnosis - Female

ICD10 Site Microscopic X-Ray / Imaging Clinical Others Unknown Total # % # % # % # % # % # %

C00 Lip 9 90 0 0 0 0 1 10 0 0 10 100C01-02 Tongue 20 90.9 0 0 1 4.5 1 4.5 0 0 22 100C03-06 Mouth 72 88.9 0 0 5 6.2 4 4.9 0 0 81 100C07-08 Salivary Gland 3 100 0 0 0 0 0 0 0 0 3 100C09 Tonsil 1 50 0 0 0 0 1 50 0 0 2 100C10 Oth. Oropharynx 0 0 0 0 0 0 1 100 0 0 1 100C11 Nasopharynx 2 100 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 9 81.8 0 0 0 0 2 18.2 0 0 11 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 27 84.4 1 3.1 0 0 3 9.4 1 3.1 32 100C16 Stomach 20 87 1 4.3 0 0 2 8.7 0 0 23 100C17 Small Intestine 0 0 1 100 0 0 0 0 0 0 1 100C18 Colon 21 77.8 2 7.4 0 0 4 14.8 0 0 27 100C19-20 Rectum 34 97.1 1 2.9 0 0 0 0 0 0 35 100C21 Anus & Anal Canal 3 75 1 25 0 0 0 0 0 0 4 100C22 Liver 3 100 0 0 0 0 0 0 0 0 3 100C23-24 Gallbladder 5 83.3 1 16.7 0 0 0 0 0 0 6 100C25 Pancreas 1 20 3 60 0 0 1 20 0 0 5 100C30-31 Nose,Sinuses 3 100 0 0 0 0 0 0 0 0 3 100C32 Larynx 4 100 0 0 0 0 0 0 0 0 4 100C33-34 Lung 30 75 10 25 0 0 0 0 0 0 40 100


C40-41 Bone 16 88.9 2 11.1 0 0 0 0 0 0 18 100C43 Melanoma of Skin 4 100 0 0 0 0 0 0 0 0 4 100C44 Other Skin 16 100 0 0 0 0 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0


71

C47+C49 Conn. & Soft Tissue 15 100 0 0 0 0 0 0 0 0 15 100C50 Breast 282 93.7 3 1 7 2.3 8 2.7 1 0.3 301 100C51 Vulva 4 100 0 0 0 0 0 0 0 0 4 100C52 Vagina 7 100 0 0 0 0 0 0 0 0 7 100C53 Cervix Uteri 106 85.5 4 3.2 12 9.7 2 1.6 0 0 124 100C54 Corpus Uteri 43 93.5 1 2.2 0 0 2 4.3 0 0 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 54 72 9 12 1 1.3 11 14.7 0 0 75 100


C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 6 100 0 0 0 0 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 1 100 0 0 0 0 0 0 0 0 1 100C67 Bladder 3 100 0 0 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 1 100 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 7 77.8 2 22.2 0 0 0 0 0 0 9 100C73 Thyroid 25 100 0 0 0 0 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 6 100 0 0 0 0 0 0 0 0 6 100C82-85,C96 NHL 27 100 0 0 0 0 0 0 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 15 71.4 1 4.8 0 0 5 23.8 0 0 21 100C91 Lymphoid Leuk. 1 100 0 0 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 4 100 0 0 0 0 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 15 62.5 8 33.3 0 0 1 4.2 0 0 24 100

All Sites 925 87.8 51 4.8 26 2.5 50 4.7 2 0.2 1054 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


72

Table 32 : Mother Tongue of patients - Male

ICD10 Site Malayalam Nepali English Oriya Bengali Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 60 98.4 0 0 0 0 0 0 0 0 1 1.6 0 0 61 100C03-06 Mouth 105 99.1 0 0 0 0 0 0 1 0.9 0 0 0 0 106 100C07-08 Salivary Gland 5 100 0 0 0 0 0 0 0 0 0 0 0 0 5 100C09 Tonsil 12 100 0 0 0 0 0 0 0 0 0 0 0 0 12 100C10 Oth. Oropharynx 27 100 0 0 0 0 0 0 0 0 0 0 0 0 27 100C11 Nasopharynx 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 47 97.9 0 0 1 2.1 0 0 0 0 0 0 0 0 48 100


C15 Oesophagus 58 100 0 0 0 0 0 0 0 0 0 0 0 0 58 100C16 Stomach 96 99 0 0 0 0 1 1 0 0 0 0 0 0 97 100C17 Small Intestine 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C18 Colon 38 100 0 0 0 0 0 0 0 0 0 0 0 0 38 100C19-20 Rectum 52 100 0 0 0 0 0 0 0 0 0 0 0 0 52 100

C21 Anus & Anal Canal 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100

C22 Liver 20 100 0 0 0 0 0 0 0 0 0 0 0 0 20 100C23-24 Gallbladder 7 100 0 0 0 0 0 0 0 0 0 0 0 0 7 100C25 Pancreas 18 100 0 0 0 0 0 0 0 0 0 0 0 0 18 100C30-31 Nose,Sinuses 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100C32 Larynx 63 100 0 0 0 0 0 0 0 0 0 0 0 0 63 100C33-34 Lung 237 98.3 1 0.4 0 0 0 0 0 0 3 1.2 0 0 241 100


C40-41 Bone 17 100 0 0 0 0 0 0 0 0 0 0 0 0 17 100C43 Melanoma of Skin 9 100 0 0 0 0 0 0 0 0 0 0 0 0 9 100C44 Other Skin 19 100 0 0 0 0 0 0 0 0 0 0 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


73


C50 Breast 7 100 0 0 0 0 0 0 0 0 0 0 0 0 7 100C60 Penis 5 100 0 0 0 0 0 0 0 0 0 0 0 0 5 100C61 Prostate 51 98.1 0 0 0 0 0 0 0 0 1 1.9 0 0 52 100C62 Testis 6 100 0 0 0 0 0 0 0 0 0 0 0 0 6 100

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C64 Kidney 14 100 0 0 0 0 0 0 0 0 0 0 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 29 100 0 0 0 0 0 0 0 0 0 0 0 0 29 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 19 100 0 0 0 0 0 0 0 0 0 0 0 0 19 100C73 Thyroid 13 100 0 0 0 0 0 0 0 0 0 0 0 0 13 100C74 Adrenal Gland 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100C81 Hodgkins Disease 5 100 0 0 0 0 0 0 0 0 0 0 0 0 5 100C82-85,C96 NHL 37 100 0 0 0 0 0 0 0 0 0 0 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 20 100 0 0 0 0 0 0 0 0 0 0 0 0 20 100C91 Lymphoid Leuk. 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100

C92-94 Myeloid Leukaemia 7 100 0 0 0 0 0 0 0 0 0 0 0 0 7 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 47 100 0 0 0 0 0 0 0 0 0 0 0 0 47 100

All Sites 1190 99.2 1 0.1 1 0.1 1 0.1 1 0.1 5 0.4 0 0 1199 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


74

Table 33 : Mother Tongue of patients - Female

ICD10 Site Malayalam Tamil Oriya Kashmiri Bengali Others Unknown Total # % # % # % # % # % # % # % # %

C00 Lip 10 100 0 0 0 0 0 0 0 0 0 0 0 0 10 100C01-02 Tongue 22 100 0 0 0 0 0 0 0 0 0 0 0 0 22 100C03-06 Mouth 81 100 0 0 0 0 0 0 0 0 0 0 0 0 81 100C07-08 Salivary Gland 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C09 Tonsil 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C11 Nasopharynx 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 11 100 0 0 0 0 0 0 0 0 0 0 0 0 11 100


C15 Oesophagus 31 96.9 0 0 0 0 0 0 0 0 1 3.1 0 0 32 100C16 Stomach 23 100 0 0 0 0 0 0 0 0 0 0 0 0 23 100C17 Small Intestine 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C18 Colon 27 100 0 0 0 0 0 0 0 0 0 0 0 0 27 100C19-20 Rectum 35 100 0 0 0 0 0 0 0 0 0 0 0 0 35 100

C21 Anus & Anal Canal 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100

C22 Liver 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C23-24 Gallbladder 6 100 0 0 0 0 0 0 0 0 0 0 0 0 6 100C25 Pancreas 5 100 0 0 0 0 0 0 0 0 0 0 0 0 5 100C30-31 Nose,Sinuses 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C32 Larynx 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100C33-34 Lung 39 97.5 1 2.5 0 0 0 0 0 0 0 0 0 0 40 100


C40-41 Bone 18 100 0 0 0 0 0 0 0 0 0 0 0 0 18 100C43 Melanoma of Skin 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100C44 Other Skin 16 100 0 0 0 0 0 0 0 0 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


75


C50 Breast 299 99.3 0 0 1 0.3 0 0 1 0.3 0 0 0 0 301 100

C51 Vulva 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100C52 Vagina 7 100 0 0 0 0 0 0 0 0 0 0 0 0 7 100

C53 Cervix Uteri 123 99.2 0 0 0 0 0 0 0 0 0 0 1 0.8 124 100

C54 Corpus Uteri 46 100 0 0 0 0 0 0 0 0 0 0 0 0 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 74 98.7 0 0 0 0 1 1.3 0 0 0 0 0 0 75 100

C57 Other Female Genital 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 6 100 0 0 0 0 0 0 0 0 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C67 Bladder 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 9 100 0 0 0 0 0 0 0 0 0 0 0 0 9 100C73 Thyroid 25 100 0 0 0 0 0 0 0 0 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 6 100 0 0 0 0 0 0 0 0 0 0 0 0 6 100C82-85, C96 NHL 27 100 0 0 0 0 0 0 0 0 0 0 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 21 100 0 0 0 0 0 0 0 0 0 0 0 0 21 100C91 Lymphoid Leuk. 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 4 100 0 0 0 0 0 0 0 0 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 24 100 0 0 0 0 0 0 0 0 0 0 0 0 24 100

All Sites 1048 99.4 1 0.1 1 0.1 1 0.1 1 0.1 1 0.1 1 0.1 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


76

Table 34 : Religion of patients - Male

ICD10 Site Hindu Muslim Christian Others Unknown Total

# % # % # % # % # % # % C00 Lip 3 100 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 46 75.4 11 16.4 4 6.6 1 1.6 0 0 61 100C03-06 Mouth 65 61.3 20 18.9 20 18.9 1 0.9 0 0 106 100C07-08 Salivary Gland 4 80 1 20 0 0 0 0 0 0 5 100C09 Tonsil 6 50 3 25 3 25 0 0 0 0 12 100C10 Oth. Oropharynx 24 88.9 3 11.1 0 0 0 0 0 0 27 100C11 Nasopharynx 2 100 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 33 68.8 7 14.6 8 16.7 0 0 0 0 48 100C14 Pharynx Unspecified 1 100 0 0 0 0 0 0 0 0 1 100C15 Oesophagus 40 69 10 17.2 8 13.8 0 0 0 0 58 100C16 Stomach 59 60.8 31 32 7 7.2 0 0 0 0 97 100C17 Small Intestine 2 66.7 1 33.3 0 0 0 0 0 0 3 100C18 Colon 24 63.2 10 26.3 3 7.9 1 2.6 0 0 38 100C19-20 Rectum 35 67.3 16 30.8 1 1.9 0 0 0 0 52 100C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100C22 Liver 8 40 10 50 2 10 0 0 0 0 20 100C23-24 Gallbladder 4 57.1 2 28.6 0 0 1 14.3 0 0 7 100C25 Pancreas 10 55.6 6 33.3 2 11.1 0 0 0 0 18 100C30-31 Nose,Sinuses 2 50 2 50 0 0 0 0 0 0 4 100C32 Larynx 44 69.8 13 20.6 6 9.5 0 0 0 0 63 100C33-34 Lung 123 51 92 37.8 24 10 2 0.8 1 0.4 241 100


C40-41 Bone 10 58.8 6 35.3 1 5.9 0 0 0 0 17 100C43 Melanoma of Skin 6 66.7 1 11.1 2 22.2 0 0 0 0 9 100C44 Other Skin 9 47.4 10 52.6 0 0 0 0 0 0 19 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 15 75 3 15 2 10 0 0 0 0 20 100


77

C50 Breast 5 71.4 0 0 2 28.6 0 0 0 0 7 100C60 Penis 3 60 0 0 2 40 0 0 0 0 5 100C61 Prostate 31 59.6 15 28.8 6 11.5 0 0 0 0 52 100C62 Testis 4 66.7 2 33.3 0 0 0 0 0 0 6 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 7 50 6 42.9 1 7.1 0 0 0 0 14 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 16 55.2 11 37.9 2 6.9 0 0 0 0 29 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 13 68.4 6 31.6 0 0 0 0 0 0 19 100C73 Thyroid 9 69.2 3 23.1 1 7.7 0 0 0 0 13 100C74 Adrenal Gland 1 50 1 50 0 0 0 0 0 0 2 100C81 Hodgkins Disease 1 20 4 80 0 0 0 0 0 0 5 100C82-85,C96 NHL 25 67.6 10 27 2 5.4 0 0 0 0 37 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 12 60 5 25 3 15 0 0 0 0 20 100C91 Lymphoid Leuk. 0 0 2 66.7 1 33.3 0 0 0 0 3 100C92-94 Myeloid Leukaemia 6 85.7 1 14.3 0 0 0 0 0 0 7 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 39 83 8 17 0 0 0 0 0 0 47 100

All Sites 747 62.3 332 27.7 113 9.4 6 0.5 1 0.1 1199 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


78

Table 35 : Religion of patients - Female

ICD10 Site Hindu Muslim Christian Others Unknown Total

# % # % # % # % # % # % C00 Lip 6 60 4 40 0 0 0 0 0 0 10 100C01-02 Tongue 14 63.6 5 22.7 3 13.6 0 0 0 0 22 100C03-06 Mouth 54 66.7 24 29.6 3 3.7 0 0 0 0 81 100C07-08 Salivary Gland 1 33.3 1 33.3 1 33.3 0 0 0 0 3 100C09 Tonsil 1 50 1 50 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 1 100 0 0 0 0 0 0 0 0 1 100C11 Nasopharynx 2 100 0 0 0 0 0 0 0 0 2 100C12-13 Hypopharynx 7 63.6 4 36.4 0 0 0 0 0 0 11 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 26 81.2 6 18.8 0 0 0 0 0 0 32 100C16 Stomach 18 78.3 5 21.7 0 0 0 0 0 0 23 100C17 Small Intestine 0 0 1 100 0 0 0 0 0 0 1 100C18 Colon 22 81.5 4 14.8 1 3.7 0 0 0 0 27 100C19-20 Rectum 26 74.3 8 22.9 1 2.9 0 0 0 0 35 100C21 Anus & Anal Canal 4 100 0 0 0 0 0 0 0 0 4 100C22 Liver 2 66.7 1 33.3 0 0 0 0 0 0 3 100C23-24 Gallbladder 5 83.3 0 0 1 16.7 0 0 0 0 6 100C25 Pancreas 3 60 2 40 0 0 0 0 0 0 5 100C30-31 Nose,Sinuses 2 66.7 0 0 1 33.3 0 0 0 0 3 100C32 Larynx 2 50 1 25 1 25 0 0 0 0 4 100C33-34 Lung 26 65 14 35 0 0 0 0 0 0 40 100


C40-41 Bone 10 55.6 6 33.3 2 11.1 0 0 0 0 18 100C43 Melanoma of Skin 3 75 1 25 0 0 0 0 0 0 4 100C44 Other Skin 8 50 6 37.5 2 12.5 0 0 0 0 16 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 10 66.7 5 33.3 0 0 0 0 0 0 15 100C50 Breast 199 66.1 72 23.9 30 10 0 0 0 0 301 100C51 Vulva 4 100 0 0 0 0 0 0 0 0 4 100


79

C52 Vagina 4 57.1 2 28.6 1 14.3 0 0 0 0 7 100C53 Cervix Uteri 102 82.3 17 13.7 4 3.2 1 0.8 0 0 124 100C54 Corpus Uteri 30 65.2 14 30.4 2 4.3 0 0 0 0 46 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 52 69.3 20 26.7 2 2.7 0 0 1 1.3 75 100C57 Other Female Genital 0 0 1 100 0 0 0 0 0 0 1 100C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 1 16.7 4 66.7 1 16.7 0 0 0 0 6 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 1 100 0 0 0 0 1 100C67 Bladder 0 0 3 100 0 0 0 0 0 0 3 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 1 100 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 3 33.3 4 44.4 2 22.2 0 0 0 0 9 100C73 Thyroid 16 64 7 28 2 8 0 0 0 0 25 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 4 66.7 2 33.3 0 0 0 0 0 0 6 100C82-85,C96 NHL 20 74.1 6 22.2 1 3.7 0 0 0 0 27 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 13 61.9 4 19 3 14.3 1 4.8 0 0 21 100C91 Lymphoid Leuk. 1 100 0 0 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 2 50 2 50 0 0 0 0 0 0 4 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 18 75 5 20.8 1 4.2 0 0 0 0 24 100

All Sites 723 68.6 262 24.9 66 6.3 2 0.2 1 0.1 1054 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


80

Table 36 : Treatment Status at Reporting Institution (Excluding the Cancers Previously Treated) - Male

ICD10 Site Received Not Received Not Accepted Incomplete Unknown Total

# % # % # % # % # % # % C00 Lip 0 0 1 100 0 0 0 0 0 0 1 100C01-02 Tongue 30 71.4 7 16.7 0 0 5 11.9 0 0 42 100C03-06 Mouth 55 68.8 23 28.7 0 0 2 2.5 0 0 80 100C07-08 Salivary Gland 1 100 0 0 0 0 0 0 0 0 1 100C09 Tonsil 8 80 2 20 0 0 0 0 0 0 10 100C10 Oth. Oropharynx 16 84.2 3 15.8 0 0 0 0 0 0 19 100C11 Nasopharynx 1 100 0 0 0 0 0 0 0 0 1 100C12-13 Hypopharynx 23 69.7 9 27.3 0 0 1 3 0 0 33 100C14 Pharynx Unspecified 0 0 1 100 0 0 0 0 0 0 1 100C15 Oesophagus 14 31.1 27 60 1 2.2 3 6.7 0 0 45 100C16 Stomach 17 30.9 35 63.6 1 1.8 2 3.6 0 0 55 100C17 Small Intestine 1 50 1 50 0 0 0 0 0 0 2 100C18 Colon 8 57.1 3 21.4 0 0 3 21.4 0 0 14 100C19-20 Rectum 13 43.3 16 53.3 0 0 1 3.3 0 0 30 100C21 Anus & Anal Canal 0 0 1 100 0 0 0 0 0 0 1 100C22 Liver 1 6.2 15 93.8 0 0 0 0 0 0 16 100C23-24 Gallbladder 1 25 2 50 1 25 0 0 0 0 4 100C25 Pancreas 3 17.6 13 76.5 1 5.9 0 0 0 0 17 100C30-31 Nose,Sinuses 1 100 0 0 0 0 0 0 0 0 1 100C32 Larynx 29 69 11 26.2 1 2.4 1 2.4 0 0 42 100C33-34 Lung 84 45.2 86 46.2 2 1.1 14 7.5 0 0 186 100


C40-41 Bone 2 50 2 50 0 0 0 0 0 0 4 100C43 Melanoma of Skin 4 80 1 20 0 0 0 0 0 0 5 100C44 Other Skin 8 57.1 6 42.9 0 0 0 0 0 0 14 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 5 55.6 4 44.4 0 0 0 0 0 0 9 100C50 Breast 4 100 0 0 0 0 0 0 0 0 4 100


81

C60 Penis 3 100 0 0 0 0 0 0 0 0 3 100C61 Prostate 9 52.9 7 41.2 0 0 1 5.9 0 0 17 100C62 Testis 0 0 0 0 0 0 0 0 0 0 0 0C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 1 20 4 80 0 0 0 0 0 0 5 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 4 44.4 5 55.6 0 0 0 0 0 0 9 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 4 66.7 2 33.3 0 0 0 0 0 0 6 100C74 Adrenal Gland 0 0 1 100 0 0 0 0 0 0 1 100C81 Hodgkins Disease 2 50 2 50 0 0 0 0 0 0 4 100C82-85, C96 NHL 3 15 15 75 2 10 0 0 0 0 20 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 1 14.3 6 85.7 0 0 0 0 0 0 7 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 3 100 0 0 0 0 0 0 3 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 13 31.7 25 61 1 2.4 2 4.9 0 0 41 100 All Sites 369 49 339 45 10 1.3 35 4.6 0 0 753 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


82

Table 37: Treatment Status at Reporting Institution (Excluding the Cancers Previously Treated) - Female

ICD10 Site Received Not Received Not Accepted Incomplete Unknown Total# % # % # % # % # % # %

C00 Lip 4 57.1 2 28.6 0 0 1 14.3 0 0 7 100C01-02 Tongue 13 81.2 3 18.8 0 0 0 0 0 0 16 100C03-06 Mouth 41 78.8 9 17.3 1 1.9 1 1.9 0 0 52 100C07-08 Salivary Gland 2 100 0 0 0 0 0 0 0 0 2 100C09 Tonsil 2 100 0 0 0 0 0 0 0 0 2 100C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 2 100 0 0 0 0 0 0 2 100C12-13 Hypopharynx 4 44.4 5 55.6 0 0 0 0 0 0 9 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 8 34.8 14 60.9 1 4.3 0 0 0 0 23 100C16 Stomach 5 31.2 10 62.5 0 0 0 0 1 6.2 16 100C17 Small Intestine 0 0 1 100 0 0 0 0 0 0 1 100C18 Colon 5 35.7 9 64.3 0 0 0 0 0 0 14 100C19-20 Rectum 8 36.4 11 50 0 0 3 13.6 0 0 22 100C21 Anus & Anal Canal 0 0 2 66.7 0 0 1 33.3 0 0 3 100C22 Liver 0 0 2 100 0 0 0 0 0 0 2 100C23-24 Gallbladder 3 75 0 0 1 25 0 0 0 0 4 100C25 Pancreas 1 25 3 75 0 0 0 0 0 0 4 100C30-31 Nose,Sinuses 0 0 0 0 0 0 1 100 0 0 1 100C32 Larynx 4 100 0 0 0 0 0 0 0 0 4 100C33-34 Lung 12 38.7 12 38.7 0 0 7 22.6 0 0 31 100C37-38 Other Thoracic Organs 0 0 0 0 0 0 0 0 0 0 0 0C40-41 Bone 3 50 3 50 0 0 0 0 0 0 6 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 4 66.7 2 33.3 0 0 0 0 0 0 6 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 4 44.4 5 55.6 0 0 0 0 0 0 9 100C50 Breast 113 74.8 29 19.2 1 0.7 8 5.3 0 0 151 100C51 Vulva 1 33.3 2 66.7 0 0 0 0 0 0 3 100


83

C52 Vagina 3 100 0 0 0 0 0 0 0 0 3 100C53 Cervix Uteri 48 63.2 26 34.2 1 1.3 1 1.3 0 0 76 100C54 Corpus Uteri 16 84.2 3 15.8 0 0 0 0 0 0 19 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 12 32.4 17 45.9 2 5.4 6 16.2 0 0 37 100C57 Other Female Genital 1 100 0 0 0 0 0 0 0 0 1 100C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 1 100 0 0 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 1 100 0 0 0 0 0 0 0 0 1 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 2 100 0 0 0 0 0 0 2 100C73 Thyroid 7 63.6 3 27.3 1 9.1 0 0 0 0 11 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 2 50 2 50 0 0 0 0 0 0 4 100C82-85, C96 NHL 8 42.1 8 42.1 0 0 3 15.8 0 0 19 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 4 57.1 2 28.6 1 14.3 0 0 0 0 7 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 1 100 0 0 0 0 0 0 1 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 7 38.9 9 50 0 0 2 11.1 0 0 18 100 All Sites 346 58.6 200 33.9 9 1.5 34 5.8 1 0.2 590 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


84

Table 38: Type of Treatment (Prior Treatment Only, No Treatment) – Male

ICD10 Site

Type of Treatment

Surgery R-Therapy C-

Therapy S + R S + C R + C S + R + C Others Unknown Total # % # % # % # % # % # % # % # % # % # %

C00 Lip 1 50 0 0 0 0 1 50 0 0 0 0 0 0 0 0 0 0 2 100 C01-02 Tongue 1 9.1 4 36.4 0 0 0 0 0 0 3 27.3 3 0 0 0 0 0 11 100 C03-06 Mouth 1 5.6 6 33.3 1 5.6 5 27.8 1 5.6 3 16.7 1 27.8 0 0 0 0 18 100 C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C09 Tonsil 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100 C10 Oth. Oropharynx 2 40 0 0 0 0 0 0 0 0 3 60 0 0 0 0 0 0 5 100 C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100 C12-13 Hypopharynx 2 22.2 0 0 0 0 2 22.2 0 0 4 44.4 1 22.2 0 0 0 0 9 100 C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C15 Oesophagus 2 18.2 1 9.1 2 18.2 0 0 2 18.2 3 27.3 1 0 0 0 0 0 11 100 C16 Stomach 6 25 0 0 6 25 0 0 9 37.5 1 4.2 2 0 0 0 0 0 24 100 C17 Small Intestine 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100 C18 Colon 3 23.1 1 7.7 1 7.7 0 0 8 61.5 0 0 0 0 0 0 0 0 13 100 C19-20 Rectum 3 30 1 10 2 20 0 0 1 10 0 0 3 0 0 0 0 0 10 100 C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C22 Liver 0 0 0 0 1 50 0 0 1 50 0 0 0 0 0 0 0 0 2 100 C23-24 Gallbladder 2 66.7 0 0 0 0 0 0 1 33.3 0 0 0 0 0 0 0 0 3 100 C25 Pancreas 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C30-31 Nose,Sinuses 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C32 Larynx 1 7.7 6 46.2 0 0 2 15.4 0 0 4 30.8 0 0 0 0 0 0 13 100 C33-34 Lung 0 0 5 16.7 13 43.3 1 3.3 1 3.3 10 33.3 0 0 0 0 0 0 30 100

C37-38 Other Thoracic Organs 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100

C40-41 Bone 2 40 0 0 0 0 0 0 2 40 1 20 0 0 0 0 0 0 5 100 C43 Melanoma of Skin 3 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 100 C44 Other Skin 3 75 0 0 0 0 0 0 1 25 0 0 0 0 0 0 0 0 4 100 C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


85

C47+C49 Conn. & Soft Tissue 1 16.7 0 0 0 0 1 16.7 0 0 0 0 4 16.7 0 0 0 0 6 100 C50 Breast 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 100 C60 Penis 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100 C61 Prostate 1 8.3 0 0 0 0 0 0 0 0 1 8.3 0 0 10 0 0 0 12 100 C62 Testis 1 33.3 0 0 0 0 0 0 2 66.7 0 0 0 0 0 0 0 0 3 100 C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C64 Kidney 4 80 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 5 100 C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C67 Bladder 7 58.3 0 0 1 8.3 2 16.7 0 0 1 8.3 1 16.7 0 0 0 0 12 100 C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C70-72 Brain, NS 4 33.3 0 0 1 8.3 2 16.7 0 0 1 8.3 4 16.7 0 0 0 0 12 100 C73 Thyroid 3 60 0 0 0 0 1 20 0 0 0 0 1 20 0 0 0 0 5 100 C74 Adrenal Gland 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100 C81 Hodgkins Disease 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C82-85, C96 NHL 0 0 0 0 11 78.6 0 0 1 7.1 2 14.3 0 0 0 0 0 0 14 100 C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C90 Multiple Myeloma 0 0 3 33.3 4 44.4 1 11.1 0 0 1 11.1 0 0 0 0 0 0 9 100 C91 Lymphoid Leuk. 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C92-94 Myeloid Leukaemia 0 0 0 0 1 50 0 0 0 0 0 0 0 0 1 0 0 0 2 100 C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O&U Other and Uns 0 0 0 0 1 33.3 0 0 1 33.3 1 33.3 0 0 0 0 0 0 3 100 All Sites 56 21.7 27 10.5 48 18.6 19 7.4 32 12.4 41 15.9 23 8.9 12 4.7 0 0 258 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


86

Table 39: Type of Treatment (Prior Treatment Only, No Treatment) –Female

ICD10 Site

Type of Treatment

Surgery R-

Therapy C-


C00 Lip 2 66.7 0 0 0 0 1 33.3 0 0 0 0 0 0 0 0 0 0 3 100C01-02 Tongue 0 0 0 0 0 0 1 33.3 0 0 1 33.3 1 33.3 0 0 0 0 3 100C03-06 Mouth 2 13.3 3 20 0 0 1 6.7 0 0 5 33.3 4 6.7 0 0 0 0 15 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 0 0 0 0 1 16.7 0 0 0 0 5 83.3 0 0 0 0 0 0 6 100C16 Stomach 3 75 0 0 1 25 0 0 0 0 0 0 0 0 0 0 0 0 4 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 4 44.4 0 0 0 0 0 0 5 55.6 0 0 0 0 0 0 0 0 9 100C19-20 Rectum 0 0 0 0 0 0 1 33.3 2 66.7 0 0 0 0 0 0 0 0 3 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C22 Liver 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C23-24 Gallbladder 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 100C25 Pancreas 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C30-31 Nose,Sinuses 0 0 0 0 0 0 2 100 0 0 0 0 0 0 0 0 0 0 2 100C32 Larynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C33-34 Lung 0 0 0 0 2 66.7 0 0 0 0 1 33.3 0 0 0 0 0 0 3 100


C40-41 Bone 2 50 0 0 0 0 0 0 2 50 0 0 0 0 0 0 0 0 4 100C43 Melanoma of Skin 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C44 Other Skin 6 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 1 25 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 4 100


87

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97

C50 Breast 14 20.3 1 1.4 2 2.9 1 1.4 15 21.7 0 0 14 1.4 22 21.7 0 0 69 100C51 Vulva 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C52 Vagina 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C53 Cervix Uteri 1 3.4 11 37.9 0 0 3 10.3 0 0 14 48.3 0 0 0 0 0 0 29 100C54 Corpus Uteri 6 54.5 1 9.1 0 0 4 36.4 0 0 0 0 0 0 0 0 0 0 11 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 5 26.3 0 0 6 31.6 1 5.3 5 26.3 0 0 1 5.3 1 26.3 0 0 19 100

C57 Other Female Genital

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 2 50 0 0 0 0 2 50 0 0 0 0 0 0 0 0 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 1 50 0 0 0 0 1 50 0 0 0 0 0 0 0 0 0 0 2 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C70-72 Brain, NS 2 50 0 0 0 0 1 25 0 0 0 0 1 25 0 0 0 0 4 100C73 Thyroid 8 80 0 0 0 0 2 20 0 0 0 0 0 0 0 0 0 0 10 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C82-85, C96 NHL 1 14.3 0 0 6 85.7 0 0 0 0 0 0 0 0 0 0 0 0 7 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 2 25 0 0 4 50 0 0 0 0 2 25 0 0 0 0 0 0 8 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C92-94 Myeloid Leukaemia 0 0 0 0 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 1 25 0 0 2 50 1 25 0 0 0 0 0 0 0 0 0 0 4 100 All Sites 66 27.6 16 6.7 27 11.3 22 9.2 29 12.1 31 13 25 10.5 23 9.6 0 0 239 100


88

Table 40: Type of Treatment (Treatment Only at RI, No Treatment) - Male

ICD10 Site

Type of Treatment

Surgery R-

Therapy C-


C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 11 31.4 6 17.1 3 8.6 8 22.9 0 0 4 11.4 3 22.9 0 0 0 0 35 100C03-06 Mouth 8 14 19 33.3 4 7 5 8.8 0 0 16 28.1 5 8.8 0 0 0 0 57 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C09 Tonsil 0 0 2 25 0 0 1 12.5 0 0 5 62.5 0 0 0 0 0 0 8 100C10 Oth. Oropharynx 0 0 8 50 0 0 2 12.5 0 0 6 37.5 0 0 0 0 0 0 16 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C12-13 Hypopharynx 0 0 11 45.8 0 0 1 4.2 1 4.2 9 37.5 1 4.2 0 0 1 37.5 24 100

C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C15 Oesophagus 0 0 9 52.9 4 23.5 0 0 1 5.9 3 17.6 0 0 0 0 0 0 17 100C16 Stomach 4 21.1 0 0 9 47.4 0 0 4 21.1 1 5.3 1 0 0 0 0 0 19 100C17 Small Intestine 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C18 Colon 5 45.5 0 0 2 18.2 0 0 3 27.3 1 9.1 0 0 0 0 0 0 11 100C19-20 Rectum 4 28.6 0 0 2 14.3 1 7.1 4 28.6 0 0 3 7.1 0 0 0 0 14 100

C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C22 Liver 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C23-24 Gallbladder 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C25 Pancreas 0 0 0 0 3 100 0 0 0 0 0 0 0 0 0 0 0 0 3 100C30-31 Nose,Sinuses 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C32 Larynx 2 6.7 14 46.7 1 3.3 2 6.7 0 0 9 30 2 6.7 0 0 0 0 30 100C33-34 Lung 0 0 28 28.6 23 23.5 0 0 1 1 46 46.9 0 0 0 0 0 0 98 100


C40-41 Bone 0 0 0 0 0 0 0 0 1 50 0 0 1 0 0 0 0 0 2 100

C43 Melanoma of Skin 3 75 0 0 0 0 1 25 0 0 0 0 0 0 0 0 0 0 4 100

C44 Other Skin 5 62.5 2 25 0 0 0 0 0 0 1 12.5 0 0 0 0 0 0 8 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


89

C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C47+C49 Conn. & Soft Tissue 2 40 0 0 0 0 0 0 0 0 2 40 1 0 0 0 0 0 5 100

C50 Breast 0 0 0 0 0 0 0 0 0 0 0 0 2 0 2 0 0 0 4 100C60 Penis 3 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 100C61 Prostate 1 10 1 10 1 10 0 0 0 0 1 10 0 0 6 0 0 0 10 100C62 Testis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C64 Kidney 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 3 75 1 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C73 Thyroid 4 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C81 Hodgkins Disease 0 0 1 50 1 50 0 0 0 0 0 0 0 0 0 0 0 0 2 100

C82-85,C96 NHL 0 0 1 33.3 2 66.7 0 0 0 0 0 0 0 0 0 0 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C90 Multiple Myeloma 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100

C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 1 6.7 5 33.3 4 26.7 1 6.7 0 0 4 26.7 0 0 0 0 0 0 15 100 All Sites 57 14.1 110 27.2 60 14.9 22 5.4 16 4 111 27.5 19 4.7 8 2 1 0.2 404 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


90

Table 41: Type of Treatment (Treatment Only at RI, No Treatment) - Female

ICD10 Site Type of Treatment

Surgery R-Therapy C-Therapy S + R S + C R + C S + R + C Others Unknown Total # % # % # % # % # % # % # % # % # % # %

C00 Lip 2 40 0 0 0 0 1 20 0 0 2 40 0 0 0 0 0 0 5 100 C01-02 Tongue 4 30.8 1 7.7 0 0 3 23.1 0 0 4 30.8 1 23.1 0 0 0 0 13 100 C03-06 Mouth 9 21.4 7 16.7 0 0 9 21.4 0 0 16 38.1 1 21.4 0 0 0 0 42 100 C07-08 Salivary Gland 1 50 1 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100 C09 Tonsil 1 50 1 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100 C10 Oth. Oropharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C12-13 Hypopharynx 0 0 1 25 0 0 0 0 0 0 3 75 0 0 0 0 0 0 4 100 C14 Pharynx

Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C15 Oesophagus 2 25 4 50 1 12.5 0 0 0 0 1 12.5 0 0 0 0 0 0 8 100 C16 Stomach 1 20 0 0 3 60 0 0 0 0 1 20 0 0 0 0 0 0 5 100 C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C18 Colon 2 40 0 0 1 20 0 0 2 40 0 0 0 0 0 0 0 0 5 100 C19-20 Rectum 5 45.5 0 0 0 0 0 0 3 27.3 0 0 3 0 0 0 0 0 11 100 C21 Anus & Anal

Canal 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100

C22 Liver 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C23-24 Gallbladder 0 0 1 33.3 2 66.7 0 0 0 0 0 0 0 0 0 0 0 0 3 100 C25 Pancreas 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C30-31 Nose,Sinuses 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100 C32 Larynx 2 50 1 25 0 0 0 0 0 0 1 25 0 0 0 0 0 0 4 100 C33-34 Lung 0 0 1 5.3 10 52.6 0 0 1 5.3 7 36.8 0 0 0 0 0 0 19 100 C37-38 Other Thoracic

Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C40-41 Bone 1 33.3 1 33.3 0 0 0 0 1 33.3 0 0 0 0 0 0 0 0 3 100 C43 Melanoma of

Skin 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C44 Other Skin 3 75 1 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 100 C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


91

C47+ C49

Conn. & Soft Tissue 1 25 0 0 0 0 0 0 1 25 0 0 2 0 0 0 0 0 4 100

C50 Breast 4 3.3 1 0.8 16 13.2 1 0.8 10 8.3 4 3.3 43 0.8 42 8.3 0 0 121 100 C51 Vulva 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C52 Vagina 0 0 2 66.7 0 0 0 0 0 0 1 33.3 0 0 0 0 0 0 3 100 C53 Cervix Uteri 1 2 16 32.7 0 0 4 8.2 1 2 27 55.1 0 0 0 0 0 0 49 100 C54 Corpus Uteri 2 12.5 1 6.2 0 0 10 62.5 1 6.2 1 6.2 1 62.5 0 0 0 0 16 100 C55 Uterus

Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C56 Ovary 0 0 1 5.6 9 50 0 0 5 27.8 2 11.1 1 0 0 0 0 0 18 100 C57 Other Female

Genital 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C64 Kidney 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C67 Bladder 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100 C68 Uns.Urinary

Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C70-72 Brain, NS 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C73 Thyroid 4 57.1 2 28.6 0 0 1 14.3 0 0 0 0 0 0 0 0 0 0 7 100 C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C81 Hodgkins Disease 0 0 1 50 1 50 0 0 0 0 0 0 0 0 0 0 0 0 2 100 C82-85,C96

NHL 1 9.1 1 9.1 6 54.5 0 0 0 0 3 27.3 0 0 0 0 0 0 11 100

C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C90 Multiple Myeloma 0 0 2 50 0 0 0 0 0 0 2 50 0 0 0 0 0 0 4 100 C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C92-94 Myeloid

Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O&U Other and Uns 0 0 3 33.3 4 44.4 0 0 0 0 1 11.1 1 0 0 0 0 0 9 100

All Sites 47 12.4 51 13.4 55 14.5 30 7.9 25 6.6 77 20.3 53 13.9 42 11.1 0 0 380 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


92

Table 42: Type of Treatment (Prior + Treatment at RI(RI Tmt), No Treatment) - Male

ICD10 Site

Type of Treatment

Surgery R-

Therapy C-


C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 5 62.5 0 0 2 25 0 0 1 12.5 0 0 0 0 0 0 0 0 8 100C03-06 Mouth 1 12.5 0 0 5 62.5 1 12.5 0 0 0 0 1 12.5 0 0 0 0 8 100C07-08 Salivary Gland 0 0 2 50 1 25 1 25 0 0 0 0 0 0 0 0 0 0 4 100C09 Tonsil 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C10 Oth. Oropharynx 0 0 1 33.3 0 0 0 0 0 0 1 33.3 1 0 0 0 0 0 3 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 1 16.7 1 16.7 3 50 1 16.7 0 0 0 0 0 0 0 0 0 0 6 100C14 Pharynx Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C15 Oesophagus 1 50 0 0 0 0 0 0 0 0 1 50 0 0 0 0 0 0 2 100C16 Stomach 2 11.1 0 0 15 83.3 0 0 1 5.6 0 0 0 0 0 0 0 0 18 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 0 0 1 9.1 9 81.8 0 0 0 0 1 9.1 0 0 0 0 0 0 11 100C19-20 Rectum 1 8.3 2 16.7 5 41.7 0 0 1 8.3 3 25 0 0 0 0 0 0 12 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 0 0 0 0 1 50 0 0 0 0 0 0 0 0 1 0 0 0 2 100C23-24 Gallbladder 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C25 Pancreas 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 1 50 0 0 0 0 0 0 1 50 0 0 0 0 0 0 2 100C32 Larynx 0 0 4 50 1 12.5 0 0 0 0 2 25 1 0 0 0 0 0 8 100C33-34 Lung 0 0 8 32 12 48 0 0 0 0 5 20 0 0 0 0 0 0 25 100


C40-41 Bone 7 87.5 0 0 1 12.5 0 0 0 0 0 0 0 0 0 0 0 0 8 100C43 Melanoma of Skin 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C44 Other Skin 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


93

C47+C49 Conn. & Soft Tissue 2 40 1 20 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 100C50 Breast 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100C60 Penis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C61 Prostate 0 0 7 30.4 1 4.3 0 0 0 0 0 0 0 0 15 0 0 0 23 100C62 Testis 0 0 1 33.3 2 66.7 0 0 0 0 0 0 0 0 0 0 0 0 3 100C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 3 75 1 25 0 0 0 0 0 0 0 0 0 0 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 1 12.5 3 37.5 3 37.5 0 0 0 0 0 0 0 0 1 0 0 0 8 100C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 0 0 3 42.9 1 14.3 0 0 0 0 3 42.9 0 0 0 0 0 0 7 100C73 Thyroid 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C82-85,C96 NHL 0 0 0 0 1 33.3 0 0 0 0 2 66.7 0 0 0 0 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 3 75 1 25 0 0 0 0 0 0 0 0 0 0 0 0 4 100C91 Lymphoid Leuk. 0 0 1 50 0 0 0 0 0 0 1 50 0 0 0 0 0 0 2 100C92-94 Myeloid Leukaemia 0 0 1 50 1 50 0 0 0 0 0 0 0 0 0 0 0 0 2 100C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 1 33.3 0 0 1 33.3 0 0 0 0 1 33.3 0 0 0 0 0 0 3 100 All Sites 25 13.3 43 22.9 68 36.2 3 1.6 3 1.6 23 12.2 5 2.7 18 9.6 0 0 188 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


94

Table 43: Type of Treatment (Prior + Treatment at RI(Prior Tmt), No Treatment) - Male

ICD10 Site

Type of Treatment

Surgery R-TherapyC-


C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 2 25 1 12.5 0 0 2 25 0 0 2 25 1 25 0 0 0 0 8 100C03-06 Mouth 1 12.5 1 12.5 4 50 1 12.5 0 0 1 12.5 0 0 0 0 0 0 8 100C07-08 Salivary Gland 2 50 0 0 0 0 1 25 0 0 1 25 0 0 0 0 0 0 4 100C09 Tonsil 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C10 Oth. Oropharynx 1 33.3 1 33.3 1 33.3 0 0 0 0 0 0 0 0 0 0 0 0 3 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 1 16.7 0 0 2 33.3 0 0 0 0 3 50 0 0 0 0 0 0 6 100


C15 Oesophagus 0 0 0 0 0 0 1 50 0 0 1 50 0 0 0 0 0 0 2 100C16 Stomach 7 38.9 0 0 4 22.2 1 5.6 6 33.3 0 0 0 0 0 0 0 0 18 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 7 63.6 0 0 0 0 0 0 3 27.3 0 0 1 0 0 0 0 0 11 100C19-20 Rectum 2 16.7 0 0 0 0 2 16.7 3 25 2 16.7 3 16.7 0 0 0 0 12 100C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C22 Liver 1 50 0 0 0 0 0 0 1 50 0 0 0 0 0 0 0 0 2 100C23-24 Gallbladder 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C25 Pancreas 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C30-31 Nose,Sinuses 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100C32 Larynx 4 50 1 12.5 2 25 0 0 0 0 1 12.5 0 0 0 0 0 0 8 100C33-34 Lung 2 8 4 16 13 52 0 0 1 4 5 20 0 0 0 0 0 0 25 100


C40-41 Bone 0 0 0 0 6 75 1 12.5 1 12.5 0 0 0 0 0 0 0 0 8 100C43 Melanoma of Skin 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C44 Other Skin 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100


95

C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C47+C49 Conn. & Soft Tissue 2 40 0 0 0 0 0 0 0 0 2 40 1 0 0 0 0 0 5 100

C50 Breast 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 100C60 Penis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C61 Prostate 0 0 0 0 1 4.3 0 0 0 0 0 0 0 0 22 0 0 0 23 100C62 Testis 2 66.7 0 0 0 0 0 0 0 0 1 33.3 0 0 0 0 0 0 3 100

C63 Other Male Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C64 Kidney 3 75 0 0 0 0 0 0 1 25 0 0 0 0 0 0 0 0 4 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C67 Bladder 6 75 0 0 0 0 1 12.5 0 0 0 0 0 0 1 0 0 0 8 100

C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 6 85.7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 7 100C73 Thyroid 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C82-85, C96 NHL 2 66.7 0 0 1 33.3 0 0 0 0 0 0 0 0 0 0 0 0 3 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 0 0 0 0 2 50 0 0 1 25 1 25 0 0 0 0 0 0 4 100C91 Lymphoid Leuk. 0 0 0 0 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100

C92-94 Myeloid Leukaemia 0 0 0 0 2 100 0 0 0 0 0 0 0 0 0 0 0 0 2 100

C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 0 0 0 0 1 33.3 0 0 2 66.7 0 0 0 0 0 0 0 0 3 100 All Sites 56 29.8 8 4.3 43 22.9 10 5.3 20 10.6 20 10.6 7 3.7 24 12.8 0 0 188 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


96

Table 44: Type of Treatment (Prior + Treatment at RI(Prior Tmt), No Treatment) - Female

ICD10 Site

Type of Treatment

Surgery R-

Therapy C-Therapy S + R S + C R + C S + R + C Others Unknown Total # % # % # % # % # % # % # % # % # % # %

C00 Lip 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C01-02 Tongue 0 0 0 0 0 0 0 0 1 33.3 2 66.7 0 0 0 0 0 0 3 100C03-06 Mouth 5 35.7 2 14.3 1 7.1 1 7.1 1 7.1 4 28.6 0 0 0 0 0 0 14 100C07-08 Salivary Gland 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 100C09 Tonsil 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C10 Oth. Oropharynx 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C11 Nasopharynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C12-13 Hypopharynx 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100


C15 Oesophagus 0 0 0 0 2 66.7 0 0 1 33.3 0 0 0 0 0 0 0 0 3 100C16 Stomach 2 66.7 0 0 1 33.3 0 0 0 0 0 0 0 0 0 0 0 0 3 100C17 Small Intestine 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C18 Colon 4 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 100C19-20 Rectum 6 60 0 0 0 0 0 0 4 40 0 0 0 0 0 0 0 0 10 100

C21 Anus & Anal Canal 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 1 100

C22 Liver 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C23-24 Gallbladder 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 1 100C25 Pancreas 1 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 100C30-31 Nose,Sinuses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C32 Larynx 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C33-34 Lung 1 16.7 0 0 5 83.3 0 0 0 0 0 0 0 0 0 0 0 0 6 100


C40-41 Bone 1 12.5 0 0 5 62.5 0 0 0 0 1 12.5 1 0 0 0 0 0 8 100C43 Melanoma of Skin 3 75 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 4 100C44 Other Skin 2 50 0 0 0 0 0 0 1 25 0 0 1 0 0 0 0 0 4 100C45 Mesothelioma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0


97

C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C47+C49 Conn. & Soft Tissue 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100C50 Breast 25 30.9 0 0 3 3.7 0 0 31 38.3 2 2.5 5 0 15 38.3 0 0 81 100C51 Vulva 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C52 Vagina 3 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 100C53 Cervix Uteri 5 26.3 6 31.6 3 15.8 1 5.3 1 5.3 3 15.8 0 0 0 0 0 0 19 100C54 Corpus Uteri 13 81.2 0 0 1 6.2 1 6.2 1 6.2 0 0 0 0 0 0 0 0 16 100C55 Uterus Unspecified 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C56 Ovary 8 42.1 1 5.3 4 21.1 0 0 6 31.6 0 0 0 0 0 0 0 0 19 100

C57 Other Female Genital 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

C58 Placenta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C64 Kidney 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C65 Renal Pelvis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C66 Ureter 0 0 0 0 0 0 0 0 1 100 0 0 0 0 0 0 0 0 1 100C67 Bladder 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C68 Uns.Urinary Organs 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C69 Eye 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C70-72 Brain, NS 2 66.7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 3 100C73 Thyroid 1 25 1 25 0 0 2 50 0 0 0 0 0 0 0 0 0 0 4 100C74 Adrenal Gland 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C81 Hodgkins Disease 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C82-85, C96 NHL 0 0 0 0 1 100 0 0 0 0 0 0 0 0 0 0 0 0 1 100C88 Malig Imn.Prol D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C90 Multiple Myeloma 1 16.7 1 16.7 3 50 0 0 0 0 1 16.7 0 0 0 0 0 0 6 100C91 Lymphoid Leuk. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C92-94 Myeloid Leukaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0C95 Leukaemia Uns 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0O&U Other and Uns 2 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 100 All Sites 87 38.7 11 4.9 33 14.7 6 2.7 49 21.8 14 6.2 9 4 16 7.1 0 0 225 100 O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


98

Table 45: Type of Treatment (Prior + Treatment at RI (RI Tmt) - Female

ICD10 Site

Type of Treatment Surgery R-Therapy C-Therapy S + R S + C R + C S + R + C Others Unknown Total # % # % # % # % # % # % # % # % # % # %

C00 Lip - - - - - - - - - - - - - - - - - - - - C01-02 Tongue 1 33.3 - - 1 33.3 - - - - 1 33.3 - - - - - - 3 100 C03-06 Mouth 3 21.4 5 35.7 6 42.9 - - - - - - - - - - - - 14 100 C07-08 Salivary Gland - - - - 1 100 - - - - - - - - - - - - 1 100 C09 Tonsil - - - - - - - - - - - - - - - - - - - - C10 Oth. Oropharynx - - 1 100 - - - - - - - - - - - - - - 1 100 C11 Nasopharynx - - - - - - - - - - - - - - - - - - - - C12-13 Hypopharynx - - - - - - - - - - 1 100 - - - - - - 1 100 C14 Pharynx Unspecified - - - - - - - - - - - - - - - - - - - - C15 Oesophagus - - 1 33.3 2 66.7 - - - - - - - - - - - - 3 100 C16 Stomach - - - - 2 66.7 - - 1 33.3 - - - - - - - - 3 100 C17 Small Intestine - - - - - - - - - - - - - - - - - - - -C18 Colon - - - - 4 100 - - - - - - - - - - - - 4 100 C19-20 Rectum 1 10 1 10 4 40 - - - - 4 40 - - - - - - 10 100 C21 Anus & Anal Canal - - - - - - - - - - 1 100 - - - - - - 1 100 C22 Liver - - - - 1 100 - - - - - - - - - - - - 1 100 C23-24 Gallbladder - - - - 1 100 - - - - - - - - - - - - 1 100 C25 Pancreas - - - - 1 100 - - - - - - - - - - - - 1 100 C30-31 Nose,Sinuses - - - - - - - - - - - - - - - - - - - - C32 Larynx - - - - - - - - - - - - - - - - - - - - C33-34 Lung - - 2 33.3 2 33.3 - - - - 2 33.3 - - - - - - 6 100 C37-38 Other Thoracic Organs - - - - - - - - - - - - - - - - - - - - C40-41 Bone 5 62.5 2 25 1 12.5 - - - - - - - - - - - - 8 100 C43 Melanoma of Skin 1 25 1 25 - - - - 1 25 1 25 - - - - - - 4 100 C44 Other Skin 2 50 2 50 - - - - - - - - - - - - - - 4 100 C45 Mesothelioma - - - - - - - - - - - - - - - - - - - -


99

C46 Kaposi Sarcoma - - - - - - - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue - - - - - - - - 2 100 - - - - - - - - 2 100 C50 Breast 5 6.2 29 35.8 7 8.6 - - 4 4.9 7 8.6 5 0 24 4.9 - - 81 100 C51 Vulva - - - - - - - - - - - - - - - - - - - - C52 Vagina - - 3 100 - - - - - - - - - - - - - - 3 100 C53 Cervix Uteri - - 13 68.4 2 10.5 - - - - 3 15.8 1 0 - - - - 19 100 C54 Corpus Uteri - - 14 87.5 2 12.5 - - - - - - - - - - - - 16 100 C55 Uterus Unspecified - - - - - - - - - - - - - - - - - - - - C56 Ovary - - - - 16 84.2 - - 3 15.8 - - - - - - - - 19 100 C57 Other Female Genital - - - - - - - - - - - - - - - - - - - - C58 Placenta - - - - - - - - - - - - - - - - - - - - C64 Kidney - - - - - - - - - - 1 100 - - - - - - 1 100 C65 Renal Pelvis - - - - - - - - - - - - - - - - - - - - C66 Ureter - - - - 1 100 - - - - - - - - - - - - 1 100 C67 Bladder - - - - - - - - - - - - - - - - - - - - C68 Uns.Urinary Organs - - - - - - - - - - - - - - - - - - - - C69 Eye - - - - - - - - - - - - - - - - - - - - C70-72 Brain, NS - - 1 33.3 1 33.3 - - - - 1 33.3 - - - - - - 3 100 C73 Thyroid 4 100 - - - - - - - - - - - - - - - - 4 100 C74 Adrenal Gland - - - - - - - - - - - - - - - - - - - - C81 Hodgkins Disease - - 1 100 - - - - - - - - - - - - - - 1 100 C82-85, C96 NHL - - - - 1 100 - - - - - - - - - - - - 1 100 C88 Malig Imn.Prol D - - - - - - - - - - - - - - - - - - - - C90 Multiple Myeloma 1 16.7 1 16.7 3 50 - - - - 1 16.7 - - - - - - 6 100C91 Lymphoid Leuk. - - - - - - - - - - - - - - - - - - - - C92-94 Myeloid Leukaemia - - - - - - - - - - - - - - - - - - - - C95 Leukaemia Uns - - - - - - - - - - - - - - - - - - - - O&U Other and Uns - - 1 50 1 50 - - - - - - - - - - - - 2 100 All Sites 23 10.2 78 34.7 60 26.7 - - 11 4.9 23 10.2 6 2.7 24 11 - - 225 100

O & U : C26, C39, C48, C75, C76, C77, C78, C79, C80, C97


100

Table 46: Any Specific Treatment (Prior Treatment Only) - Male

Any S Any CAny R Any H Others Unknown TotalICD 10 Site


101

Table 47: Any Specific Treatment (Prior Treatment Only) - Female



102

Table 48: Any Specific Treatment(Treatment Only At RI) – Male



103

Table 49: Any Specific Treatment(Treatment Only At RI) – Female

Any R Any C Any H Others Unknown TotalAny SICD 10 Site


104

Table 50: Any Specific Treatment(Prior +Treatment At RI(Prior Tmt)) – Male

Any S Any C Any R Any H Others Unknown TotalICD 10 Site


105

Table 51: Any Specific Treatment(Prior +Treatment At RI(Prior Tmt)) – Female

Any S Any C Any R Unknown TotalICD 10 Site OthersAny H


106

Table 52: Any Specific Treatment (Prior +Treatment At RI (RI Tmt)) – Male



107

Table 53: Any Specific Treatment (Prior +Treatment At RI(RI Tmt)) – Female



108

Table 54: Distribution of all cases by language spoken

Report Based on Year of Registration: 2010

Language Spoken

Males Females # % # %

Assamese 1 0.1

Bengali - - - -

Gujarati - - - -

Hindi - - - -

Kannada - - 1 0.1

Kashmiri - - - -

Malayalam 1196 99.75 1051 99.72

Marati - - - -

Oriya - - - -

Punjabi - - - -

Sanskrit - - - -

Sindhi - - - -

Tamil - - 1 0.1

Telugu 1 0.1 - -

Urudu - - - -

English - - - -

Nepali 1 0.1 - -

Unknown - - 1 0.1

1199 1054


109

SUMMARY OF STATISTICS


110

Table 55:

Fig.9

Per

c en

tage

Malabar Cancer Centre HBCR- 2010

111

Table 56:

Fig.10

Table 57:

Per

c en

tage


112

Fig. 11 P

erc

enta

ge


113

Table 58:

Fig. 12

Per

c en

tage


114

Table 59:

Table 60:


115

Table 61:

Fig .13

Per

cent

age


116

Table 62:

Fig. 14

Per

cent

age


117

Table 63:


118

Table 64:


119

Table 65:


120

SUMMARY OF ALL CANCERS- (DEMOGRAPHIC, DIAGNOSTIC AND

CLINICAL DETAILS)


121

Table 66: Relative/Next of Kin (including parent) Accompanying Person

Accompanying Person Male (N=1178) Female (N=1036)

# % # %

Father 3 0.25 5 0.48

Mother 1 0.08 2 0.19

Husband - 0.00 10 0.97

Wife 2 0.17 - 0.00

Son 54 4.58 39 3.76

Daughter 30 2.55 65 6.27

Other Relative/Friend/Neighbour 1016 86.25 864 83.40

Others(including accompany person) 12 1.02 14 1.35

Unknown 60 5.09 37 3.57


122

Table 67: TNM (Tumor, Node, Metastasis) Staging

T-Tumor Male (N=457) Female (N=459)

# % # % T0 1 0.22 0 0.00

T1 28 6.13 38 8.28

T1a 1 0.22 0 0.00

T1b 4 0.88 2 0.44

T2 72 15.75 133 28.98

T2a 0 0.00 0 0.00

T2b 1 0.22 0 0.00

T3 72 15.75 73 15.90

T3a 9 1.97 3 0.65

T3b 174 38.07 110 23.97

T3c 0 0.00 0 0.00

T4 75 16.41 45 9.80

T4a 16 3.50 13 2.83

T4b 2 0.44 35 7.63

T4c 2 0.44 4 0.87

Tx 0 0.00 3 0.65 Table 68: N-Nodes

N-Nodes Male (N=271) Female (N=336)

# % # % N0 114 42.07 121 36.01 N1 63 23.25 115 34.23 N2 74 27.31 66 19.64 N3 12 4.43 25 7.44 Nx 8 2.95 9 2.68

Table 69: M-Metastasis

M-Metastasis Male (N= 269) Female (N= 337)

# % # % M0 198 73.61 225 66.77 M1 2 0.74 32 9.50 Mx 69 25.65 80 23.74


123

Table 70: Composite Stage TNM (C50) - Breast Cancer

Stage Male (N=6) Female (N=246)

# % # % I 1 16.67 22 8.94 II 0 0.00 6 2.44 IIA 2 33.33 48 19.51 IIB 0 0.00 28 11.38 III 0 0.00 5 2.03 IIIA 1 16.67 28 11.38 IIIB 0 0.00 14 5.69 IV 1 16.67 51 20.73 Unknown 1 16.67 44 17.89

Table 71: Composite Stage TNM(C00-13)- Oral Cancer -Lip and Oral Cavity



Table 72: Composite Stage TNM (C30-32)- Nasal cavity & middle ear, accessory sinus and larynx




124

Table 73: Composite Stage TNM (C43-44)- Skin Cancer


# % # % I 1 6.25 1 7.14 II 2 12.5 1 7.14 IIA 0 0 0 0.00 IIB 0 0 0 0.00 III 1 6.25 1 7.14 IIIA 0 0 0 0.00 IIIB 0 0 0 0.00 IV 0 0 0 0.00 Unknown 12 75 11 78.57

Table 74: Composite Stage TNM (C60-68)- Male Genital Organs

Stage Male (N= 101)

# % I 2 1.98 II 5 4.95

IIA 0 0.00 IIB 1 0.99 III 8 7.92

IIIA 0 0.00 IIIB 0 0.00 IV 3 2.97

Unknown 82 81.19


125

Table 75: Composite Stage FIGO (C51-57) - Female Genital Organs

Stage Female (N=230)

# % 0 0 0.00 I 3 1.30 IA 5 2.17 1B 21 9.13 II 3 1.30 IIA 5 2.17 IIB 39 16.96 III 6 2.61 IIIA 4 1.74 IIIB 35 15.22 IV 14 6.09 IVA 2 0.87 IVB 4 1.74 Unknown 89 38.70

Table 76: Composite Stage

ANN ARBOUR-HODGKINS LYMPHOMA


# % # % 1 2 40 0 0 II 1 20 0 0 IIA 0 0 1 100 IIB 0 0 0 0 III 0 0 0 0 IIIA 0 0 0 0 IV 1 20 0 0 Unknown 1 20 0 0


126


ANN ARBOUR-NON-HODGKINS LYMPHOMA


# % # % 1 0 0 0 0 II 0 0 0 0

IIA 0 0 0 0

IIB 0 0 0 0 III 0 0 1 25

IIIA 0 0 0 0 IV 0 0 0 0 Unknown 2 100 3 75


Clinical Extent {C15-C25,C34,C40,C41,C47-C49,C70-C73}

Digestive Organs C15-C25


# % # % Localised 23 7.99 12 8.89 Reg.Extension 87 30.21 54 40.00 Dist.Mets 145 50.35 55 40.74 Unknown 33 11.46 14 10.37

Table 79: Bronchus and Lung C34




127

Table 80: Bones, Joints and Articular Cartilage C40


# % # % Localised 1 0.1 1 7.69Reg.Extension 3 0.3 8 61.54Dist.Mets 6 0.6 0 0.00Unknown 0 0 4 30.77

Table 81: Bones, Joints and Articular Cartilage of other

and unspecified sites C41



Table 82: Peripheral Nerves and autonomic nervous system, Retro peritoneum

and Peritoneum, connective, subcutaneous and other soft tissues C47-C49



Table 83: Meninges, Brain, Spinal Cord, Cranial Nerves and other parts of CNS

and Thyroid C70-C73




128

Table 84: Diagnostic Status of all Cancers at Registration At Source of registration/Reporting institution (RI)

Diagnostic Status Male (N= 1194) Female (N= 1045) # % # %

Not Registered at RI 107 8.96 123 11.77

Microscopically Confirmed 785 65.75 765 73.21

Suspected(Microscopically/ Radiologically)

200 16.75 82 7.85

Unequivocal Clinical Diagnosis 2 0.17 0 0.00

Suspected Clinically/To rule out Malignancy

96 8.04 69 6.60

Others specify 0 0.00 0 0.00

Unknown 4 0.34 6 0.57 Table 85: Method of Diagnosis (Most Valid Final Basis) of all Cancers

Method Male (N= 1192) Female (N= 963) # % # %

Clinical Only 33 2.77 26 2.70

X-Ray 0 0.00 1 0.10

Isotopes 0 0.00 0 0.00

Endoscopy 35 2.94 9 0.93

Angiography 0 0.00 0 0.00

Exploratory Surgery or Autopsy without Histology 1 0.08 0 0.00

Specific Biochemical and /or Immunological Tests 14 1.17 14 1.45

Cytology 135 11.33 14 1.45

Blood Film 3 0.25 3 0.31

Bone Marrow 15 1.26 6 0.62

Histology of Primary 761 63.84 782 81.20

Histology of Metastasis 70 5.87 30 3.12

Autopsy with concurrent or prior Histology 1 0.08 0 0.00

Death Certificate only 0 0.00 0 0.00

Others-(No documents) 28 2.35 26 2.70

Ultrasonogram 14 1.17 18 1.87

All other Diagnostic Imaging Techniques including CT,MRI,PET 80 6.71 32 3.32

Unknown 2 0.17 2 0.21


129

Table 86: Anatomical Site of all Cancers

Site Male (N=1158) Female (N=1028) # % # %

Specimen 177 15.28 271 26.36

Biopsy 424 36.61 362 35.21

Smear 2 0.17 4 0.39

FNAC 120 10.36 67 6.52

Pleural Fluid 1 0.09 1 0.10

Ascitic Fluid 1 0.09 6 0.58

Bone Marrow Aspiration/BX 3 0.26 3 0.29

Unknown 430 37.13 314 30.54

Table 87: Treatment Given Prior to Registration at RI (All Cancers)

Treatment Male (N= 1180) Female (N= 1043) # % # %

Yes 441 37.37 457 43.82

No 739 62.63 585 56.09

Unknown 0 0.00 1 0.10

Table 88: Performance Status (WHO) before treatment at –RI (All Cancers)

Performance Status PS Male (N= 1124) Female (N= 978)

# % # % Able to carry out all normal activity without restriction 0 6 0.53 4 0.41

Restricted in physically strenuous activity but ambulatory and able to carry out light work

1 660 58.72 662 67.69

Ambulatory and capable of all self care but unable to carry out any work up and about more than 50 % of working hours

2 273 24.29 191 19.53

Capable of only limited self -care confined to bed or chair more than 50% working hours

3 149 13.26 101 10.33

Completely disabled ,cannot carry on any self care totally confined to bed or chair

4 36 3.20 20 2.04


130

Table 89: Intention to treat at RI (All Cancers)

Intention Male (N= 1072) Female (N= 979) # % # %

Radical/Curative 355 33.12 478 48.83

Palliative 433 40.39 286 29.21

Pain relief only 5 0.47 5 0.51

Symptomatic 195 18.19 109 11.13

No treatment 84 7.84 101 10.32

Unknown 0 0.00 0 0.00

Table 90: Cancer directed treatment given at RI (All Cancers)


Yes 540 45.38 555 53.16

No 583 48.99 425 40.71

Treatment advised but not accepted 17 1.43 12 1.15

Incomplete Treatment 50 4.20 49 4.69

Unknown 0 0.00 3 0.29

Table 91: Type of Treatment Given at RI (All Cancers)


Surgery(S) 81 13.73 70 11.59

Radio Therapy(R) 153 25.93 128 21.19

Chemo Therapy(C) 128 21.69 115 19.04

S+R 25 4.24 30 4.97

S+C 19 3.22 36 5.96

R+C 134 22.71 100 16.56

S+R+C 24 4.07 59 9.77

Hormone Therapy(H) 15 2.54 6 0.99

S+H 0 0.00 4 0.66

R+H 5 0.85 13 2.15

C+H 1 0.17 2 0.33

S+R+H 0 0.00 2 0.33

S+C+H 0 0.00 6 0.99

R+C+H 2 0.34 6 0.99

S+R+C+H 1 0.17 27 4.47

Others (BCG Vaccine) 2 0.34 0 0.00


131

Table 92: Treatment Advised but not received at RI (All Cancers)

Treatment Male (N=16) Female (N=11)

# % # % Surgery(S) 5 31.25 2 18.18

Radio Therapy(R) 4 25 4 36.36

Chemo Therapy(C) 4 25 3 27.27

S+R 1 6.25 0 0.00

S+C 1 6.25 0 0.00

R+C 0 0 2 18.18

S+R+C 1 6.25 0 0.00

Hormone Therapy(H) 0 0 0 0.00

S+H 0 0 0 0.00

R+H 0 0 0 0.00

C+H 0 0 0 0.00

S+R+H 0 0 0 0.00

S+C+H 0 0 0 0.00

R+C+H 0 0 0 0.00

S+R+C+H 0 0 0 0.00

Others (BCG Vaccine) 0 0 0 0.00

Table 93: Reason for Non-Treatment/Partial Treatment/Incomplete Treatment (All Cancers)

Reason Male (N= 634) Female (N= 479)

# % # % Declined Treatment 16 2.52 14 2.92

Advised to take planned treatment outside the RI 45 7.10 44 9.19

Advised to take symptomatic treatment else where 188 29.65 102 21.29

Death during treatment 14 2.21 15 3.13

Death before initiating treatment 21 3.31 13 2.71

Others(follow up /not reported) 61 9.62 73 15.24

Discontinued because of inability to tolerate treatment 11 1.74 8 1.67

Unknown 278 43.85 210 43.84


132

Table 94: Multiple Malignancies

Primaries Male (N=14) Female (N= 17)

# % # % Two Primaries 14 100 14 82.35 Three Primaries 0 0 3 17.65

Table 95: Performance Status (WHO) at first follow up or 6 months whichever is earlier(All Cancers)

Performance Status PS Male (N=1185) Female (N=1042)

# % # % Able to carry out all normal activity without restriction 0 2 0.17 0 0.00

Restricted in physically strenuous activity but ambulatory and able to carry out light work

1 75 6.33 115 11.04

Ambulatory and capable of all self care but unable to carry out any work up and about more than 50 % of working hours

2 26 2.19 18 1.73

Capable of only limited self -care confined to bed or chair more than 50% working hours

3 74 6.24 47 4.51

Completely disabled ,cannot carry on any self care totally confined to bed or chair 4 70 5.91 39 3.74

Unknown 938 79.16 823 78.98

Table 96: Disease Status at First follow -Up or at 6 Months whichever is earlier

Disease Status Male (N= 1188) Female (N= 1049) # % # %

No Evidence of Disease (NED) 141 11.87 281 26.84

NED but Second Primary Present 14 1.18 11 1.05

NED but non malignant Disease Present 9 0.76 7 0.67

Cancer in regression/residual disease present

67 5.64 68 6.49

Cancer in progression/recurrence/primary Disease and /or Metastasis

252 21.21 147 14.04

Too Advanced 100 8.42 70 6.69

Patient Dead 88 7.41 49 4.68

Others (Not Reported) 4 0.34 3 0.29

Unknown 513 43.18 411 39.26


133

LEADING CANCERS – DETAILED INFORMATION


134

I. BREAST CANCER

Total Number(ICD10:C50):308(97.73% females and 2.27% males)

Breast Cancer in females ranks first among all the cancers.

1st leading Cancer among Females (28.6%)

Peak age group: 45-49 in Females.

Marital Status: Females 66.88% in married.

Mother Tongue : Malayalam: Females 99.34%

Religion: Female: Hindus 66.1%.

Education: Female -Secondary 36.9%

Detailed Microscopic Diagnosis: Female-Primary Histology-77.4%.

Histology -Infiltrating Duct Carcinoma 67.7% in Females.

Method of Diagnosis: Female -Microscopic-93.7%

Clinical extent of disease:

1. Prior treatment: Female Regional LN 36.2%

2. Treatment Only At RI Female Regional LN 71.9%

3. Prior +Treatment At RI Female Regional LN 61.7%

4. No Treatment Female Regional LN 63.3%

Laterality Female Left Right 48.83%

Type of Treatment :

1. Prior Treatment Only Female S+R+C 20.28%

2.Treatment Only At RI Female S+R+C 35.53%

3. Prior + Treatment At RI

a) Prior Treatment Female H+C 38.3%

b) Treatment At RI Female R 35.8%

Any Specific treatment :

1. Prior Treatment Only Female Any Surgery 38.9%

2. Treatment Only At RI Female Any CT 33.4%

3. Prior + Treatment At RI

a) Prior Treatment Female Any Surgery . 8%

b) Treatment At RI Female Any RT 45.5%

Treatment Status At RI ( Excluding the Cancers Previously Treated)

Female Received 74 .8%

Intention to treat At RI ( Excluding the Cancers Previously Treated)

Female Radical 81.8%


135

Table 97: Number (#) and relative proportion (%) of Breast cancer by age

Age(years)

Female(n=301) Male(n=7) Total(n=308) # % # % # %

25-29 2 0.66 1 14.29 3 0.97

30-34 11 3.65 0 0 11 3.57

35-39 25 8.3 0 0 25 8.12

40-44 48 15.95 1 14.29 49 15.9

45-49 60 19.93 0 0 60 19.48

50-54 51 16.94 1 14.29 52 16.88

55-59 40 13.29 1 14.29 41 13.31

60-64 33 10.96 2 28.57 35 11.36

65-69 9 2.99 0 0 9 2.92

70-74 9 2.99 1 14.29 10 3.25

75+ 13 4.3 0 0 13 4.22 Table 98: Number (#) and relative proportion (%) of breast cancer by Marital Status

Marital Status

Female(n=301) Male(n=7) Total(n=308)

# % # % # %

Unmarried 17 5.6 0 0 17 5.52

Married 202 67.1 4 57.1 206 66.88

Widowed 76 25.2 2 28.6 78 25.32

Divorced 1 0.3 0 0 1 0.32

Others 3 1 0 0 3 97.4

Separated 0 0 0 0 0 0

Unknown 2 0.7 1 14.3 3 0.97


136

Table 99: Number (#) and relative proportion (%) of breast cancer by Religion

Religion


Hindu 199 66.1 5 71.4 204 66.23

Muslim 72 23.9 0 0 72 23.37

Christian 30 10 2 28.6 32 10.39

Others 0 0 0 0 0 0

Unknown 0 0 0 0 0 0

Table 100: Number (#) and relative proportion (%) of breast cancer by Education

Education


Primary 109 36.2 2 28.6 111 36.03

Secondary 111 36.9 2 28.6 113 36.69

Illiterate 29 9.6 1 14.3 30 9.74

Literate 13 4.3 0 0 13 4.22

College 26 8.6 1 14.3 27 8.77

Others 10 3.3 0 0 10 3.25

Unknown 3 1 1 14.3 4 1.3

Table 101: Number (#) and relative proportion (%) of breast cancer by

Detailed Microscopic Diagnosis



# % # % # % Primary Histology 233 77.4 5 71.4 238 77.27

Secondary Histology 4 1.3 0 0 4 1.3

Cytology 45 15 1 14.3 46 14.94

Others(NO Documents) 19 6.3 1 14.3 20 6.64


137

Table 102: Number (#) and relative proportion (%) of breast cancer

by Histology – Female

Type of Histology # % Neoplasm Malignant 1 0.33

Carcinoma 4 1.32

Papillary Carcinoma 1 0.33

Squamous Cell Ca. 0 0

Adenocarcinoma Nos. 1 0.33

Mucinous Adenocarcinoma 5 1.66

Infiltrating duct Ca. 204 67.77

Medullary Ca. 3 0.97

Lobular Carcinoma 3 0.97

Paget's Disease 0 0

CystoSarc.Phylloides 0 0

Ductal Carcinoma 20 6.64

Others 59 19.60

Total 301 100

Table 103: Number (#) and relative proportion (%) of breast cancer by Method of Diagnosis

Method of Diagnosis


# % # % # % Microscopic 282 93.7 6 85.7 288 93.5

X-ray / Imaging 3 1 0 0 3 0.97

Clinical 7 2.3 0 0 7 2.27

Others(CT/MRI/PET) 8 2.7 1 14.3 9 2.92

Unknown 1 0.3 0 0 1 0.32


138

Table 104: Number (#) and relative proportion (%) of breast cancer by Clinical

Extent of Disease

Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment Females

Clinical Extent of Disease

Prior Treatment Only

Treatment Only At RI

Prior+ Treatment At RI No Treatment

# % # % # % # %

Localized 15 21.7 4 3.3 7 8.6 3 10

Regional lymph node 25 36.2 87 71.9 50 61.7 19 63.3

Distant metastasis 19 27.5 28 23.1 16 19.8 8 26.7

Others 10 14.5 2 1.7 8 9.9 0 0

Unknown 0 0 0 0 0 0 0 0

Total 69 100 121 100 81 100 30 100


Laterality

Laterality Female(n=301) Male(n=7) Total(n=308)

# % # % # %

Right(R) 147 48.83 3 42.85 150 48.7

Left(L) 147 48.83 4 57.14 151 49.02

Only one site involved, R or L, unknown 1 0.3 0 0 1 0.32

Bilateral involvement, lateral origin unknown 3 1 0 0 3 0.97

Paired site but no information concerning laterality 0 0 0 0 0 0


139



Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment -Male





# % # % # % # %

Localized 1 50 0 0 0 0 0 0

Regional lymph node 1 50 4 100 0 0 0 0

Distant metastasis 0 0 0 0 1 100 0 0

Others 0 0 0 0 0 0 0 0

Unknown 0 0 0 0 0 0 0 0

Total 2 100 4 100 1 100 0 0

Table 107: Number (#) and relative proportion (%) of breast cancer by Type

of Treatment

Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI(Prior Treatment),RI Treatment -Female

Type of Treatment

Prior+ Treatment at RI Prior Treatment

Only Treatment Only

At RI

Prior Treatment

RI Treatment # % # % # % # %

Surgery 14 20.3 4 3.3 25 30.9 5 6.2

RT 1 1.4 1 0.8 0 0 29 35.8

CT 2 2.9 16 13.2 3 3.7 7 8.6

S+R 1 1.4 1 0.8 0 0 0 0

S+C 15 21.7 10 8.3 31 38.3 4 4.9

R+C 0 0 4 3.3 2 2.5 7 8.6

S+R+C 14 20.28 43 35.53 5 6.2 5 6.2

Others 22 31.8 42 34.71 15 38.3 24 29.63

Unknown 0 0 0 0 0 0 0 0

Total 69 100 121 100 81 100 81 100


140

Table 108: Number (#) and relative proportion (%) of breast cancer by Any specific treatment

Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment -Female

Any Specific Treatment


Only Treatment Only

At RI Prior Treatment RI Treatment

# % # % # % # %

Any Surgery 63 38.9 93 29.1 74 46.8 18 13.6

Any RT 30 18.5 78 24.4 15 9.5 60 45.5

Any CT 47 29 107 33.4 54 34.2 30 22.7

Any H 22 13.6 42 13.1 15 9.5 24 18.2

Total 162 100 320 100 158 100 132 100

Table 109: Number (#) and relative proportion (%) of breast cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status


# % # % # %

Received 113 74.8 4 100 117 75.5

Not Received 29 19.2 0 0 29 18.7

Not Accepted 1 0.7 0 0 1 0.65

Incomplete 8 5.3 0 0 8 5.2


Intention to treat at RI(Excluding the Cancers previously treated)

Intention

Female (n=121) Male(n=4) Total (n=125)

# % # % # %

Radical 99 81.8 3 75 102 81.6

Palliative 22 18.2 1 25 23 18.4

Pain Relief Only 0 0 0 0 0 0

Symptomatic 0 0 0 0 0 0

Unknown 0 0 0 0 0 0


141

II. LUNG CANCER Total Number(ICD10:C33-C34):281(85.77% males and 14.2%) females 2nd leading Cancer among all Cancers. 1st leading Cancer among Males (20.1%) and 6th leading among Females(3.8%) Male to female ratio:5.28:1 Peak age group:60-64 in Males and 55-59 in Females. Marital Status: Males 94.2% in married and Females 47.5% in widows Mother Tongue :Malayalam: Males 99.5% and Females 97.5% Religion :Male: Hindus 51% and Female: Hindus 53%. Education:Male-Primary56.6% Female -Primary 51.6% Detailed Microscopic Diagnosis :Male -Cytology-37.3% and Female-Cytology-36.3% Histology-Neoplasm Malignant Males- 37.76 Females -50% Method of Diagnosis:Male-Microscopic-77.2% and Female -Microscopic-76.86% Clinical extent of disease:

1. Prior treatment Male- Regional LN and Distant Metastasis 46.7% Female Distant Metastasis 100%

2. Treatment Only At RI Male Distant Metastasis 72.4% Female Distant Metastasis 68.4%

3. Prior+Treatment At RI - Male Distant Metastasis 80% Female Distant Metastasis 66.7%

Laterality Male Right 46.05%

Female Left 45% Type of Treatment

1. Prior Treatment Only Male Chemo Therapy 43.3% Female Chemo Therapy 66.7%

2. Treatment Only At RI Male R+C 44.9% - Female CT 52.6%

3. Prior + Treatment At RI a) Prior Treatment Male Chemo Therapy 52%

Female Chemo Therapy 60% b) Treatment At RI Male Chemo Therapy 48%

Female CT/RT/R+C 33.3% Any Specific treatment :

1. Prior Treatment Only - Male Any Chemo Therapy 57% - Female Any Chemo Therapy 75%

2.Treatment Only At RI - Male Any RT 51% - Female Any CT 66.7%

3. Prior + Treatment At RI a) Prior Treatment Male Any Chemo Therapy 61.3%

Female Any Chemo Therapy 67.7% b) Treatment At RI: Male Any Chemo Therapy 56.7%

Female Any CT/ Any RT 50% Treatment Status At RI ( Excluding the Cancers Previously Treated)

Male Not Received 46.2% Female Received/Not Received 38.7%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male Palliative 78.6% Female Palliative 100%


142

Table 111: Number (#) and relative proportion (%) of lung cancer by age

Age(years)

Male(n=241) Female(n=40) Total(n=281) # % # % # %

35-39 1 0.4 - 0 1 0.3

40-44 3 1.2 4 10 7 2.5

45-49 14 5.8 1 2.5 15 5.3

50-54 29 12 3 7.5 32 11.4

55-59 47 19.5 9 22.5 56 19.9

60-64 51 21.17 7 17.5 58 20.6

65-69 41 17 8 20 49 17.4

70-74 34 14.1 4 10 38 13.5

75+ 21 8.7 4 10 25 8.9

Table 112: Number (#) and relative proportion (%) of lung cancer by Marital Status

Marital Status


Unmarried 1 0.4 3 7.5 4 1.4

Married 227 94.2 17 42.5 244 86.8

Widowed 11 4.6 19 47.5 30 10.7

Divorced - - - - - -

Others 1 0.4 - - 1 0.3

Separated - - - - - -

Unknown 1 0.4 1 2.5 2 0.7

Table 113: Number (#) and relative proportion (%) of lung cancer by Religion

Religion


Hindu 123 51 26 65 149 53

Muslim 91 37.8 14 35 105 37.36

Christian 24 10 - - 24 8.54

Others 1 0.4 - - 1 0.36

Unknown 2 0.8 - - 2 0.71


143

Table 114: Number (#) and relative proportion (%) of lung cancer by Education

Education Male(n=241) Female(n=40) Total(n=281) # % # % # %

Primary 134 55.6 11 27.5 145 51.6

Secondary 47 19.5 8 20 55 19.5

Illiterate 22 9.1 8 20 30 10.68

Literate 22 9.1 6 15 28 9.96

College 8 3.3 2 5 10 3.5

Others 3 1.2 2 5 5 1.77

Unknown 5 2.1 3 7.5 8 2.85

Table 115: Number (#) and relative proportion (%) of lung cancer by Detailed Microscopic Diagnosis



Primary Histology 61 25.3 10 25 71 25.26


Cytology 90 37.3 12 30 102 36.3

Others(NO Documents) 55 22.8 10 25 65 23.13

Table 116: Number (#) and relative proportion (%) of lung cancer by Histology

Type of Histology Male(n=241) Female(n=40) Total(n=281) # % # % # %

Neoplasm Malignant 91 37.76 20 50 111 39.5

Carcinoma 8 3.32 1 2.5 9 3.2

Large Cell Carcinoma 0 0 0 0 0 0

Non Small Cell Ca. 30 12.45 6 15 36 12.81

Small cell Ca. 14 5.8 0 0 14 4.98

Oat Cell Ca 0 0 0 0 0 0

Sq. Cell Ca. 36 14.94 1 2.5 37 13.17

Papillary Adeno Ca 0 0 0 0 0 0

Adeno Ca. 21 8.71 5 12.5 26 9.25

Adeno Squamous Ca 0 0 0 0 0 0

No HPR 39 16.18 7 17.5 46 26.37

Others 22 9.13 0 0 22 7.83


144

Table 117: Number (#) and relative proportion (%) of lung cancer by Method

of Diagnosis

Method of Diagnosis

Male(n=241) Female(n=40) Total(n=281)

# % # % # % Microscopic 186 77.2 30 75 216 76.86

X-ray/ Imaging 49 20.3 10 25 59 20.99

Clinical 1 0.4 - - 1 0.36

Others(CT/ MRI/PET) 5 2.1 - - 5 1.78

Table 118: Number (#) and relative proportion (%) of lung cancer by

Laterality

Laterality Male(n=241) Female(n=40) Total(n=281)

# % # % # %

Right(R) 111 46.05 16 40 127 45.19

Left(L) 101 41.9 18 45 119 42.34

Only one site involved, R or L,unknown

2 0.82 1 2.5 3 1.06

Bilateral involvement, lateral origin unknown

2 0.82 0 0 2 0.7

Paired site but no information concerning laterality

25 10.37 5 12.5 30 10.68

Table 119: Number (#) and relative proportion (%) of lung cancer by Clinical

Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment – Male




Prior+ Treatment At RI

No Treatment

# % # % # % # %

Localized 0 0 0 0 0 0 2 2.3

Regional lymph node 14 46.7 27 27.6 5 20 40 45.5

Distant metastasis 14 46.7 71 72.4 20 80 43 48.9

Others 2 6.7 0 0 0 0 3 3.4

Unknown 0 0 0 0 0 0 0 0

Total 30 100 98 100 25 100 88 100


145

Table 120: Number (#) and relative proportion (%) of lung cancer by Clinical

Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI,No Treatment - Female


Prior Treatment

Only Treatment Only

At RI Prior+

Treatment At RI No Treatment

# % # % # % # %

Localized 0 0 0 0 0 0 0 0

Regional lymph node 0 0 6 31.6 1 16.7 6 50

Distant metastasis 3 100 13 68.4 4 66.7 6 50

Others 0 0 0 0 1 16.7 0 0

Unknown 0 0 0 0 0 0 0 0

Total 3 100 19 100 6 100 12 100

Table 121: Number (#) and relative proportion (%) of lung cancer by Type of Treatment

Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Male

Type of Treatment


Only Treatment Only


# % # % # % # %

Surgery 0 0 0 0 2 8 0 0

RT 5 16.7 28 28.6 4 16 8 32

CT 13 43.3 23 23.5 13 52 12 48

S+R 1 3.3 0 0 1 4 0 0

S+C 1 3.3 1 1 5 20 0 0

R+C 10 33.3 46 46.9 0 0 5 20

Total 30 100 98 100 25 100 25 100


146

Table 122: Number (#) and relative proportion (%) of lung cancer by Type of Treatment

Prior Treatment Only, Treatment Only at RI, Prior + Treatment at RI(Prior Treatment), RI Treatment - Female

Type of Treatment

Prior +Treatment at RI Prior

Treatment Only

Treatment Only At RI Prior Treatment RI Treatment

# % # % # % # %

Surgery 0 0 0 0 1 4 0 0

RT 0 0 1 5.3 1 1 2 33.3

CT 2 66.7 10 52.6 15 60 2 33.3

S+R 0 0 0 0 0 0 0 0

S+C 0 0 1 5.3 1 4 0 0

R+C 1 33.3 7 36.8 7 28 2 33.3

Total 3 100 19 100 25 100 6 100

Table 123: Number (#) and relative proportion (%) of lung cancer by Any

specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment - Male



Only Treatment Only At RI Prior Treatment RI Treatment

# % # % # % # %

Any Surgery 2 4.8 1 0.7 3 9.7 0 0

Any RT 16 38.1 74 51 9 29 13 43.3

Any CT 24 57.1 70 48.3 19 61.3 17 56.7

Total 42 100 145 100 31 100 30 100


147

Table 124: Number (#) and relative proportion(%) of lung cancer by Any

specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment), RI Treatment – Female



Only Treatment Only


# % # % # % # %

Any Surgery 0 0 1 3.7 2 6.1 0 0

Any RT 1 25 8 29.6 8 24.2 4 50

Any CT 3 75 18 66.7 23 69.7 4 50

Total 4 100 27 100 33 100 8 100

Table 125: Number (#) and relative proportion (%) of lung cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status Male(n=186) Female(n=31) Total(n=217) # % # % # %

Received 84 45.2 12 38.7 96 44.2

Not Received 86 46.2 12 38.7 98 45.1

Not Accepted 2 1.1 0 0 2 0.9

Incomplete 14 7.5 7 22.6 21 9.67

Table 126: Number (#) and relative proportion (%) of lung cancer by

Intention to treat at RI (Excluding the Cancers previously treated)

Intention Male(n=98) Female(n=19) Total(n=117)

# % # % # %

Radical 20 20.4 0 0 20 17.09

Palliative 77 78.6 19 100 96 82.05



Unknown 1 1 0 0 1 0.85


148

III. ORAL CANCER

Total Number(ICD10:C03-C06):187(56.68% males and 43.32%) females 3rd leading Cancer among all Cancers. 2nd leading Cancer among Males (8.8%) and 3rd leading among Females (7.7%) Male to female ratio:1.14:1 Peak age group: more than 75 Males and 65-69 in Females. Marital Status: Males 89.1% in married and Females 53.1% in widows Mother Tongue : Malayalam : Males 99.05% and Females 100% Religion: Male: Hindus 61.3% and Female: Hindus 66.7%. Education: Male-Primary 54.7% Female -Illiterate 50.6% Detailed Microscopic Diagnosis: Primary Histology: Male-75.5%; Female- 87.7% Histology-Squamous Cell Carcinoma-Males 61.32% Females-67.9% Method of Diagnosis: Male-Microscopic-77.4% and Female -Microscopic-88.9% Clinical extent of disease :

1. Prior treatment Male- Others (Not Evaluated) 50% Female Others (Not Evaluated) 66.7%

2. Treatment Only At RI Male Regional LN 84.7% Female Regional LN 85.7%

3. Prior+Treatment At RI Male Regional LN 50% Female Others (Not Evaluated) 40%

4. No Treatment Regional LN Male 82.6% Regional LN Female 90%

Type of Treatment : 1. Prior Treatment Only Male Radiation Therapy 33.3%

Female R+C 33.3% 2. Treatment Only At RI Male RT 33.3%

Female R+C 38.1% 3. Prior + Treatment At RI

a) Prior Treatment Male Chemo Therapy 50 Female Surgery 35.7%

b) Treatment At RI Male Chemo Therapy 62.5% Female Chemo Therapy 42.9%

Any Specific treatment : 1. Prior Treatment Only - Male Any RT 57.7%

- Female Any RT 44.8% 2. Treatment Only At RI - Male Any CT 51.1%

- Female Any RT 47.8% 3. Prior + Treatment At RI

a) Prior Treatment Male Any Chemo Therapy 50 % Female Any Surgery= Any RT 35%

b) Treatment At RI: Male Any CT 50% Female Any CT 42.9%

Treatment Status At RI ( Excluding the Cancers Previously Treated) Male Received 70.1% Female Received/ 82.6%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male Radical 59.2% Female Radical 71.8%


149

Table 127: Number (#) and relative proportion (%) of Oral cancer by age

Age(years)


40-44 3 2.83 0 0 3 1.6

45-49 4 3.77 3 3.7 7 3.7

50-54 7 6.6 2 2.47 9 4.81

55-59 15 14.15 9 11.11 24 12.83

60-64 17 16.03 19 23.46 36 19.25

65-69 17 16.03 22 27.16 39 20.86

70-74 12 11.32 7 8.64 19 10.16

75+ 31 29.25 19 23.46 50 26.73

Table 128: Number (#) and relative proportion (%) of Oral cancer by Marital

Status

Marital Status Male(n=106) Female(n=81) Total(n=187) # % # % # %

Unmarried 2 1.9 4 4.9 6 3.2

Married 95 89.1 33 40.7 128 68.45

Widowed 9 8.5 43 53.1 52 27.81

Divorced 0 0 0 0 0 0

Others 0 0 1 1.2 1 0.53


Unknown 0 0 0 0 0 0

Table 129: Number (#) and relative proportion (%) of Oral cancer by Religion

Religion Male(n=106) Female(n=81) Total(n=187) # % # % # %

Hindu 65 61.3 54 66.7 119 63.64

Muslim 20 18.9 24 29.6 44 23.53

Christian 20 18.9 3 3.7 23 12.3

Others 0 0 0 0 0 0

Unknown 1 0 0 0 1 0.53


150

Table 130: Number (#) and relative proportion (%) of Oral cancer by Education

Education Male(n=106) Female(n=81) Total(n=187)

# % # % # %

Primary 58 54.7 17 21 75 40.10

Secondary 20 18.9 7 8.6 27 14.44

Illiterate 14 13.2 41 50.6 55 29.41

Literate 11 10.4 10 12.3 21 11.23

College 3 2.8 1 1.2 4 2.14

Others 0 0 1 1.2 1 0.53

Unknown 0 0 4 4.9 4 2.14

Table 131: Number (#) and relative proportion (%) of Oral cancer by Detailed Microscopic Diagnosis

Detailed Microscopic

Diagnosis Male(n=106) Female(n=81) Total(n=187) # % # % # %

Primary Histology 80 75.5 71 87.7 151 80.75


Cytology 1 0.9 1 1.2 2 1.07


Table 132: Number (#) and relative proportion (%) of Oral cancer by

Histology

Type of Histology Male(n=106) Female(n=81) Total(n=187)

# % # % # %

Neoplasm Malignant 12 11.32 5 6.17 17 9.09

Carcinoma 0 0 0 0 0 0

Verrucous Ca. 5 4.71 5 6.17 10 5.35

Sq. Cell Ca. 65 61.32 55 67.90 120 64.17

Adeno.Ca. 0 0 0 0 0 0

Adenoid cystic Ca. 1 0.94 2 2.47 3 1.6

No HPR 22 20.75 14 17.28 36 19.25

Others 1 0.94 0 0 1 0.53


151

Table 133: Number (#) and relative proportion (%) of Oral cancer by Method of Diagnosis

Method of Diagnosis Male(n=106) Female(n=81) Total(n=187) # % # % # %

Microscopic 82 77.4 72 88.9 154 82.35

X-ray/Imaging 1 0.9 0 0 1 0.53

Clinical 17 16 5 6.2 22 11.76

Others(CT/MRI/PET) 5 4.7 4 4.9 9 4.81

Unknown 1 0.9 0 0 1 0.53

Table 134: Number (#) and relative proportion (%) of Oral cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment – Male





# % # % # % # %

Localized 1 5.6 2 3.5 0 0 3 13


Distant metastasis 4 22.6 7 12.3 2 25 0 0

Others(Not Evaluated) 9 50 0 0 2 25 1 4.3

Unknown 0 0 0 0 0 0 0 0

Total 18 100 57 100 8 100 23 100 Table 135: Number (#) and relative proportion (%) of Oral cancer by Clinical

Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment –Female





No Treatment

# % # % # % # %

Localized 1 6.7 2 4.8 0 0 0 0


Distant metastasis 1 6.7 2 4.8 3 21.4 1 10

Others (Not Evaluated) 10 66.7 2 4.8 7 40 0 0

Unknown 0 0 0 0 0 0 0 0

Total 15 100 42 100 14 100 10 100


152

Table 136: Number (#) and relative proportion (%) of Oral cancer by Type of

Treatment

Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI(Prior Treatment),RI Treatment - Male

Type of Treatment



# % # % # % # %

Surgery 1 5.6 8 14 1 12.5 1 12.5

RT 6 33.3 19 33.3 1 12.5 0 0

CT 1 5.6 4 7 4 50 5 62.5

S+R 5 27.8 5 8.8 1 12.5 1 12.5

S+C 1 5.6 0 0 0 0 0 0

R+C 3 16.7 16 28.1 1 12.5 0 0

S+R+C 1 5.6 5 8.8 0 0 1 12.5

Total 18 100 57 100 8 100 8 100

Table 137: Number (#) and relative proportion (%) of Oral cancer by Type of

Treatment

Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Female

Type of Treatment


Only Treatment Only


# % # % # % # %

Surgery 2 13.3 9 21.4 5 35.7 3 21.4

RT 3 20 7 16.7 2 14.3 5 35.7

CT 0 0 0 0 1 7.1 6 42.9

S+R 1 6.7 9 21.4 1 7.1 0 0

S+C 0 0 0 0 1 7.1 0 0

R+C 5 33.3 16 38.1 4 28.6 0 0

S+R+C 4 6.7 1 21.4 0 0 0 0

Total 15 100 42 100 14 100 14 100


153

Table 138: Number (#) and relative proportion (%) of Oral cancer by Any

specific treatment

Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment – Male



Only Treatment Only

At RI Prior

Treatment RI Treatment

# % # % # % # %

Any Surgery 8 27.6 18 20.5 2 20 3 27.3

Any RT 15 57.7 45 51.1 3 30 2 18.2

Any CT 6 20.7 25 28.4 5 50 6 54.5

Total 29 100 88 100 10 100 11 100

Table 139: Number (#) and relative proportion (%) of Oral cancer by Any specific treatment

Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI (Prior Treatment), RI Treatment – Female


Prior+ Treatment at RI



# % # % # % # %

Any Surgery 7 24.1 19 27.5 7 35 3 21.4

Any RT 13 44.8 33 47.8 7 35 5 35.7

Any CT 9 31 17 24.6 6 30 6 42.9

Total 29 100 69 100 20 100 14 100


154

Table 140: Number (#) and relative proportion (%) of Oral cancer by

Treatment Status at RI (Excluding the Cancers previously treated)

Treatment

Status Male(n=67) Female(n=46) Total(n=113)

# % # % # %

Received 47 70.1 38 82.6 85 75.22

Not Received 18 26.9 6 13 24 21.24

Not Accepted 0 0 1 2.2 1 0.88

Incomplete 2 3.0 1 2.2 3 2.65

Table 141: Number (#) and relative proportion (%) of Oral cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention Male(n=49) Female(n=39) Total(n=88)

# % # % # %

Radical 29 59.2 28 71.8 57 64.77

Palliative 20 40.8 10 25.6 30 34.09



Unknown 0 0 1 2.6 1 1.13


155

IV. CERVICAL CANCER

Total Number(ICD10:C53):124

Cervical Cancer ranks fourth among all the cancers.

2nd leading Cancer among Females (11.8%)

Peak age group: 45-49 in Females.

Marital Status: Females 54.8% in married.

Mother Tongue :Malayalam: Females 99.2%

Religion: Female: Hindus 82.3%.

Education: Female -Primary 46.8%

Detailed Microscopic Diagnosis : Female-Primary Histology-81.5%

Histology Non Keratinizing Large Cell Ca.-33.8%.

Method of Diagnosis: Female -Microscopic-85.5%

Clinical extent of disease :

1. Prior treatment: Female Others(No documents) 44.8% 2. Treatment Only At RI Female Regional LN 79.6% 3. Prior+ Treatment At RI Female Regional LN 63.2% 4. No Treatment Female Regional LN 63.0%

Type of Treatment : 1. Prior Treatment Only Female R+C 48.3% 2. Treatment Only At RI Female R+C 55.2% 3. Prior + Treatment At RI a) Prior Treatment Female R 31.6% b) Treatment At RI Female R 68.4%


1. Prior Treatment Only Female Any RT 60.9% 2. Treatment Only At RI Female Any RT 68.0% 3. Prior + Treatment At RI

a) Prior Treatment Female Any RT 41.7% b) Treatment At RI Female Any RT 70.8%

Treatment Status At RI ( Excluding the Cancers Previously Treated) Female Received 63 .2%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Female Radical 87.8%


156

Table 142: Number (#) and relative proportion (%)

of Cervical cancer by age

Age(years)

Female(n=124) # %

35-39 3 0.02

40-44 4 3.2

45-49 27 21.77

50-54 18 14.5

55-59 16 12.9

60-64 17 13.7

65-69 18 14.5

70-74 9 7.26

75+ 7 5.65

Table 143: Number (#) and relative proportion (%) of Cervical cancer by Marital Status

Marital Status

Female(n=124) # %

Unmarried 6 4.8

Married 68 54.8

Widowed 50 40.3

Divorced 0 0

Others 0 0

Separated 0 0

Unknown 0 0

Table 144: Number (#) and relative proportion (%) of Cervical cancer by Religion

Religion

Female(n=124) # %

Hindu 102 82.3

Muslim 17 30.7

Christian 4 3.2

Others 1 0.8

Unknown 0 0


157

Table 145: Number (#) and relative proportion (%) of

Cervical cancer by Education

Education Female(n=124)

# %

Primary 58 46.8

Secondary 29 23.4

Illiterate 24 19.4

Literate 6 4.8

College 3 2.4

Others 0 0

Unknown 4 3.2

Table 146: Number (#) and relative proportion (%) of Cervical cancer by Detailed Microscopic Diagnosis

Detailed Microscopic

Diagnosis Female(n=124)

# %

Primary Histology 101 81.5

Secondary Histology 1 0.8

Cytology 4 3.2

Others(NO Documents) 18 14.5

Table 147: Number (#) and relative proportion (%) of

Cervical cancer by Histology –Female

Type of Histology # %

Neoplasm Malignant 0 0

Carcinoma 2 1.61

Non Keratinizing Large Cell S.C.C 42 33.87

Non Keratinizing Small Cell S.C.C 0 0

Keratinizing Small Cell S.C.C 9 7.25

Squamous Cell Ca.Nos 29 23.39

Adenocarcinoma Nos. 8 6.45

Adeno Squamous Carcinoma 1 0.80

Others 33 26.61

Total 124 100


158

Table 148: Number (#) and relative proportion (%) of Cervical cancer by Method of Diagnosis

Method of Diagnosis Female(n=124)

# %

Microscopic 106 85.5

X-ray /Imaging 4 3.2

Clinical 12 9.7

Others(CT/MRI/PET) 2 1.6

Unknown 0 0

Table 149: Number (#) and relative proportion (%) of Cervical cancer by Clinical Extent of Disease

Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment -Female


Prior Treatment

Only Treatment Only At RI

Prior+ Treatment At

RI No

Treatment

# % # % # % # %

Localized 1 3.4 3 6.1 1 5.3 3 11.1

Regional lymph node 12 41.4 39 79.6 12 63.2 17 63


Others(No Documents) 13 44.8 0 0 1 5.3 0 0

Unknown 0 0 0 0 0 0 0 0

Total 29 100 49 100 19 100 27 100


159

Table 150: Number (#) and relative proportion (%) of Cervical cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Female

Type of Treatment


Only Treatment Only


# % # % # % # %

Surgery 1 3.4 1 2 5 26.3 0 0

RT 11 37.9 16 32.7 6 31.6 13 68.4

CT 0 0 0 0 3 5.8 2 10.5

S+R 3 10.3 4 8.2 1 5.3 0 0

S+C 0 0 1 2.0 1 5.3 0 0

R+C 14 48.3 27 55.2 3 15.8 3 15.8

S+R+C 0 0 0 0 0 0 1 5.2

Others 0 0 0 0 0 0 0 0

Unknown 0 0 0 0 0 0 0 0

Total 29 100 49 100 19 100 19 100 Table 151: Number (#) and relative proportion (%) of Cervical cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment – Female



Only Treatment Only


# % # % # % # % Any Surgery 4 8.7 6 7.4 7 29.2 1 4.2

Any RT 28 60.9 47 68 10 41.7 17 70.8

Any CT 14 30.4 28 34.6 7 29.2 6 25

Total 46 100 81 100 24 100 24 100


160

Table 152: Number (#) and relative proportion (%) of Cervical cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status Female(n=76)

# %

Received 48 63.2

Not Received 26 34.2

Not Accepted 1 1.3

Incomplete 1 1.3

Table 153: Number (#) and relative proportion (%) of Cervical cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention Female(n=49)

# %

Radical 43 87.8

Palliative 6 12.2

Pain Relief Only 0 0

Symptomatic 0 0

Unknown 0 0


161

V. STOMACH CANCER

Total Number(ICD10:C16):120(80.83% males and 19.17%) females 5th leading Cancer among all Cancers. 3rd leading Cancer among Males (8.1%) Peak age group: more than 75 in Males and Females. Marital Status: Males 93.8% in married and Females 47.8% in widows Mother Tongue : Malayalam : Males 100% and Females 100% Religion: Male: Hindus 60.8% and Female: Hindus 78.3%. Education: Male-Primary 60.8% Female -Primary 52.2% Detailed Microscopic Diagnosis :Male -Primary Histology-84.5% and Female-Primary

Histology-87% Method of Diagnosis:Male-Microscopic-87.6% and Female -Microscopic-87% Histology- Adeno Carcinoma -Male 61.86 % and Female-60.83% Clinical extent of disease :

1. Prior treatment Male Regional LN 41.7% Female Distant Met. 50%

2. Treatment Only At RI Male Distant Met. 57.9% Female Regional LN 60%

3. Prior+Treatment At RI Male Regional LN 44.4% Female Distant Met. 66.7%

4. No Treatment Male Distant Met. 52.8% Female Distant Met. 90.9%

Type of Treatment :

1. Prior Treatment Only Male S+C 37.5% Female S 75%

2.Treatment Only At RI Male CT 47.4% Female CT 60%

3. Prior + Treatment At RI a) Prior Treatment Male Surgery 38.9%

Female Surgery 66.7% b) Treatment At RI Male Chemo Therapy 83.3%

Female Chemo Therapy 66.7%


1. Prior Treatment Only Male Any CT 47.4% Female Any S 75%

2.Treatment Only At RI Male Any CT 57.7% Female Any CT 66.7%

3. Prior + Treatment At RI a) Prior Treatment Male Any S 56 %

Female Any S 66.7% b) Treatment At RI Male Any CT 84.9%

Female Any CT 75% Treatment Status At RI ( Excluding the Cancers Previously Treated)

Male Not Received 63.6% Female Not Received 62.5%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male Palliative 57.9% Female Palliative 100%


162

Table 154: Number (#) and relative proportion (%) of Stomach cancer by age

Age(years) Male(n=97) Female(n=23) Total(n=120)

# % # % # %

35-39 3 3.09 1 4.35 4 3.33

40-44 3 3.09 0 0 3 2.5

45-49 5 5.15 2 8.7 7 5.83

50-54 13 13.4 1 4.35 14 11.67

55-59 13 13.4 3 13.04 16 13.33

60-64 13 13.4 3 13.04 16 13.33

65-69 13 13.4 3 13.04 16 13.33

70-74 13 13.4 2 8.7 15 12.5

75+ 21 21.65 8 34.78 29 24.17

Table 155: Number (#) and relative proportion (%) of Stomach cancer by Marital Status

Marital Status Male(n=97) Female(n=23) Total(n=120)

# % # % # %

Unmarried 0 0 4 17.4 4 3.33

Married 91 93.8 8 34.8 99 82.5

Widowed 6 6.2 11 47.8 17 14.16


Others 0 0 0 0 0 0


Unknown 0 0 0 0 0 0

Table 156: Number (#) and relative proportion (%) of Stomach cancer by Religion

Religion


Hindu 59 60.8 18 78.2 77 64.17

Muslim 31 32 5 21.7 36 30

Christian 7 7.2 0 0 7 5.83

Others 0 0 0 0 0 0

Unknown 0 0 0 0 0 0


163

Table 157: Number (#) and relative proportion (%) of Stomach cancer by Education


# % # % # %

Primary 59 60.8 12 52.2 71 37.97

Secondary 24 24.7 1 4.3 25 13.37

Illiterate 4 4.1 4 17.4 8 4.28

Literate 4 4.1 3 13 7 3.74

College 2 2.1 1 4.3 3 1.6

Others 2 2.1 0 0 2 1.06

Unknown 2 2.1 2 8.7 4 2.13 Table 158: Number (#) and relative proportion (%) of Stomach cancer by Detailed Microscopic Diagnosis



Primary Histology 82 84.5 20 87 102 85


Cytology 1 1 0 0 1 0.833

Others(NO Documents) 12 12.4 3 13 15 12.5 Table 159: Number (#) and relative proportion (%) of Stomach cancer by Histology

Type of Histology


# % # % # %


Carcinoma 3 3.09 1 4.35 4 3.33

Adeno Carcinoma 60 61.86 13 56.52 73 60.83

Signet Ring Cell 9 9.28 0 0 9 7.5

Sarcoma 0 0 1 4.35 1 0.83

No HPR 14 14.43 2 8.7 16 13.33

Others 3 3.09 4 17.39 7 5.83


164

Table 160: Number (#) and relative proportion(%) of Stomach cancer by Method of Diagnosis

Method of Diagnosis Male(n=97) Female(n=23) Total(n=120)

# % # % # %

Microscopic 85 87.6 20 87 105 87.5

X-ray/Imaging 1 1 1 4.3 2 1.67

Clinical 0 0 0 0 0 0

Others(CT/MRI/PET) 11 11.3 2 8.7 13 10.83

Unknown 0 0 0 0 0 0 Table 161: Number (#) and relative proportion (%) of Stomach cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment – Male





# % # % # % # %

Localized 1 4.2 3 15.8 2 11.1 1 2.8



Others (Not Evaluated) 5 20.8 0 0 3 16.7 5 13.9

Unknown 0 0 0 0 0 0 0 0

Total 24 100 19 100 18 100 36 100


165

Table 162: Number (#) and relative proportion (%) of Stomach cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment –Female





No Treatment

# % # % # % # %

Localized 1 25 0 0 0 0 0 0

Regional lymph node 1 25 3 60 1 33.3 0 0

Distant metastasis 2 50 2 40 2 66.7 10 90.9


Unknown 0 0 0 0 0 0 0 0

Total 4 100 5 100 3 100 11 100

Table 163: Number (#) and relative proportion (%) of Stomach cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment - Male

Type of Treatment




# % # % # % # %

Surgery 6 25 4 21.1 7 38.9 2 11.1

RT 0 0 0 0 0 0 0 0

CT 6 25 9 47.4 4 22.2 15 83.3

S+R 0 0 0 0 1 5.6 0 0

S+C 9 37.5 4 21.1 6 33.3 1 5.6

R+C 1 4.2 1 5.3 0 0 0 0

S+R+C 2 8.33 1 5.3 0 0 0 0

Total 24 100 19 100 18 100 18 100


166

Table 164: Number (#) and relative proportion (%) of Stomach cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment – Female

Type of Treatment



# % # % # % # %

Surgery 3 75 1 20 2 66.7 0 0

RT 0 0 0 0 0 0 0 0

CT 1 25 3 60 1 33.3 2 66.7

S+R 0 0 0 0 0 0 0 0

S+C 0 0 0 0 0 0 1 33.3

R+C 0 0 1 20 0 0 0 0

S+R+C 0 0 0 0 0 0 0 0

Total 4 100 5 100 3 100 3 100 Table 165: Number (#) and relative proportion (%) of Stomach cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Male



Only Treatment Only


# % # % # % # %

Any Surgery 17 44.7 9 34.6 14 56 3 15.8

Any RT 3 7.9 2 7.7 1 4 0 0

Any CT 18 47.4 15 57.7 10 40 16 84.2

Total 38 100 26 100 25 100 19 100


167

Table 166: Number (#) and relative proportion (%) of Stomach cancer by

Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI (Prior Treatment), RI Treatment - Female





Prior Treatment RI Treatment

# % # % # % # %

Any Surgery 3 75 1 16.7 2 66.7 1 25

Any RT 0 0 1 16.7 0 0 0 0

Any CT 1 25 4 66.7 1 33.3 3 75

Total 4 100 6 100 3 100 4 100

Table 167: Number (#) and relative proportion (%) of Stomach cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status Male(n=55) Female(n=16) Total(n=71) # % # % # %

Received 17 39.9 5 31.2 22 30.99

Not Received 35 63.6 10 62.5 45 63.38

Not Accepted 1 1.8 0 0 1 1.4

Incomplete 2 3.6 1 6.2 3 4.23

Table 168: Number (#) and relative proportion (%) of Stomach cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention Male(n=19) Female(n=5) Total(n=24) # % # % # %

Radical 8 42.1 0 0 8 33.33

Palliative 11 57.9 5 100 16 66.67



Unknown 0 0 0 0 0 0


168

VI. OESOPHAGEALCANCER Total Number(ICD10): 90 (4.8% males and 3% females) 6th leading Cancer among all Cancers. 6th leading Cancer among Males (4.8%) and 8th leading Cancer in Females(3%). Male to female ratio:1.6:1 Peak age group: 50-54 in Males and in Females more than 75. Marital Status: Males 94.8% in married and Females 50% widowed. Mother Tongue: Malayalam : Males 100% and Females 100% Religion: Male: Hindus 69% and Female: Hindus 66%. Education: Male-Primary 56.9% Female -Primary 34.4% Detailed Microscopic Diagnosis :Male -Primary Histology-75.6% and Female-Primary

Histology-84.4% Histology-Squamous Cell Carcinoma-Males 50% Females-75% Method of Diagnosis: Microscopic: Male-77.6% and Female - 84.4% Clinical extent of disease:

1. Prior treatment Male Regional LN 45.5% Female Regional LN/Distant Mets.

/ Not evaluated 33.3% 2. Treatment Only At RI- Male Distant mets. 52.9%

Female Regional LN 50% 3. Prior+Treatment At RI

Male Distant mets.& Not Evaluated 50%

Female Regional LN/Distant mets./ Others (Not Evaluated) 33.3%

4. No Treatment Regional LN Male 39.3% Distant mets. Female 26.7%

Type of Treatment : 1. Prior Treatment Only Male R+C 27.3%

Female R+C 83.3% 2.Treatment Only At RI Male RT 52.9%

Female CT /R+C 12.5% 3. Prior + Treatment At RI

a) Prior Treatment Male RT 47.4% Female CT 66.7%

b) Treatment At RI Male Surgery/RT 50% Female CT 66.7%

Any Specific treatment 1. Prior Treatment Only Male Any CT 44.4%

Female Any CT 54.5% 2. Treatment Only At RI Male Any RT 57.1%

Female Any RT 55.5 % 3. Prior + Treatment At RI

a) Prior Treatment Male Any RT 50 % Female Any CT7 5 %

b) Treatment At RI Male Any S /R/C 33.3% Female Any CT 66.7%

Treatment Status At RI ( Excluding the Cancers Previously Treated) Male Not Received 88.2 %

Female Not Received 62.5% Intention to treat At RI ( Excluding the Cancers Previously Treated)

Male Palliative 88.2% Female Palliative 62.5%


169

Table 169: Number (#) and relative proportion (%) of Oesophageal cancer by age

Age(years) Male(n=58) Female(n=32) Total(n=90)

# % # % # %

35-39 1 1.72 0 0 1 1.11

40-44 1 1.72 0 0 1 1.11

45-49 6 10.34 1 3.13 7 7.78

50-54 13 22.41 1 3.13 14 15.56

55-59 10 17.24 4 12.5 14 15.56

60-64 7 12.06 8 25 15 16.67

65-69 7 12.06 5 15.63 12 13.33

70-74 9 15.51 4 12.5 13 14.44

75+ 0 0 9 28.13 9 10

Table 170: Number (#) and relative proportion (%) of Oesophageal cancer by Marital Status


# % # % # %

Unmarried 1 1.7 1 3.1 2 2.22

Married 55 94.8 15 46.9 70 77.78

Widowed 2 3.4 16 50 18 20


Others 0 0 0 0 0 0


Unknown 0 0 0 0 0 0

Table 171: Number (#) and relative proportion (%) of Oesophageal cancer by Religion

Religion Male(n=58) Female(n=32) Total(n=90)

# % # % # %

Hindu 40 69 26 81.2 66 73.33

Muslim 10 17.2 6 18.8 16 17.77

Christian 8 13.8 0 0 8 8.89

Others 0 0 0 0 0 0

Unknown 0 0 0 0 0 0


170

Table 172: Number (#) and relative proportion (%) of Oesophageal cancer

by Education


# % # % # %

Primary 33 56.9 11 34.4 44 48.89

Secondary 13 22.4 2 6.2 15 16.66

Illiterate 6 10.3 9 28.1 15 16.66

Literate 2 3.4 5 15.6 7 7.77

College 1 1.7 1 3.1 2 2.22

Others 2 3.4 2 6.2 4 4.44

Unknown 1 17 2 6.2 3 3.33 Table 173: Number (#) and relative proportion (%) of Oesophageal cancer by Detailed Microscopic Diagnosis



# % # % # %



Cytology 0 0 0 0 0 0

Others (No Documents)

13 22.4 5 15.6 18 20

Table 174: Number (#) and relative proportion (%) of Oesophageal cancer by Histology



Adenosquamous 1 1.72 2 6.25 3 3.33

Signet ring cell adenoca. 1 1.72 1 3.13 2 2.22

Sq. Cell Ca. 29 50 24 75 53 58.88

Adeno.Ca. 6 10.34 2 6.25 8 8.88

Mucin secreting adenoca. 1 1.72 0 0 1 1.11

No HPR 13 22.4 0 0 13 14.44


171


by Method of Diagnosis


# % # % # %

Microscopic 45 77.6 27 84.4 82 91.11

X-ray/ Imaging 1 1.7 1 3.1 2 2.22

Clinical 1 1.7 0 0 1 1.11

Others(CT/ MRI/PET) 11 19 3 9.4 14 15.56

Unknown 0 0 1 3.1 1 1.11

Table 176: Number (#) and relative proportion (%) of Oesophageal cancer by Clinical Extent of Disease

Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment - Male





# % # % # % # %

Localized 0 0 0 0 0 0 1 3.6



Others(Not Evaluated) 3 27.3 0 0 1 50 4 14.3

Unknown 0 0 0 0 0 0 2 7.1

Total 11 100 17 100 2 100 28 100


172


by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment - Female




Prior+ Treatment At

RI No Treatment

# % # % # % # %

Localized 0 0 2 25 0 0 0 0

Regional lymph node 2 33.3 4 50 1 33.3 10 66.7

Distant metastasis 2 33.3 2 25 1 33.3 4 26.7

Others(Not Evaluated) 2 33.3 0 0 1 33.3 1 6.7

Unknown 0 0 0 0 0 0 0 0

Total 6 100 8 100 3 100 15 100

Table 178: Number (#) and relative proportion (%) of Oesophageal cancer by Type of Treatment

Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI (Prior Treatment), RI Treatment – Male

Type of

Treatment


Prior Treatment

Only Treatment Only

At RI

Prior Treatment

RI Treatment

# % # % # % # %

Surgery 2 18.2 0 0 0 0 1 50

RT 1 9.1 9 52.9 9 47.4 1 50

CT 2 18.2 4 23.5 4 21.1 0 0

S+R 0 0 0 0 1 5.3 0 0

S+C 2 18.2 1 5..9 1 5.3 0 0

R+C 3 27.3 3 17.6 4 21.1 0 0

S+R+C 1 9.1 0 0 0 0 0 0

Total 11 100 17 100 19 100 2 100


173


by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment), RI Treatment – Female

Type of

Treatment


Only Treatment Only At

RI

Prior Treatment

RI Treatment # % # % # % # %

Surgery 0 0 2 2.5 0 0 0 0

RT 0 0 4 50 0 0 1 33.3

CT 1 16.7 1 12.5 2 66.7 2 66.7

S+R 0 0 0 0 0 0 0 0

S+C 0 0 0 0 1 33.3 0 0

R+C 5 83.3 1 12.5 0 0 0 0

S+R+C 0 0 0 0 0 0 0 0

Total 6 100 8 100 3 100 3 100 Table 180: Number (#) and relative proportion (%) of Oesophageal cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment - Male

Any Specific

Treatment




Prior

Treatment

RI Treatment

# % # % # % # %

Any Surgery 5 27.8 1 4.8 1 25 1 33.3

Any RT 5 27.8 12 57.1 2 50 1 33.3

Any CT 8 44.4 8 38.1 1 25 1 33.3

Total 18 100 21 100 4 100 3 100


174

Table 181: Number (#) and relative proportion (%) of Oesophageal cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Female



Only Treatment Only


# % # % # % # %

Any Surgery 0 0 2 22.2 1 25 0 0

Any RT 5 45.5 5 55.5 0 0 1 33.3

Any CT 6 54.5 2 22.2 3 75 2 66.7

Total 11 100 9 100 4 100 3 100 Table 182: Number (#) and relative proportion (%) of Oesophageal cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status Male(n=17) Female(n=8) Total(n=25)

# % # % # %

Received 2 11.8 2 25 4 16

Not Received 15 88.2 5 62.5 20 80

Not Accepted 0 0 0 0 0 0

Incomplete 0 0 0 0 0 0

Unknown 0 0 1 12.5 1 4 Table 183: Number (#) and relative proportion (%) of Oesophageal cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention


# % # % # %

Radical 2 11.8 2 25 4 16

Palliative 15 88.2 5 62.5 20 80



Unknown 0 0 1 12.5 1 4


175

VII. RECTAL CANCER

Total Number(ICD10:C19-C20) : 87(4.3% males and 3.3% females) 7th leading Cancer among all Cancers. 7th leading Cancer among Males (4.3%) and 7th leading Cancer among Females(3.3%) . Male to female ratio : 1.30:1 Peak age group : Males and Females between 65-69 yrs. Marital Status : Males 90.4% in married and Females 57.1% widowed. Mother Tongue : Malayalam : Males 100% and Females 100% Religion : Male : Hindus 67.3% and Female : Hindus 74.3%. Education: Male - Primary 48.1% Female - Primary 31.4% Detailed Microscopic Diagnosis : Male - Primary Histology-88.5% and Female-Primary

Histology 94.3% Histology-Adenocarcinoma - Males 65.38% Females - 62.85% Method of Diagnosis : Male – Microscopic - 90.4% and Female – Microscopic - 97.1% Clinical extent of disease :

1. Prior treatment Male Distant mets 50% Female Regional LN 100%


3.Prior+Treatment At RI Male Regional LN 58.3% Female Regional LN 90%

4. No Treatment Male Distant mets. 37.5% Female Regional LN 54.5%

Type of Treatment : 1. Prior Treatment Only Male Surgery/S+R+C 30.%

Female S+C 66.7% 2.Treatment Only At RI Male Surgery /S+C 28.6%

Female Surgery 45.5% 3. Prior + Treatment At RI Surgery /R+C

a) Prior Treatment Male S+C 26.9% Female Surgery 60%

b) Treatment At RI Male CT 41.7% Female CT 40%

Any Specific treatment : 1. Prior Treatment Only Male Any Surgery 41.2%

Female Any Surgery 50% 2. Treatment Only At RI Male Any S 48%

Female Any S 55% 3. Prior + Treatment At RI

a) Prior Treatment Male Any Surgery 40% Female Any Surgery 71.4%

b) Treatment At RI Male Any CT 56.2% Female Any CT 57.1%

Treatment Status At RI ( Excluding the Cancers Previously Treated) Male Not Received 53.3% Female Not Received 50%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male - Radical 71.4% Female – Radical 81.8%


176

Table 184: Number (#) and relative proportion (%) of Rectal cancer by age

Age(years)


# % # % # %

25-29 0 0 1 2.86 1 1.15

30-34 2 3.85 1 2.86 3 3.45

35-39 3 5.77 0 0 3 3.45

40-44 2 3.85 1 2.86 3 3.45

45-49 5 9.62 2 5.71 7 8.05

50-54 2 3.85 1 2.86 3 3.45

55-59 8 15.38 5 14.29 13 14.94

60-64 3 5.77 2 5.71 5 5.75

65-69 11 21.15 11 31.43 22 25.29

70-74 4 7.69 5 14.29 9 10.34

75+ 12 23.08 6 17.14 18 20.69

Table 185: Number (#) and relative proportion (%) of Rectal cancer by

Marital Status

Marital Status


# % # % # %

Unmarried 1 1.9 3 8.6 4 4.59

Married 47 90.4 12 34.3 59 67.81

Widowed 4 7.7 20 57.1 24 27.58


Others 0 0 0 0 0 0


Unknown 0 0 0 0 0 0 Table 186: Number (#) and relative proportion (%) of Rectal cancer by Religion


# % # % # %

Hindu 35 67.3 26 74.3 61 70.11

Muslim 16 30.8 8 22.9 24 27.58

Christian 1 1.9 1 2.9 2 2.29

Others 0 0 0 0 0 0

Unknown 0 0 0 0 0 0


177

Table 187: Number (#) and relative proportion (%) of Rectal cancer by Education

Education


# % # % # %

Primary 25 48.1 11 31.4 36 41.38

Secondary 22 42.3 8 22.9 30 34.48

Illiterate 3 5.8 5 14.3 8 9.19

Literate 1 1.9 6 17.1 7 8.04

College 1 1.9 3 8.6 4 4.59

Others 0 0 2 5.7 0 0

Unknown 0 0 0 0 0 0 Table 188: Number (#) and relative proportion (%) of Rectal cancer by Detailed Microscopic Diagnosis





Cytology 0 0 1 2.9 1 1.15

Others (No Documents) 5 9.6 1 2.9 6 6.89

Table 189: Number (#) and relative proportion (%) of Rectal cancer by Histology

Type of Histology Male(n=52) Female(n=35) Total(n=87)

# % # % # %


Signet ring cell ca. 1 1.92 1 2.86 2 2.29

Mucin secreting adenoca. 2 3.85 2 5.71 4 4.59

Adeno.Ca. 34 65.38 22 62.85 56 64.37

No HPR 11 21.15 8 22.86 19 21.83


178

Table 190: Number (#) and relative proportion (%) of Rectal cancer by Method of Diagnosis

Method of Diagnosis


Microscopic 47 90.4 34 97.1 81 93.1

X-ray /Imaging 1 1.9 1 2.9 2 2.29

Clinical 1 1.9 0 0 1 1.15

Others(CT/MRI/PET) 2 3.8 0 0 2 2.29

Unknown 1 1.9 0 0 1 1.15 Table 191: Number (#) and relative proportion (%) of Rectal cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment - Male





# % # % # % # %

Localized 0 0 2 14.3 0 0 0 0


Distant metastasis 5 50 4 28.6 3 25 6 37.5

Others(Not Evaluated) 2 20 0 0 2 16.7 2 12.5

Unknown 0 0 0 0 0 0 0 0

Total 10 100 14 100 12 100 16 100

Table 192: Number (#) and relative proportion (%) of Rectal cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI,No Treatment - Female





No Treatment

# % # % # % # %

Localized 0 0 0 0 0 0 1 9.1

Regional lymph node 3 100 6 54.5 9 90 6 54.5

Distant metastasis 0 0 5 45.5 1 10 3 27.3


Unknown 0 0 0 0 0 0 0 0

Total 3 100 11 100 10 100 11 100


179

Table 193: Number (#) and relative proportion (%) of Rectal cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI(Prior Treatment), RI Treatment –Male

Type of Treatment


Only Treatment Only

At RI

Prior Treatment

RI Treatment # % # % # % # %

Surgery 3 30 4 28.6 6 23.1 1 8.3

RT 1 10 0 0 0 0 2 16.7

CT 2 20 2 14.3 2 7.7 5 41.7

S+R 0 0 1 7.1 3 11.5 0 0

S+C 1 10 4 28.6 7 26.9 1 8.3

R+C 0 0 0 0 2 7.7 3 25

S+R+C 3 30 3 7.1 6 11.5 0 0

Total 10 100 14 100 26 100 12 100

Table 194: Number (#) and relative proportion (%) of Rectal cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment),RI Treatment – Female

Type of

Treatment


Only Treatment Only At RI

Prior Treatment

RI Treatment

# % # % # % # %

Surgery 0 0 5 45.5 6 60 1 10

RT 0 0 0 0 0 0 1 10

CT 0 0 0 0 0 0 4 40

S+R 1 33.3 0 0 0 0 0 0

S+C 2 66.7 3 27.3 4 40 0 0

R+C 0 0 0 0 0 0 4 40

S+R+C 0 0 3 27.3 0 0 0 0

Total 3 100 11 100 10 100 10 100


180

Table 195: Number (#) and relative proportion (%) of Rectal cancer by Any

specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Male





Prior Treatment RI Treatment

# % # % # % # %

Any Surgery 7 41.2 12 48 10 40 2 12.5

Any RT 4 23.5 4 16 7 28 5 31.2

Any CT 6 35.3 9 36 8 32 9 56.2

Total 17 100 25 100 25 100 16 100

Table 196: Number (#) and relative proportion (%) of Rectal cancer by Any specific treatment

Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment), RI Treatment - Female



Only Treatment Only


# % # % # % # %

Any Surgery 3 50 11 55 10 71.4 1 7.1

Any RT 1 16.7 3 15 0 0 5 35.7

Any CT 2 33.3 6 30 4 28.6 8 57.1

Total 6 100 20 100 14 100 14 100


181

Table 197: Number (#) and relative proportion (%) of Rectal cancer by Treatment Status at RI(Excluding the Cancers previously treated)

Treatment Status


Received 13 43.3 8 36.4 21 40.38

Not Received 16 53.3 11 50 27 51.92


Incomplete 1 3.3 3 13.6 4 7.69

Table 198: Number (#) and relative proportion (%) of Rectal cancer by Intention to treat at RI(Excluding the Cancers previously treated)

Intention


Radical 10 71.4 9 81.8 19 76

Palliative 4 28.6 2 18.2 6 24



Unknown 0 0 0 0 0 0


182

VIII. TONGUE CANCER

Total Number(ICD10:C01-C02):83(5.1% males and 2.1% females) 8th leading Cancer among all Cancers. 5th leading Cancer among Males(5.1%). Male to female ratio:2.42:1 Peak age group: more than 75 Males. Marital Status: Males 90.4% in married and Females 50% widowed. Mother Tongue : Malayalam : Males 100% and Females 100% Religion: Male: Hindus 71.4% and Female: Hindus 63.6%. Education: Male-Primary 47.5% Female -Primary 40.9% Detailed Microscopic Diagnosis :Male -Primary Histology-86.9% and Female-Primary

Histology-90.9% Histology-Squamous Cell Carcinoma-Males 77.04% Females-77.27% Method of Diagnosis : Male-Microscopic-88.5% and Female -Microscopic-90.9% Clinical extent of disease :

1. Prior treatment Male Other(Not Evaluated) 72.7% Female Other(Not Evaluated) 100%


3. Prior+Treatment At RI Male Regional LN & Not Evaluated 50% Female Others (Not Evaluated) 66.7%

4. No Treatment Regional LN Male 71.4% Regional LN Female 100%

Type of Treatment : 1. Prior Treatment Only Male Radiation Therapy 36.4%

Female S+R/R+C/S+R+C 33.3% 2.Treatment Only At RI Male Surgery 31.4%

Female Surgery /R+C 30.8% 3. Prior + Treatment At RI

a) Prior Treatment Male Surgery 30.2% Female R+C 37.5%

b) Treatment At RI Male Surgery 62.5% Female Surgery/CT/R+C 33.3%

Any Specific treatment : 1. Prior Treatment Only Male Any RT 50%

Female Any RT 42.9% 2.Treatment Only At RI Male Any S 41.5%

Female Any RT 40.9 % 3. Prior + Treatment At RI

a) Prior Treatment Male Any RT 42.9 % Female Any CT 50 %

b) Treatment At RI Male Any S 66.7% Female Any CT 50 %

Treatment Status At RI ( Excluding the Cancers Previously Treated) Male Received 71.4%

Female Received 81.2%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male Radical 74.3% Female Radical 61.5%


183

Table 199: Number (#) and relative proportion (%) of Tongue cancer by

age

Age(years)


# % # % # %

20-24 1 1.64 0 0 1 1.2

25-29 0 0 0 0 0 0

30-34 1 1.64 1 4.55 2 2.4

35-39 2 3.28 1 4.55 3 3.61

40-44 1 1.64 1 4.55 2 2.4

45-49 7 11.48 2 9.09 9 10.84

50-54 10 16.39 2 9.09 12 14.46

55-59 3 4.92 2 9.09 5 6.02

60-64 10 16.39 5 22.72 15 18.07

65-69 7 11.48 1 4.55 8 9.64

70-74 3 4.92 2 9.09 5 6.02

75+ 16 26.23 5 22.72 21 25.3 Table 200: Number (#) and relative proportion (%) of Tongue cancer by Marital Status

Marital Status


Unmarried 3 4.9 0 0 3 3.61

Married 55 90.4 10 45.5 65 78.31

Widowed 2 3.3 11 50 13 15.66


Others 0 0 0 0 0 0

Separated 1 1.6 0 0 1 1.2

Unknown 0 0 1 4.5 1 1.2


184

Table 201: Number (#) and relative proportion (%) of Tongue cancer by Religion


# % # % # %

Hindu 46 75.4 14 63.6 60 72.29

Muslim 10 16.4 5 22.7 15 18.07

Christian 4 6.6 3 13.6 7 8.43

Others 1 1.6 0 0 1 1.2

Unknown 0 0 0 0 0 0

Table 202: Number (#) and relative proportion (%) of Tongue cancer by

Education

Education


Primary 29 47.5 9 40.9 38 45.78

Secondary 15 24.6 3 13.6 18 21.69

Illiterate 6 9.8 5 22.7 11 13.25

Literate 5 8.2 3 13.6 8 9.64

College 4 6.6 0 0 4 4.82

Others 1 1.6 1 4.5 2 2.4

Unknown 1 1.6 1 4.5 2 2.4 Table 203: Number (#) and relative proportion (%) of Tongue cancer by Detailed Microscopic Diagnosis





Cytology 0 0 0 0 0 0



185

Table 204: Number (#) and relative proportion (%) of Tongue cancer by Histology



Verrucous Ca. 1 1.63 0 0 1 1.2

Sq. Cell Ca. 47 77.04 17 77.27 64 77.10

No HPR 9 14.75 3 13.63 12 14.46

Table 205: Number (#) and relative proportion (%) of Tongue cancer by Method of Diagnosis

Method of Diagnosis Male(n=61) Female(n=22) Total(n=83) # % # % # %

Microscopic 54 88.5 20 90.9 74 89.16

X-ray/Imaging 0 0 0 0 0 0

Clinical 5 8.2 1 4.5 6 7.23

Others(CT/MRI/PET) 2 3.2 1 4.5 3 3.61

Unknown 0 0 0 0 0 0 Table 206: Number (#) and relative proportion (%) of Tongue cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment- Male




Prior+ Treatment At

RI No Treatment

# % # % # % # %

Localized 0 0 4 11.4 0 0 0 0


Distant metastasis 0 0 0 0 0 0 2 28.6

Others(Not Evaluated) 8 72.7 0 0 4 50 0 0

Unknown 0 0 0 0 0 0 0 0

Total 11 100 35 100 8 100 7 100


186

Table 207: Number (#) and relative proportion (%) of Tongue cancer by Clinical Extent of Disease

Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment –Female





# % # % # % # %

Localized 0 0 1 7.7 0 0 0 0

Regional lymph node 0 0 11 84.6 0 0 3 100

Distant metastasis 0 0 1 7.7 1 33.3 0 0

Others(Not Evaluated) 3 100 0 0 2 66.7 0 0

Unknown 0 0 0 0 0 0 0 0

Total 3 100 13 100 3 100 3 100

Table 208: Number (#) and relative proportion (%) of Tongue cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI(Prior Treatment),RI Treatment - Male

Type of Treatment


Only Treatment Only

At RI

Prior Treatment

RI Treatment # % # % # % # %

Surgery 1 9.1 11 31.4 13 30.2 5 62.5

RT 4 36.4 6 17.1 7 16.3 0 0

CT 0 0 3 8.6 3 7 2 25

S+R 0 0 8 22.9 10 23.3 0 0

S+C 0 0 0 0 0 0 1 12.5

R+C 3 27.3 4 11.5 6 14 0 0

S+R+C 3 27.3 3 22.9 4 23.3 0 0

Total 11 100 35 100 43 100 8 100


187

Table 209: Number (#) and relative proportion (%) of Tongue cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment), RI Treatment - Female

Type of Treatment




Prior Treatment

RI Treatment

# % # % # % # %

Surgery 0 0 4 30.8 4 25 1 33.3

RT 0 0 1 7.7 1 6.2 0 0

CT 0 0 0 0 0 0 1 33.3

S+R 1 33.3 3 23.1 3 18.8 0 0

S+C 0 0 0 0 1 6.2 0 0

R+C 1 33.3 4 30.8 6 37.5 1 33.3

S+R+C 1 33.3 1 23.1 1 18.8 0 0

Total 3 100 13 100 16 100 3 100

Table 210: Number (#) and relative proportion (%) of Tongue cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment - Male

Any Specific

Treatment




# % # % # % # %

Any Surgery 4 20 22 41.5 5 35.7 6 66.7

Any RT 10 50 21 39.6 6 42.9 0 0

Any CT 6 30 10 18.9 3 21.4 3 33.3

Total 20 100 53 100 14 100 9 100


188

Table 211: Number (#) and relative proportion (%) of Tongue cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment),RI Treatment - Female

Any Specific

Treatment




# % # % # % # %

Any Surgery 2 28.6 8 36.7 1 16.7 1 25

Any RT 3 42.9 9 40.9 2 33.3 1 25

Any CT 2 28.6 5 22.7 3 50 2 50

Total 7 100 22 100 6 100 4 100 Table 212: Number (#) and relative proportion(%) of Tongue cancer by Treatment Status at RI(Excluding the Cancers previously treated)

Treatment Status


Received 30 71.4 13 81.2 43 74.14

Not Received 7 16.7 3 18.8 10 17.24


Incomplete 5 11.9 0 0 5 8.62

Table 213: Number (#) and relative proportion(%) of Tongue cancer by Intention to treat at RI(Excluding the Cancers previously treated)

Intention


Radical 26 74.3 8 61.5 34 70.83

Palliative 9 25.7 4 30.8 13 27.08


Symptomatic 0 0 1 7.7 1 2.08

Unknown 0 0 0 0 0 0


189

IX. OVARIAN CANCER

Total Number (ICD10:C56): 75 Ovarian Cancer ranks ninth among all the cancers. 4th leading Cancer among Females (7.1%) Peak age group: 55-59 in Females. Marital Status: Females 44% in married. Mother Tongue :Malayalam: Females 100% Religion: Female: Hindus 69.3%. Education: Female -Primary 45.3% Detailed Microscopic Diagnosis : Female-Primary Histology-44% Histology - NO HPR (CA125)-28%. Method of Diagnosis: Female -Microscopic-72% Clinical extent of disease:

1. Prior treatment: Female Regional LN 47.4% 2. Treatment Only At RI Female Distant Mets. 77.8% 3. Prior+ Treatment At RI Female Distant Mets. 42.1% 4. No Treatment Female Distant Mets. 68.4%

Type of Treatment : 1. Prior Treatment Only Female CT 31.6% 2. Treatment Only At RI Female S+C 27.8% 3. Prior + Treatment At RI

a) Prior Treatment Female S 42.1% b) Treatment At RI: Female C 84.2%


1. Prior Treatment Only Female Any S/Any CT 43.3% 2. Treatment Only At RI Female Any CT 63% 3. Prior + Treatment At RI

a) Prior Treatment Female Any S 56% b) Treatment At RI: Female Any CT 86.4%

Treatment Status At RI ( Excluding the Cancers Previously Treated)

Female Not Received 45.9%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Female Palliiative 55.6%

Laterality : Paired Site but no information concerning laterality 49.33%


190


of ovarian cancer by age

Age(years) Female(n=75)

# %

20-24 1 1.33

25-29 1 1.33

30-34 4 5.33

35-39 3 4

40-44 6 8

45-49 10 13.33

50-54 7 9.33

55-59 13 17.33

60-64 5 6.66

65-69 12 16

70-74 3 4

75+ 10 13.33


of ovarian cancer by Marital Status

Marital Status

Female(n=75)

# %

Unmarried 13 17.3

Married 33 44

Widowed 28 37.3

Divorced 0 0

Others 0 0

Separated 0 0

Unknown 1 1.3


191


of ovarian cancer by Religion

Religion Female(n=75) # %

Hindu 52 69.3

Muslim 20 26.7

Christian 2 2.7

Others 0 0

Unknown 1 1.3

Table 217: Number (#) and relative proportion (%) of ovarian cancer by Education

Education Female(n=75)

# %

Primary 34 45.3

Secondary 17 22.7

Illiterate 13 17.3

Literate 16 8

College 4 5.3

Others 1 1.3

Unknown 0 0

Table 218: Number (#) and relative proportion (%) of ovarian cancer by Detailed Microscopic Diagnosis


Female(n=75)

# %

Primary Histology 33 44

Secondary Histology 7 9.3

Cytology 14 18.7

Others(NO Documents) 21 28


192

Table 219: Number (#) and relative proportion(%) of

Ovarian cancer by Histology –Female

Type of Histology # (n=75) % Neoplasm Malignant 20 26.66

Papillary Serous Cyst Adenocarcinoma 10 13.33

Dysgerminoma 2 2.66

Mucin Secreting Adeno carcinoma 6 8

Grannulosa cell tumour 1 1.33

Endometroid Ca. 3 4

Teratoma 1 1.33

Clear Cell Ca. 1 1.33

Small Endocrine Ca. 1 1.33

Mixed Germ Cell Tumour 1 1.33

Cyst Adenocarcinoma 2 2.66

No HPR 21 28

Others 6 8

Table 220: Number (#) and relative proportion (%) of ovarian cancer by Method of Diagnosis

Method of Diagnosis

Female(n=75)

# %

Microscopic 54 72

X-ray /Imaging 9 12

Clinical 1 1.3

Others(CT/MRI/PET) 11 14.7

Unknown 0 0


193

Table 221: Number (#) and relative proportion (%) of Ovarian cancer by Clinical Extent of Disease

Prior Treatment Only, Prior +Treatment at RI, Treatment Only at RI, No Treatment - Female





No Treatment

# % # % # % # %

Localized 0 0 1 5.6 1 5.3 0 0



Others(No Documents) 3 15.8 0 0 5 26.3 1 5.3

Unknown 0 0 0 0 0 0 0 0

Total 19 100 18 100 19 100 19 100 Table 222: Number (#) and relative proportion (%) of Ovarian cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment -Female

Type of Treatment


Prior Treatment

Only Treatment Only

At RI

Prior Treatment

RI Treatment

# % # % # % # %

Surgery 5 26.3 0 0 8 42.1 0 0

RT 0 0 1 5.6 1 5.3 0 0

CT 6 31.6 9 15 4 21.1 16 84.2

S+R 1 5.3 0 0 0 0 0 0

S+C 5 26.3 5 27.8 6 31.6 3 15.8

R+C 0 0 2 11.1 0 0 0 0

S+R+C 1 5.3 1 5.6 0 0 0 0

Others 1 5.3 0 0 0 0 0 0

Unknown 0 0 0 0 0 0 0 0

Total 19 100 18 100 19 100 19 100


194

Table 223: Number (#) and relative proportion (%) of Ovarian cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI(Prior Treatment), RI Treatment -Female

Any Specific

Treatment




# % # % # % # %

Any Surgery 13 43.3 6 22.2 14 56 3 14.6

Any RT 3 10 4 14.8 1 4 0 0

Any CT 13 43.3 17 63 10 40 19 86.4

Any H 1 3.3 0 0 0 0 0 0

Total 30 100 27 100 25 100 22 100

Table 224: Number (#) and relative proportion (%) of ovarian cancer by Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status Female(n=37)

# %

Received 12 32.4

Not Received 17 45.9

Not Accepted 2 5.4

Incomplete 6 16.2


195

Table 225: Number (#) and relative proportion (%) of Ovarian cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention Female(n=18)

# %

Radical 7 38.9

Palliative 10 55.6

Pain Relief Only 0 0

Symptomatic 1 56

Unknown 0 0 Table 226: Number (#) and relative proportion (%) of Ovarian cancer by Laterality

Laterality Female(n=75)

# %

Right(R) 12 16

Left(L) 11 14.66

Only one site involved, R or L, unknown 1 1.33

Bilateral involvement, lateral origin unknown 14 18.66

Paired site but no information concerning laterality 37 49.33


196

X. LARYNGEAL CANCER

Total Number (ICD10:C32) : 67 (5.3% males and 0.4% females)

10th leading Cancer among all Cancers.

4th leading Cancer among Males (5.3%).

Male to female ratio : 13.25:1

Peak age group : more than 75 Males.

Marital Status : Males 87.3% in married and Females 75% in married.

Mother Tongue : Malayalam : Males 100% and Females 100%

Religion : Male : Hindus 69.8% and Female : Hindus 50%.

Education : Male-Primary 44.6% Female -Primary 75%

Detailed Microscopic Diagnosis :Male -Primary Histology-79.4% and Female-Primary Histology-100%

Histology-Squamous Cell Carcinoma-Males 73.02% Females-100%

Method of Diagnosis : Male-Microscopic-81% and Female -Microscopic-100%

Clinical extent of disease:

1. Prior treatment: Male Localised and Regional LN 30.8% 2. Treatment Only At RI Male Regional LN 83.8%

Female Regional LN 75% 3. Prior+Treatment At RI Male Regional LN & Not Evaluated 37.5% 4. No Treatment Male Regional LN 75%

Type of Treatment 1. Prior Treatment Only Male Radiation Therapy 46.2% 2. Treatment Only At RI Male RT 46.7.3%

Female Surgery 50 % 3. Prior + Treatment At RI

a) Prior Treatment Male RT 39% Female Surgery 50%

b) Treatment At RI Male RT 50%

Any Specific treatment : 1. Prior Treatment Only Male Any RT 63.2 2. Treatment Only At RI Male Any RT 60%

Female Any RT 50 % 3. Prior + Treatment At RI

a) Prior Treatment Male Any Surgery 44.4 b) Treatment At RI Male Any RT 58%

Treatment Status At RI ( Excluding the Cancers Previously Treated) Male Received 69% Female Received 100%

Intention to treat At RI ( Excluding the Cancers Previously Treated) Male Radical 77.7% Female Radical/Palliative 50%


197

Table 227: Number (#) and relative proportion (%) of Laryngeal cancer by age


# % # % # %

40-44 1 1.59 0 0 1 1.49

45-49 1 1.59 0 0 1 1.49

50-54 3 4.76 1 25 4 5.97

55-59 13 20.63 0 0 13 19.4

60-64 10 15.87 1 25 11 16.42

65-69 11 17.46 1 25 12 17.91

70-74 10 15.87 0 0 10 14.93

75+ 14 22.22 1 25 15 22.39 Table 228: Number (#) and relative proportion (%) of Laryngeal cancer by Marital Status


# % # % # %

Unmarried 4 6.3 0 0 4 5.97

Married 55 87.3 3 75 58 86.57

Widowed 3 4.8 1 25 4 5.97


Others 0 0 0 0 0 0


Unknown 1 1.6 0 0 1 1.49 Table 229: Number (#) and relative proportion (%) of Laryngeal cancer by Religion


# % # % # %

Hindu 44 69.8 2 50 46 68.66

Muslim 13 20.6 1 25 14 20.90

Christian 6 9.5 1 25 7 10.45

Others 0 0 0 0 0 0

Unknown 0 0 0 0 0 0


198

Table 230: Number (#) and relative proportion (%) of Laryngeal cancer by

Education


# % # % # %

Primary 30 44.6 3 75 33 49.25

Secondary 15 23.8 1 25 16 23.88

Illiterate 8 12.7 0 0 8 11.94

Literate 5 7.9 0 0 5 7.46

College 3 4.8 0 0 3 4.48

Others 0 0 0 0 0 0

Unknown 2 3.2 0 0 2 2.99 Table 231: Number (#) and relative proportion (%) of Laryngeal cancer by Detailed Microscopic Diagnosis



Primary Histology 50 79.4 4 100 54 80.60

Secondary Histology 0 0 0 0 0 0

Cytology 1 1.6 0 0 1 1.49

Others (No Documents) 12 19 0 0 12 17.91

Table 232: Number (#) and relative proportion (%) of Laryngeal cancer by Histology

Type of Histology


Neoplasm Malignant 5 7.94 0 0 5 7.46

Carcinoma 1 1.59 0 0 1 1.49

Basaloid Sq.Cell Ca. 1 1.59 0 0 1 1.49

Sq. Cell Ca. 46 73.02 4 100 50 74.63

No HPR 10 15.87 0 0 10 14.93


199

Table 233: Number (#) and relative proportion (%) of Laryngeal cancer by Method of Diagnosis


# % # % # %

Microscopic 51 81 4 100 55 82.09

X-ray /Imaging 0 0 0 0 0 0

Clinical 2 3.2 0 0 2 2.99

Others (CT/MRI/PET) 10 15.9 0 0 10 14.93

Unknown 0 0 0 0 0 0

Table 234: Number (#) and relative proportion (%) of Laryngeal cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment – Male





No Treatment

# % # % # % # %

Localized 4 30.8 3 10 0 0 1 8.3

Regional lymph node 4 30.8 25 83.8 3 37.5 9 75


Others (Not Evaluated) 3 23.1 0 0 3 37.5 0 0

Unknown 0 0 0 0 0 0 1 8.3

Total 13 100 30 100 8 100 12 100


200

Table 235: Number (#) and relative proportion (%) of Laryngeal cancer by Clinical Extent of Disease Prior Treatment Only, Prior+ Treatment at RI, Treatment Only at RI, No Treatment - Female





# % # % # % # %

Localized 0 0 1 25 0 0 0 0

Regional lymph node 0 0 3 75 0 0 0 0

Distant metastasis 0 0 0 0 0 0 0 0

Others(Not Evaluated) 0 0 0 0 0 0 0 0

Unknown 0 0 0 0 0 0 0 0

Total 0 100 4 100 0 100 0 100

Table 236: Number (#) and relative proportion (%) of Laryngeal cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior+ Treatment at RI (Prior Treatment), RI Treatment - Male

Type of Treatment


Only Treatment Only

At RI

Prior Treatment

RI Treatment # % # % # % # %

Surgery 1 7.7 2 6.7 6 15.8 0 0

RT 6 46.2 14 46.7 15 39.5 4 50

CT 0 0 1 3.3 3 7.9 1 12.5

S+R 2 15.4 2 6.7 2 5.3 0 0

S+C 0 0 0 0 0 0 0 0

R+C 4 30.8 9 30 10 26.3 2 25

S+R+C 0 0 2 6.7 2 5.3 1 12.5

Total 13 100 30 100 38 100 8 100


201

Table 237: Number (#) and relative proportion (%) of Laryngeal cancer by Type of Treatment Prior Treatment Only, Treatment Only at RI, Prior +Treatment at RI(Prior Treatment), RI Treatment -Female

Type of Treatment


Only Treatment Only


# % # % # % # %

Surgery 0 0 2 50 2 50 0 0

RT 0 0 1 25 1 25 0 0

CT 0 0 0 0 0 0 0 0

S+R 0 0 0 0 0 0 0 0

S+C 0 0 0 0 0 0 0 0

R+C 0 0 1 25 1 24 0 0

S+R+C 0 0 0 0 0 0 0 0

Total 0 100 4 100 4 100 0 100 Table 238: Number (#) and relative proportion (%) of Laryngeal cancer by Any specific treatment Prior Treatment Only, Treatment Only at RI, Prior + Treatment at RI (Prior Treatment), RI Treatment - Male



Only Treatment Only


# % # % # % # %

Any Surgery 3 15.8 6 13.3 4 44.4 1 8.3

Any RT 12 63.2 27 60 2 22.2 7 58.3

Any CT 4 21.1 12 26.7 3 33.3 4 33.3

Total 19 100 45 100 9 100 12 100


202

Table 239: Number (#) and relative proportion (%) of Laryngeal cancer by any specific treatment Prior Treatment Only, Treatment Only at RI, Prior + Treatment at RI (Prior Treatment), RI Treatment –Female



Only Treatment Only


# % # % # % # %

Any Surgery 0 0 1 25 0 0 0 0

Any RT 0 0 2 50 0 0 0 0

Any CT 0 0 1 25 0 0 0 0

Total 0 0 4 100 0 100 0 100

Table 240: Number (#) and relative proportion (%) of Laryngeal cancer by

Treatment Status at RI (Excluding the Cancers previously treated)

Treatment Status


Received 29 69 4 100 33 71.74

Not Received 11 26.2 0 0 11 23.91

Not Accepted 1 2.4 0 0 1 2.17

Incomplete 1 2.4 0 0 1 2.17

Table 241: Number (#) and relative proportion (%) of Laryngeal cancer by Intention to treat at RI (Excluding the Cancers previously treated)

Intention


Radical 23 77.7 2 50 25 73.53

Palliative 6 20 2 50 8 23.53



Unknown 1 3.3 0 0 1 2.94


203

MULTIPLE CANCERS


204

Table 242: MULTIPLE CANCERS - TWO PRIMARIES (N= 28)

Sl. No.

Hospital No Primaries -1

Age at first

diagnosisPrimaries -2

Age at first

diagnosisFamily History

Date of Registration

1 100016 Breast (Rt) 75 Breast LT) 75 Unknown 11.01.2010 2 100031 Breast (Lt) 47 Ovary 54 Unknown 05.01.2010 3 100123 Breast 60 Endometrium 61 Unknown 21.01.2010 4 100170 Larynx 56 Oesophagus 57 NIL 29.01.2010 5 100268 Rectum 65(2/10) Prostate 65(6/10) Unknown 11.02.2010 6 100295 Larynx 55 Lung 60 Unknown 16.02.2010 7 100447 CML (Blood) 28 Cricopharynx 34 NIL 11.03.2010

8 100465 Larynx 54 FOM 58 Both Parents -CA Larynx 15.03.2010

9 100516 Meduloblastoma 4 Hypopharynx 34 NIL 22.03.2010 10 100611 Lower alveolus 54 Subglottis 58 NIL 22.04.2010 11 100708 Lung 57 Pyrifom fossa 60 NIL 22.04.2010

12 100979 Tongue (post 1/3rd) 69 Tongue

(ant. 2/3 rd) 81 Sisters Ca Stomach 03.06.2010

13 100991 Rectum 42 Endometrium 45 Brothers CA Rectum 04.06.2010

14 101058 Cervix 71 Transverse colon 79 NIL 18.06.2010

15 101080 BOT 66 RMT 76 NIL 18.06.2010 16 101105 BM 50 Oesophagus 55 NIL 22.06.2010 17 101147 Larynx 65 Lung 75 NIL 30.06.2010 18 101199 Endometrium 60 Colon 63 NIL 12.07.2010

19 101301 Primary Unknown 43 Breast 47 NIL 27.07.2010

20 101369 Pyriformfossa 75 BM 80 NIL 10.08.2010 21 101526 Colon 72 Brain 79 UNKNOWN 02.09.2010 22 101598 BM 56 Breast 59 NIL 15.09.2010

23 101650 Endometrium 46 Caecum 60 Daughter CA Stomach 24.09.2010

24 101659 BM 58 Lung 68 Unknown 27.09.2010

25 101660 Breast (LT) 39 Breast (RT) 42 NIL 27.09.2010

26 102116 CML (Blood) 37 Tongue 45 NIL 08.12.2010

27 102143 Tongue 60 Vocal cord 60 Brother-CA 13.12.2010

28 102144 Penis 75 Prostate 76 NIL 13.12.2010

Table 243: MULTIPLE CANCERS - THREE PRIMARIES (N= 3)

Sl.No Hospital No Primary -1 Primary -2 Primary-3

1 101273 Lip Endometrium Kidney

2 101598 Lt. Buccal mucosa Lt. Breast Rt. Buccal Mucosa

3 100031 Breast (Lt) Endometrium Ovary


205

NON MALIGNANT TUMORS


206

Table 244: Distribution of Non Malignant Tumors (N=55)

Sl.No. Category # %

1 Benign 22 47.83 2 Non Neoplastic 10 21.74 3 Borderline/Atypical/Indeterminate or Uncertain 3 6.52 4 Pre-neoplastic –Mild/Mod./Severe or In-situ 8 17.39 5 With one Primary -2nd in situ 3 6.52

Table 245: Details of Benign Tumors (N=22 )

Sl.No Hospital No. Disease/Site

1 100133 Benign Haemangio pericytoma 2 100259 Pilocystic Astrocytoma (Gr. I) 3 100309 Neurofibroma 4 100346 Ovary 5 100380 Retroperitoneal teratoma (Mature) 6 100487 Mucinous Cyst adenoma 7 100556 Paraganglioma Ethmoid sinus 8 100744 Nodular Adenoma 9 100752 Pancreatic Endocrinetumour

10 100858 Fibro adenoma- Breast 11 100974 Haemangioma 12 101039 Benign Phylloides tumour 13 101159 Breast (Fibro adenoma) 14 101267 Nipple Adenoma 15 101304 Neurofibromatosis 16 101354 Sole of foot 17 101366 Neurofibroma 18 101880 Breast 19 101931 Inflammatory Myofibroblastic tumour 20 102073 Phylloides tumour 21 102119 Lipoma 22 102149 Benign skin adnexal tumour


207

Table 246: Details of Non- neoplastic Tumors (N= 10 )

Sl.No Hospital No. Disease 1 100862 Fibromatosis (desmoids) 2 100930 Endometriotic cyst (B/L) ovary 3 100934 Not Malignant –osteomyelitis 4 100981 Perforated diverticulitis 5 101017 Tongue (Non-neoplastic) 6 101337 Cervicitis 7 101612 Vocal cord-TB 8 101838 Cx cervicitis/Endometriosis 9 101998 Mycetoma

10 102263 BPH Prostate

Table 247: Details of Borderline/ Atypical/Indeterminate or Uncertain Tumors (N=3)

SI.No Hospital No. Diagnosis

1 100642 Giant Cell tumour 2 101153 Papillary Serous cystadenoma (Borderline) 3 101594 Lymphoproliferative

Table 248: Details of Pre-neoplastic Tumors- Mild/Mod./Severe (In-situ)

Table 249: Details of cases with one Primary

and second In-situlesion

Sl.No Hospital No. Site1 100138 Pyriformfossa 2 100199 Cervix 3 100967 Conjunctiva

Sl.No Hospital No. Site 1 100252 Supraglottis Ca in-situ 2 100330 Breast -Duct Ca in-situ 3 100905 Larynx-Mild-Mod. Dysplasia4 101389 Vocal Cord Ca in-situ 5 101906 Prostate PIN 6 102168 CX CIN III 7 101101 Forehead CIN 8 102217 Tongue - Leukoplakia


208

ABBREVIATIONS

C/CT - Chemotherapy

EQAS - External Quality Assurance Scheme

DistMets - Distant Metastasis

F - Females

HBCR - Hospital Based Cancer Registry

HL - Hodgkin's lymphoma

HPR - Histo-Pathology Report

ICMR - Indian Council of Medical Research

M - Males

MCC - Malabar cancer Centre

NCRP - National Cancer Registry Programme

NCCP - National Cancer Control Programme

NHL - Non-Hodgkin's lymphoma

R/RT - Radiation

RI - Reporting Institution

S - Surgery

TRC Tobacco Related Cancers

# - Number


209

REFERENCES:

1. Isabel dos Santos Silva (1999). Cancer Epidemiology: Principles and

Methods, IARC Publications, France.

2. Maclennan et al, (1978). Cancer Registration and its Techniques, IARC

Scientific Publications No. 21,France

3. Young, J.L. (1991). Hospital Based Cancer Registry In, Cancer Registration:

Principles and Methods, IARC Publications, France

MALABAR CANCER CENTRE, THALASSERYmcc.kerala.gov.in/dept_CanReg/HBCR_AnnualReport2010.pdf · Malabar...

Documents

Transcript of MALABAR CANCER CENTRE, THALASSERYmcc.kerala.gov.in/dept_CanReg/HBCR_AnnualReport2010.pdf · Malabar...